Interaction	O
between	O
CCAAT/enhancer	B-protein
binding	I-protein
protein	I-protein
and	O
cyclic	B-protein
AMP	I-protein
response	I-protein
element	I-protein
binding	I-protein
protein	I-protein
1	I-protein
regulates	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
transcription	O
in	O
cells	O
of	O
the	O
monocyte/macrophage	B-cell_type
lineage	I-cell_type
.	O

Recent	O
observations	O
have	O
shown	O
two	O
CCAAT/enhancer	B-DNA
binding	I-DNA
protein	I-DNA
(	I-DNA
C/EBP	I-DNA
)	I-DNA
binding	I-DNA
sites	I-DNA
to	O
be	O
critically	O
important	O
for	O
efficient	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
replication	O
within	O
cells	O
of	O
the	O
monocyte/macrophage	B-cell_type
lineage	I-cell_type
,	O
a	O
cell	O
type	O
likely	O
involved	O
in	O
transport	O
of	O
the	O
virus	O
to	O
the	O
brain	O
.	O

Additionally	O
,	O
sequence	O
variation	O
at	O
C/EBP	B-DNA
site	I-DNA
I	I-DNA
,	O
which	O
lies	O
immediately	O
upstream	O
of	O
the	O
distal	B-DNA
nuclear	I-DNA
factor	I-DNA
kappa	I-DNA
B	I-DNA
site	I-DNA
and	O
immediately	O
downstream	O
of	O
a	O
binding	O
site	O
for	O
activating	B-protein
transcription	I-protein
factor	I-protein
(	O
ATF	B-protein
)	O
/	O
cyclic	B-protein
AMP	I-protein
response	I-protein
element	I-protein
binding	I-protein
protein	I-protein
(	O
CREB	B-protein
)	O
,	O
has	O
been	O
shown	O
to	O
affect	O
HIV-1	B-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
(	O
LTR	B-DNA
)	O
activity	O
.	O

Given	O
that	O
C/EBP	B-protein
proteins	I-protein
have	O
been	O
shown	O
to	O
interact	O
with	O
many	O
other	O
transcription	B-protein
factors	I-protein
including	O
members	O
of	O
the	O
ATF/CREB	B-protein
family	I-protein
,	O
we	O
proceeded	O
to	O
determine	O
whether	O
an	O
adjacent	O
ATF/CREB	B-DNA
binding	I-DNA
site	I-DNA
could	O
affect	O
C/EBP	B-protein
protein	I-protein
binding	O
to	O
C/EBP	B-DNA
site	I-DNA
I	I-DNA
.	O

Electrophoretic	O
mobility	O
shift	O
analyses	O
indicated	O
that	O
selected	O
ATF/CREB	B-DNA
site	I-DNA
variants	I-DNA
assisted	O
in	O
the	O
recruitment	O
of	O
C/EBP	B-protein
proteins	I-protein
to	O
an	O
adjacent	O
,	O
naturally	O
occurring	O
,	O
low-affinity	O
C/EBP	B-DNA
site	I-DNA
.	O

This	O
biophysical	O
interaction	O
appears	O
to	O
occur	O
via	O
at	O
least	O
two	O
mechanisms	O
.	O

First	O
,	O
low	O
amounts	O
of	O
CREB-1	B-protein
and	O
C/EBP	B-protein
appear	O
to	O
heterodimerize	O
and	O
bind	O
to	O
a	O
site	O
consisting	O
of	O
a	O
half	O
site	O
from	O
both	O
the	O
ATF/CREB	B-DNA
and	I-DNA
C/EBP	I-DNA
binding	I-DNA
sites	I-DNA
.	O

In	O
addition	O
,	O
CREB-1	B-protein
homodimers	I-protein
bind	O
to	O
the	O
ATF/CREB	B-DNA
site	I-DNA
and	O
recruit	O
C/EBP	B-protein
dimers	I-protein
to	O
their	O
cognate	O
weak	B-DNA
binding	I-DNA
sites	I-DNA
.	O

This	O
interaction	O
is	O
reciprocal	O
,	O
since	O
C/EBP	B-protein
dimer	I-protein
binding	O
to	O
a	O
strong	O
C/EBP	B-DNA
site	I-DNA
leads	O
to	O
enhanced	O
CREB-1	B-protein
recruitment	O
to	O
ATF/CREB	B-DNA
sites	I-DNA
that	O
are	O
weakly	O
bound	O
by	O
CREB	B-protein
.	O

Sequence	O
variation	O
at	O
both	O
C/EBP	B-DNA
and	I-DNA
ATF/CREB	I-DNA
sites	I-DNA
affects	O
the	O
molecular	O
interactions	O
involved	O
in	O
mediating	O
both	O
of	O
these	O
mechanisms	O
.	O

Most	O
importantly	O
,	O
sequence	O
variation	O
at	O
the	O
ATF/CREB	B-DNA
binding	I-DNA
site	I-DNA
affected	O
basal	O
LTR	B-DNA
activity	O
as	O
well	O
as	O
LTR	B-DNA
function	O
following	O
interleukin-6	B-protein
stimulation	O
,	O
a	O
treatment	O
that	O
leads	O
to	O
increases	O
in	O
C/EBP	O
activation	O
.	O

Thus	O
,	O
HIV-1	B-DNA
LTR	I-DNA
ATF/CREB	B-DNA
binding	I-DNA
site	I-DNA
sequence	O
variation	O
may	O
modulate	O
cellular	O
signaling	O
at	O
the	O
viral	B-DNA
promoter	I-DNA
through	O
the	O
C/EBP	O
pathway	O

JOURNAL	NULL
OF	NULL
VIROLOGY	NULL
,	NULL
Feb.	NULL
2001	NULL
p.	NULL
1842-1856	NULL
0022-538	NULL
%	NULL
X/01/	NULL
$	NULL
04.00+0	NULL
-	NULL
DOI	NULL
:	NULL
10.1128/JV1.75.4.1842-1856.2001	NULL
Vol	NULL
.	NULL

75	NULL
,	NULL
No	NULL
.	NULL

4	NULL
Copyright	NULL
©	NULL
2001	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
.	NULL

All	NULL
Rights	NULL
Reserved	NULL
.	NULL

Interaction	NULL
between	NULL
CCAAT/Enhancer	NULL
Binding	NULL
Protein	NULL
and	NULL
Cyclic	NULL
AMP	NULL
Response	NULL
Element	NULL
Binding	NULL
Protein	NULL
1	NULL
Regulates	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
Type	NULL
1	NULL
Transcription	NULL
in	NULL
Cells	NULL
of	NULL
the	NULL
Monocyte/Macrophage	NULL
Lineage	NULL
HEATHER	NULL
L.	NULL
ROSS	NULL
,	NULL
``	NULL
MICHAEL	NULL
R.	NULL
NONNEMACHER	NULL
,	NULL
*	NULL
'	NULL
TRICIA	NULL
H.	NULL
HOGAN	NULL
,	NULL
``	NULL
SHANE	NULL
J.	NULL
QUITERIO	NULL
,	NULL
ANDREW	NULL
HENDERSON	NULL
,	NULL
``	NULL
JOHN	NULL
J.	NULL
McALLISTER	NULL
,	NULL
'	NULL
FRED	NULL
C.	NULL
KREBS	NULL
,	NULL
'	NULL
anp	NULL
BRIAN	NULL
WIGDAHL'*	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
The	NULL
Pennsylvania	NULL
State	NULL
University	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
Hershey	NULL
,	NULL
Pennsylvania	NULL
17033	NULL
,	NULL
``	NULL
and	NULL
Department	NULL
of	NULL
Veterinary	NULL
Science	NULL
,	NULL
The	NULL
Pennsylvania	NULL
State	NULL
University	NULL
,	NULL
University	NULL
Park	NULL
,	NULL
Pennsylvania	NULL
168022	NULL
Received	NULL
16	NULL
June	NULL
2000/Accepted	NULL
15	NULL
November	NULL
2000	NULL
Recent	NULL
observations	NULL
have	NULL
shown	NULL
two	NULL
CCAAT/enhancer	NULL
binding	NULL
protein	NULL
(	NULL
C/EBP	NULL
)	NULL
binding	NULL
sites	NULL
to	NULL
be	NULL
critically	NULL
important	NULL
for	NULL
efficient	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
replication	NULL
within	NULL
cells	NULL
of	NULL
the	NULL
monocyte/	NULL
macrophage	NULL
lineage	NULL
,	NULL
a	NULL
cell	NULL
type	NULL
likely	NULL
involved	NULL
in	NULL
transport	NULL
of	NULL
the	NULL
virus	NULL
to	NULL
the	NULL
brain	NULL
.	NULL

Additionally	NULL
,	NULL
sequence	NULL
variation	NULL
at	NULL
C/EBP	NULL
site	NULL
I	NULL
,	NULL
which	NULL
lies	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
distal	NULL
nuclear	NULL
factor	NULL
kappa	NULL
B	NULL
site	NULL
and	NULL
immediately	NULL
downstream	NULL
of	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
activating	NULL
transcription	NULL
factor	NULL
(	NULL
ATF	NULL
)	NULL
/cyclic	NULL
AMP	NULL
response	NULL
element	NULL
binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
affect	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
activity	NULL
.	NULL

Given	NULL
that	NULL
C/EBP	NULL
proteins	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
many	NULL
other	NULL
transcription	NULL
factors	NULL
including	NULL
members	NULL
of	NULL
the	NULL
ATF/	NULL
CREB	NULL
family	NULL
,	NULL
we	NULL
proceeded	NULL
to	NULL
determine	NULL
whether	NULL
an	NULL
adjacent	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
could	NULL
affect	NULL
C/EBP	NULL
protein	NULL
binding	NULL
to	NULL
C/EBP	NULL
site	NULL
I.	NULL
Electrophoretic	NULL
mobility	NULL
shift	NULL
analyses	NULL
indicated	NULL
that	NULL
selected	NULL
ATF/CREB	NULL
site	NULL
variants	NULL
assisted	NULL
in	NULL
the	NULL
recruitment	NULL
of	NULL
C/EBP	NULL
proteins	NULL
to	NULL
an	NULL
adjacent	NULL
,	NULL
naturally	NULL
occurring	NULL
,	NULL
low-affinity	NULL
C/EBP	NULL
site	NULL
.	NULL

This	NULL
biophysical	NULL
interaction	NULL
appears	NULL
to	NULL
occur	NULL
via	NULL
at	NULL
least	NULL
two	NULL
mechanisms	NULL
.	NULL

First	NULL
,	NULL
low	NULL
amounts	NULL
of	NULL
CREB-1	NULL
and	NULL
C/EBP	NULL
appear	NULL
to	NULL
heterodimerize	NULL
and	NULL
bind	NULL
to	NULL
a	NULL
site	NULL
consisting	NULL
of	NULL
a	NULL
half	NULL
site	NULL
from	NULL
both	NULL
the	NULL
ATF/CREB	NULL
and	NULL
C/EBP	NULL
binding	NULL
sites	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
CREB-1	NULL
homodimers	NULL
bind	NULL
to	NULL
the	NULL
ATF/CREB	NULL
site	NULL
and	NULL
recruit	NULL
C/EBP	NULL
dimers	NULL
to	NULL
their	NULL
cognate	NULL
weak	NULL
binding	NULL
sites	NULL
.	NULL

This	NULL
interaction	NULL
is	NULL
reciprocal	NULL
,	NULL
since	NULL
C/EBP	NULL
dimer	NULL
binding	NULL
to	NULL
a	NULL
strong	NULL
C/EBP	NULL
site	NULL
leads	NULL
to	NULL
enhanced	NULL
CREB-1	NULL
recruitment	NULL
to	NULL
ATF/CREB	NULL
sites	NULL
that	NULL
are	NULL
weakly	NULL
bound	NULL
by	NULL
CREB	NULL
.	NULL

Sequence	NULL
variation	NULL
at	NULL
both	NULL
C/EBP	NULL
and	NULL
ATF/CREB	NULL
sites	NULL
affects	NULL
the	NULL
molecular	NULL
interactions	NULL
involved	NULL
in	NULL
mediating	NULL
both	NULL
of	NULL
these	NULL
mechanisms	NULL
.	NULL

Most	NULL
importantly	NULL
,	NULL
sequence	NULL
variation	NULL
at	NULL
the	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
affected	NULL
basal	NULL
LTR	NULL
activity	NULL
as	NULL
well	NULL
as	NULL
LTR	NULL
function	NULL
following	NULL
interleukin-6	NULL
stimulation	NULL
,	NULL
a	NULL
treatment	NULL
that	NULL
leads	NULL
to	NULL
increases	NULL
in	NULL
C/EBP	NULL
activation	NULL
.	NULL

Thus	NULL
,	NULL
HIV-1	NULL
LTR	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
sequence	NULL
variation	NULL
may	NULL
modulate	NULL
cellular	NULL
signaling	NULL
at	NULL
the	NULL
viral	NULL
promoter	NULL
through	NULL
the	NULL
C/EBP	NULL
pathway	NULL
.	NULL

Previous	NULL
studies	NULL
reported	NULL
that	NULL
CCAAT/enhancer	NULL
binding	NULL
protein	NULL
B	NULL
(	NULL
C/EBP	NULL
B	NULL
)	NULL
can	NULL
transactivate	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
in	NULL
transient	NULL
transfection	NULL
analyses	NULL
and	NULL
that	NULL
the	NULL
LTR	NULL
contains	NULL
three	NULL
binding	NULL
sites	NULL
for	NULL
this	NULL
protein	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Since	NULL
then	NULL
,	NULL
evidence	NULL
regarding	NULL
the	NULL
importance	NULL
of	NULL
C/EBP	NULL
family	NULL
members	NULL
in	NULL
HIV-1	NULL
replication	NULL
has	NULL
steadily	NULL
increased	NULL
.	NULL

Recent	NULL
studies	NULL
demonstrated	NULL
that	NULL
C/EBP	NULL
proteins	NULL
transactivate	NULL
the	NULL
HIV-1	NULL
LTR	NULL
in	NULL
the	NULL
U-937	NULL
promonocytic	NULL
cell	NULL
line	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
site-directed	NULL
mutagenesis	NULL
indicated	NULL
that	NULL
LTR-directed	NULL
transcription	NULL
in	NULL
these	NULL
cells	NULL
required	NULL
one	NULL
of	NULL
two	NULL
functional	NULL
C/EBP	NULL
sites	NULL
.	NULL

Additional	NULL
studies	NULL
indicated	NULL
that	NULL
these	NULL
two	NULL
C/EBP	NULL
binding	NULL
sites	NULL
were	NULL
required	NULL
for	NULL
replication	NULL
of	NULL
an	NULL
infectious	NULL
HIV-1	NULL
molecular	NULL
clone	NULL
in	NULL
the	NULL
U-937	NULL
cell	NULL
line	NULL
as	NULL
well	NULL
as	NULL
in	NULL
primary	NULL
cells	NULL
of	NULL
the	NULL
monocyte/macrophage	NULL
lineage	NULL
.	NULL

However	NULL
,	NULL
these	NULL
sites	NULL
were	NULL
dispensable	NULL
for	NULL
replication	NULL
of	NULL
the	NULL
infectious	NULL
molecular	NULL
clone	NULL
in	NULL
various	NULL
T-cell	NULL
lines	NULL
and	NULL
primary	NULL
T-cell	NULL
populations	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

The	NULL
C/EBP	NULL
family	NULL
of	NULL
proteins	NULL
includes	NULL
at	NULL
least	NULL
eight	NULL
differ	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
(	NULL
H107	NULL
)	NULL
,	NULL
Penn	NULL
State	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
500	NULL
University	NULL
Dr.	NULL
,	NULL
P.O	NULL
.	NULL

Box	NULL
850	NULL
,	NULL
Hershey	NULL
,	NULL
PA	NULL
17033	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
717	NULL
)	NULL
531-8258	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
717	NULL
)	NULL
531-5580	NULL
.	NULL

E-mail	NULL
:	NULL
bwigdahl	NULL
@	NULL
psu.edu	NULL
.	NULL

1842	NULL
ent	NULL
proteins	NULL
,	NULL
many	NULL
of	NULL
which	NULL
are	NULL
important	NULL
activators	NULL
of	NULL
transcription	NULL
.	NULL

C/EBP	NULL
proteins	NULL
are	NULL
all	NULL
members	NULL
of	NULL
the	NULL
b-	NULL
ZIP	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
and	NULL
share	NULL
a	NULL
highly	NULL
homologous	NULL
carboxy	NULL
terminus	NULL
that	NULL
contains	NULL
the	NULL
basic	NULL
and	NULL
leucine	NULL
zipper	NULL
protein	NULL
domains	NULL
.	NULL

The	NULL
different	NULL
C/EBP	NULL
family	NULL
members	NULL
homo-	NULL
and	NULL
heterodimerize	NULL
through	NULL
their	NULL
leucine	NULL
zipper	NULL
regions	NULL
and	NULL
bind	NULL
to	NULL
their	NULL
cognate	NULL
DNA	NULL
sequences	NULL
through	NULL
the	NULL
corresponding	NULL
basic	NULL
regions	NULL
.	NULL

C/EBP	NULL
family	NULL
members	NULL
include	NULL
both	NULL
transcriptional	NULL
activators	NULL
and	NULL
repressors	NULL
.	NULL

Transcriptional	NULL
activators	NULL
include	NULL
C/EBP	NULL
a	NULL
(	NULL
4	NULL
)	NULL
,	NULL
C/EBP	NULL
B	NULL
(	NULL
nuclear	NULL
factor	NULL
interleukin-6	NULL
)	NULL
,	NULL
(	NULL
IL-6	NULL
)	NULL
(	NULL
2	NULL
,	NULL
9	NULL
,	NULL
12	NULL
,	NULL
40	NULL
)	NULL
,	NULL
C/EBP	NULL
8	NULL
(	NULL
42	NULL
)	NULL
,	NULL
C/EBP	NULL
&	NULL
(	NULL
44	NULL
)	NULL
,	NULL
and	NULL
C/EBP-related	NULL
protein	NULL
1	NULL
(	NULL
CRP-1	NULL
)	NULL
(	NULL
42	NULL
)	NULL
.	NULL

While	NULL
C/EBP	NULL
proteins	NULL
are	NULL
expressed	NULL
in	NULL
many	NULL
human	NULL
tissues	NULL
,	NULL
high	NULL
levels	NULL
of	NULL
C/EBP	NULL
mRNA	NULL
and	NULL
protein	NULL
expression	NULL
are	NULL
limited	NULL
to	NULL
only	NULL
a	NULL
few	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
cells	NULL
of	NULL
the	NULL
myeloid	NULL
lineage	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
C/EBP	NULL
proteins	NULL
are	NULL
intimately	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
myelocytic/monocytic	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
promoter	NULL
elements	NULL
of	NULL
many	NULL
monocyte-specific	NULL
genes	NULL
contain	NULL
C/EBP	NULL
binding	NULL
sites	NULL
,	NULL
including	NULL
macrophage	NULL
inflammatory	NULL
protein	NULL
1	NULL
alpha	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
32	NULL
)	NULL
,	NULL
IL-6	NULL
(	NULL
6	NULL
,	NULL
27	NULL
,	NULL
38	NULL
)	NULL
,	NULL
and	NULL
IL-8	NULL
(	NULL
27	NULL
,	NULL
36	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
selected	NULL
signaling	NULL
molecules	NULL
that	NULL
target	NULL
cells	NULL
of	NULL
the	NULL
monocyte/macrophage	NULL
lineage	NULL
,	NULL
including	NULL
Vor	NULL
.	NULL

75	NULL
,	NULL
2001	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
(	NULL
21	NULL
,	NULL
30	NULL
)	NULL
and	NULL
IL-6	NULL
(	NULL
2	NULL
)	NULL
,	NULL
increase	NULL
levels	NULL
of	NULL
C/EBP	NULL
-mediated	NULL
transactivation	NULL
.	NULL

Members	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
of	NULL
proteins	NULL
interact	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
to	NULL
synergistically	NULL
activate	NULL
transcription	NULL
of	NULL
a	NULL
number	NULL
of	NULL
eukaryotic	NULL
promoters	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Specifically	NULL
,	NULL
other	NULL
protein	NULL
families	NULL
that	NULL
commonly	NULL
interact	NULL
with	NULL
C/EBP	NULL
proteins	NULL
include	NULL
Sp	NULL
,	NULL
nuclear	NULL
factor	NULL
kappa	NULL
B	NULL
(	NULL
NF-kB	NULL
)	NULL
,	NULL
and	NULL
activating	NULL
transcription	NULL
factor/cyclic	NULL
AMP	NULL
response	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
binding	NULL
protein	NULL
(	NULL
ATF/CREB	NULL
)	NULL
(	NULL
16	NULL
,	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

For	NULL
example	NULL
C/EBP	NULL
«	NULL
has	NULL
been	NULL
implicated	NULL
as	NULL
an	NULL
important	NULL
factor	NULL
involved	NULL
in	NULL
the	NULL
liver-specific	NULL
,	NULL
cyclic	NULL
AMP	NULL
responsiveness	NULL
of	NULL
the	NULL
phosphoenolpyruvate	NULL
carboxykinase	NULL
(	NULL
PEPCK	NULL
)	NULL
promoter	NULL
(	NULL
33	NULL
)	NULL
.	NULL

In	NULL
this	NULL
instance	NULL
,	NULL
binding	NULL
of	NULL
CREB	NULL
and	NULL
C/EBP	NULL
to	NULL
their	NULL
cognate	NULL
sequences	NULL
,	NULL
along	NULL
with	NULL
activator	NULL
protein	NULL
1	NULL
,	NULL
appears	NULL
to	NULL
synergistically	NULL
activate	NULL
phosphoenolpyruvate	NULL
carboxykinase	NULL
transcription	NULL
.	NULL

However	NULL
,	NULL
ATF/CREB	NULL
and	NULL
C/EBP	NULL
proteins	NULL
do	NULL
not	NULL
merely	NULL
influence	NULL
the	NULL
activity	NULL
of	NULL
one	NULL
another	NULL
from	NULL
their	NULL
binding	NULL
sites	NULL
.	NULL

Heterodimerization	NULL
with	NULL
ATF/CREB	NULL
family	NULL
members	NULL
may	NULL
also	NULL
affect	NULL
C/EBP	NULL
binding	NULL
site	NULL
sequence	NULL
specificity	NULL
.	NULL

ATF-2	NULL
and	NULL
C/EBP	NULL
a	NULL
can	NULL
dimerize	NULL
at	NULL
asymmetric	NULL
binding	NULL
sites	NULL
composed	NULL
of	NULL
one	NULL
half	NULL
of	NULL
each	NULL
full-length	NULL
binding	NULL
site	NULL
(	NULL
35	NULL
)	NULL
.	NULL

This	NULL
type	NULL
of	NULL
interaction	NULL
increases	NULL
activation	NULL
from	NULL
asymmetric	NULL
binding	NULL
sites	NULL
while	NULL
it	NULL
decreases	NULL
transactivation	NULL
from	NULL
consensus	NULL
C/EBP	NULL
binding	NULL
sites	NULL
.	NULL

Studies	NULL
have	NULL
also	NULL
reported	NULL
the	NULL
interaction	NULL
of	NULL
C/EBP	NULL
B	NULL
and	NULL
C/EBP	NULL
-related	NULL
ATF	NULL
(	NULL
C/ATF	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
ATF/CREB	NULL
family	NULL
)	NULL
(	NULL
41	NULL
)	NULL
.	NULL

These	NULL
heterodimers	NULL
bind	NULL
to	NULL
a	NULL
subclass	NULL
of	NULL
asymmetric	NULL
CRE	NULL
sites	NULL
,	NULL
rather	NULL
than	NULL
C/EBP	NULL
sites	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
cross	NULL
talk	NULL
between	NULL
these	NULL
two	NULL
protein	NULL
families	NULL
may	NULL
allow	NULL
for	NULL
the	NULL
integration	NULL
of	NULL
different	NULL
hormonal	NULL
and	NULL
developmental	NULL
stimuli	NULL
involved	NULL
in	NULL
regulating	NULL
gene	NULL
expression	NULL
,	NULL
through	NULL
transactivation	NULL
from	NULL
a	NULL
variety	NULL
of	NULL
unconventional	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
studies	NULL
reported	NULL
herein	NULL
indicate	NULL
that	NULL
the	NULL
adjoining	NULL
ATF/	NULL
CREB	NULL
and	NULL
C/EBP	NULL
sites	NULL
found	NULL
in	NULL
the	NULL
HIV-1	NULL
LTR	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
interact	NULL
to	NULL
affect	NULL
viral	NULL
gene	NULL
expression	NULL
.	NULL

ATF/CREB	NULL
site	NULL
variants	NULL
that	NULL
preferentially	NULL
recruit	NULL
CREB-1	NULL
compared	NULL
to	NULL
other	NULL
family	NULL
members	NULL
appear	NULL
to	NULL
enhance	NULL
the	NULL
binding	NULL
of	NULL
C/EBP	NULL
proteins	NULL
to	NULL
an	NULL
immediately	NULL
adjacent	NULL
C/EBP	NULL
binding	NULL
site	NULL
I	NULL
that	NULL
exhibits	NULL
very	NULL
low	NULL
affinity	NULL
for	NULL
C/EBP	NULL
proteins	NULL
.	NULL

The	NULL
enhancement	NULL
of	NULL
C/EBP	NULL
binding	NULL
appears	NULL
to	NULL
occur	NULL
by	NULL
two	NULL
mechanisms	NULL
.	NULL

First	NULL
,	NULL
sequence-dependent	NULL
heterodimerization	NULL
between	NULL
C/EBP	NULL
and	NULL
CREB	NULL
proteins	NULL
appears	NULL
to	NULL
occur	NULL
to	NULL
a	NULL
small	NULL
degree	NULL
at	NULL
a	NULL
binding	NULL
site	NULL
consisting	NULL
of	NULL
one	NULL
half	NULL
of	NULL
each	NULL
of	NULL
the	NULL
ATF/CREB	NULL
and	NULL
C/EBP	NULL
binding	NULL
sites	NULL
.	NULL

Recruitment	NULL
of	NULL
heterodimers	NULL
to	NULL
this	NULL
site	NULL
is	NULL
affected	NULL
by	NULL
ATF/CREB	NULL
sequence	NULL
variation	NULL
.	NULL

Additionally	NULL
,	NULL
CREB	NULL
dimers	NULL
appear	NULL
to	NULL
bind	NULL
their	NULL
cognate	NULL
sequence	NULL
and	NULL
recruit	NULL
C/EBP	NULL
dimers	NULL
to	NULL
an	NULL
immediately	NULL
adjacent	NULL
C/EBP	NULL
site	NULL
I	NULL
that	NULL
exhibits	NULL
weak	NULL
recruitment	NULL
characteristics	NULL
.	NULL

In	NULL
turn	NULL
,	NULL
enhanced	NULL
C/EBP	NULL
binding	NULL
to	NULL
a	NULL
weak	NULL
C/EBP	NULL
site	NULL
I	NULL
was	NULL
shown	NULL
to	NULL
stabilize	NULL
CREB	NULL
binding	NULL
at	NULL
the	NULL
ATF/CREB	NULL
site	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
binding	NULL
of	NULL
C/EBP	NULL
proteins	NULL
to	NULL
a	NULL
C/EBP	NULL
site	NULL
I	NULL
that	NULL
recruits	NULL
significant	NULL
amounts	NULL
of	NULL
C/EBP	NULL
protein	NULL
can	NULL
lead	NULL
to	NULL
increased	NULL
binding	NULL
of	NULL
CREB-1	NULL
to	NULL
an	NULL
adjacent	NULL
weakly	NULL
reactive	NULL
ATF/CREB	NULL
site	NULL
.	NULL

Finally	NULL
,	NULL
sequence	NULL
variation	NULL
at	NULL
the	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
significantly	NULL
affects	NULL
both	NULL
basal	NULL
and	NULL
IL-6-induced	NULL
LTR	NULL
activity	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
and	NULL
nuclear	NULL
extract	NULL
preparation	NULL
.	NULL

The	NULL
U-937	NULL
(	NULL
ATCC	NULL
CRL-1593.2	NULL
)	NULL
and	NULL
THP-1	NULL
(	NULL
ATCC	NULL
TIB-202	NULL
)	NULL
human	NULL
monocytic	NULL
cell	NULL
lines	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
an	NULL
C/EBP-CREB-1	NULL
INTERACTION	NULL
REGULATES	NULL
HIV-1	NULL
TRANSCRIPTION	NULL
-	NULL
1843	NULL
A	NULL
&	NULL
$	NULL
us	NULL
CXxp	NULL
8	NULL
&	NULL
a	NULL
<	NULL
g\	NULL
@	NULL
&	NULL
0	NULL
0	NULL
r	NULL
°	NULL
b	NULL
«	NULL
dQ	NULL
’	NULL
é	NULL
‘	NULL
3	NULL
‘	NULL
zQ	NULL
qo	NULL
F	NULL
(	NULL
__	NULL
(	NULL
500	NULL
400	NULL
~300	NULL
~200	NULL
~100	NULL
+1	NULL
+100	NULL
+200	NULL
B	NULL
C/EBP	NULL
site	NULL
|	NULL
probe	NULL
:	NULL
Antisera	NULL
:	NULL
<	NULL
4	NULL
<	NULL
4	NULL
C/EBP	NULL
complex	NULL
[	NULL
_	NULL
Extract	NULL
:	NULL
tL-6-induced	NULL
U-937	NULL
Lanes	NULL
:	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
°	NULL
6	NULL
7	NULL
8	NULL
C/EBP	NULL
site	NULL
I	NULL
Clade	NULL
B	NULL
consensus	NULL
:	NULL
AGC	NULL
TTT	NULL
CTA	NULL
CAA	NULL
6G	NULL
:	NULL
acc	NULL
TTG	NULL
CTA	NULL
CAA	NULL
3T	NULL
:	NULL
AGT	NULL
TTT	NULL
CTA	NULL
CAA	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

A	NULL
C/EBP	NULL
binding	NULL
site	NULL
I	NULL
variant	NULL
exhibits	NULL
very	NULL
low	NULL
reactivity	NULL
for	NULL
members	NULL
of	NULL
the	NULL
C/EBP	NULL
transcription	NULL
factor	NULL
family	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
U3	NULL
region	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
contains	NULL
many	NULL
cis-acting	NULL
promoter	NULL
elements	NULL
that	NULL
control	NULL
viral	NULL
transcription	NULL
.	NULL

Included	NULL
among	NULL
the	NULL
many	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
which	NULL
regulate	NULL
viral	NULL
replication	NULL
are	NULL
adjacent	NULL
ATF/	NULL
CREB	NULL
and	NULL
C/EBP	NULL
binding	NULL
sites	NULL
that	NULL
lie	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
tandem	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Double-stranded	NULL
radiolabeled	NULL
oligonucleotide	NULL
probes	NULL
spanning	NULL
either	NULL
the	NULL
6G	NULL
or	NULL
3T	NULL
C/EBP	NULL
binding	NULL
site	NULL
I	NULL
sequence	NULL
variants	NULL
were	NULL
reacted	NULL
with	NULL
IL-6-stimulated	NULL
U-937	NULL
nuclear	NULL
extract	NULL
.	NULL

These	NULL
reactions	NULL
were	NULL
conducted	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
antibody	NULL
directed	NULL
against	NULL
C/EBP	NULL
a	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
or	NULL
C/EBP	NULL
f	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Control	NULL
rabbit	NULL
immunoglobulin	NULL
(	NULL
CS	NULL
)	NULL
was	NULL
added	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
to	NULL
illustrate	NULL
the	NULL
specific	NULL
nature	NULL
of	NULL
supershifted	NULL
complexes	NULL
.	NULL

Arrows	NULL
to	NULL
the	NULL
right	NULL
indicate	NULL
supershifted	NULL
C/EBP	NULL
complexes	NULL
,	NULL
and	NULL
the	NULL
bracket	NULL
to	NULL
the	NULL
left	NULL
identifies	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

The	NULL
EMS	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
probe	NULL
excess	NULL
,	NULL
and	NULL
the	NULL
unreacted	NULL
free	NULL
probe	NULL
is	NULL
visible	NULL
at	NULL
the	NULL
bottom	NULL
.	NULL

The	NULL
free	NULL
probe	NULL
accounted	NULL
for	NULL
approximately	NULL
75	NULL
to	NULL
90	NULL
%	NULL
of	NULL
the	NULL
total	NULL
probe	NULL
in	NULL
each	NULL
reaction	NULL
at	NULL
completion	NULL
.	NULL

tibiotics	NULL
(	NULL
penicillin	NULL
,	NULL
streptomycin	NULL
,	NULL
and	NULL
kanamycin	NULL
,	NULL
each	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
0.04	NULL
mg/ml	NULL
)	NULL
,	NULL
r-glutamine	NULL
(	NULL
0.3	NULL
mg/ml	NULL
)	NULL
,	NULL
and	NULL
sodium	NULL
bicarbonate	NULL
(	NULL
0.05	NULL
%	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
maintained	NULL
at	NULL
37°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
at	NULL
90	NULL
%	NULL
relative	NULL
humidity	NULL
.	NULL

U-937	NULL
cells	NULL
treated	NULL
with	NULL
recombinant	NULL
human	NULL
IL-6	NULL
(	NULL
Genzyme	NULL
)	NULL
were	NULL
prepared	NULL
by	NULL
adding	NULL
IL-6	NULL
(	NULL
875	NULL
U/ml	NULL
)	NULL
to	NULL
10°	NULL
cells	NULL
24	NULL
h	NULL
prior	NULL
to	NULL
the	NULL
preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Oligonucleotide	NULL
synthesis	NULL
and	NULL
radiolabeling	NULL
.	NULL

Complementary	NULL
single-stranded	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
published	NULL
C/EBP	NULL
sequences	NULL
were	NULL
synthesized	NULL
(	NULL
Macromolecular	NULL
Core	NULL
Facility	NULL
,	NULL
Penn	NULL
State	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
Hershey	NULL
)	NULL
and	NULL
annealed	NULL
by	NULL
brief	NULL
heating	NULL
at	NULL
100°C	NULL
followed	NULL
by	NULL
slow	NULL
cooling	NULL
to	NULL
room	NULL
tempera-ture	NULL
.	NULL

Blunt-ended	NULL
,	NULL
double-stranded	NULL
oligonucleotides	NULL
were	NULL
end	NULL
labeled	NULL
using	NULL
y-	NULL
``	NULL
°P-labeled	NULL
ATP	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
as	NULL
described	NULL
by	NULL
the	NULL
supplier	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
specific	NULL
activities	NULL
of	NULL
the	NULL
probes	NULL
used	NULL
in	NULL
our	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
(	NULL
EMS	NULL
)	NULL
analyses	NULL
did	NULL
not	NULL
generally	NULL
deviate	NULL
by	NULL
a	NULL
large	NULL
margin	NULL
.	NULL

The	NULL
average	NULL
deviation	NULL
in	NULL
specific	NULL
activity	NULL
between	NULL
probes	NULL
across	NULL
experiments	NULL
was	NULL
approximately	NULL
20	NULL
%	NULL
,	NULL
which	NULL
would	NULL
not	NULL
solely	NULL
account	NULL
for	NULL
any	NULL
of	NULL
the	NULL
differences	NULL
in	NULL
binding	NULL
patterns	NULL
observed	NULL
in	NULL
the	NULL
results	NULL
presented	NULL
in	NULL
this	NULL
report	NULL
.	NULL

1844	NULL
ROSS	NULL
ET	NULL
AL	NULL
.	NULL

EMS	NULL
analyses	NULL
.	NULL

EMS	NULL
analysis	NULL
binding	NULL
reactions	NULL
were	NULL
performed	NULL
using	NULL
75,000	NULL
cpm	NULL
of	NULL
radiolabeled	NULL
,	NULL
double-stranded	NULL
oligonucleotide	NULL
,	NULL
15	NULL
to	NULL
20	NULL
pg	NULL
of	NULL
nuclear	NULL
protein	NULL
extract	NULL
,	NULL
and	NULL
1	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
in	NULL
a	NULL
total	NULL
reaction	NULL
volume	NULL
of	NULL
15	NULL
pl	NULL
.	NULL

Experiments	NULL
using	NULL
nuclear	NULL
extract	NULL
from	NULL
baculovirus-infected	NULL
SF9	NULL
insect	NULL
cells	NULL
that	NULL
overexpressed	NULL
CREB-1	NULL
included	NULL
4	NULL
mg	NULL
of	NULL
insect	NULL
extract	NULL
,	NULL
generously	NULL
supplied	NULL
by	NULL
Patrick	NULL
Quinn	NULL
(	NULL
Penn	NULL
State	NULL
College	NULL
of	NULL
Medicine	NULL
)	NULL
.	NULL

DNA-protein	NULL
complexes	NULL
were	NULL
allowed	NULL
to	NULL
form	NULL
at	NULL
30°C	NULL
for	NULL
30	NULL
min	NULL
and	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
(	NULL
30	NULL
mA	NULL
and	NULL
200	NULL
V	NULL
)	NULL
in	NULL
either	NULL
a	NULL
4	NULL
or	NULL
5	NULL
%	NULL
high-ionic-strength	NULL
native	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

For	NULL
supershift	NULL
EMS	NULL
reactions	NULL
,	NULL
1	NULL
pl	NULL
of	NULL
antibody	NULL
(	NULL
2	NULL
ug/pl	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reactions	NULL
after	NULL
a	NULL
20-min	NULL
incubation	NULL
at	NULL
30°C	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
allowed	NULL
to	NULL
proceed	NULL
for	NULL
an	NULL
additional	NULL
20	NULL
min	NULL
at	NULL
30°C	NULL
before	NULL
loading	NULL
of	NULL
the	NULL
gel	NULL
.	NULL

A	NULL
monoclonal	NULL
antibody	NULL
recognizing	NULL
CREB-1	NULL
(	NULL
also	NULL
provided	NULL
by	NULL
Patrick	NULL
Quinn	NULL
)	NULL
was	NULL
used	NULL
as	NULL
indicated	NULL
.	NULL

All	NULL
other	NULL
antibodies	NULL
used	NULL
were	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc	NULL
.	NULL

Protein	NULL
purification	NULL
.	NULL

A	NULL
polyhistidine-tagged	NULL
C/EBP	NULL
B	NULL
construct	NULL
(	NULL
C/EBP	NULL
B-BD-pRSET	NULL
A	NULL
)	NULL
obtained	NULL
from	NULL
Edward	NULL
Maytin	NULL
(	NULL
Lerner	NULL
Research	NULL
Institute	NULL
,	NULL
Cleveland	NULL
,	NULL
Ohio	NULL
)	NULL
was	NULL
used	NULL
to	NULL
obtain	NULL
enriched	NULL
protein	NULL
extracts	NULL
.	NULL

The	NULL
plasmid	NULL
was	NULL
transformed	NULL
into	NULL
Escherichia	NULL
coli	NULL
strain	NULL
BL21	NULL
(	NULL
DE3	NULL
)	NULL
pLysS	NULL
;	NULL
transformants	NULL
were	NULL
selected	NULL
using	NULL
ampicillin	NULL
(	NULL
50	NULL
pg/ml	NULL
)	NULL
and	NULL
chloramphenicol	NULL
(	NULL
35	NULL
pg/ml	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
six	NULL
histidine-tagged	NULL
protein	NULL
was	NULL
induced	NULL
for	NULL
5	NULL
h	NULL
with	NULL
1	NULL
mM	NULL
isopropyl	NULL
B-p-thiogalactoside	NULL
(	NULL
IPTG	NULL
)	NULL
in	NULL
1	NULL
%	NULL
YT	NULL
medium	NULL
.	NULL

C/EBP	NULL
B	NULL
was	NULL
then	NULL
purified	NULL
on	NULL
nickel-chelating	NULL
columns	NULL
using	NULL
imidazole	NULL
elution	NULL
(	NULL
pRSET	NULL
Xpress	NULL
;	NULL
Invitrogen	NULL
)	NULL
.	NULL

Protein	NULL
purity	NULL
was	NULL
assessed	NULL
by	NULL
Western	NULL
immunoblot	NULL
analysis	NULL
and	NULL
silver	NULL
staining	NULL
(	NULL
7	NULL
,	NULL
8	NULL
,	NULL
15	NULL
,	NULL
34	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
analyses	NULL
.	NULL

The	NULL
probe	NULL
used	NULL
in	NULL
the	NULL
DNase	NULL
I	NULL
footprinting	NULL
analyses	NULL
spanned	NULL
nucleotides	NULL
+11	NULL
to	NULL
-193	NULL
(	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
site	NULL
of	NULL
transcription	NULL
initiation	NULL
)	NULL
of	NULL
the	NULL
HIV-1	NULL
(	NULL
strain	NULL
LAT	NULL
)	NULL
LTR	NULL
.	NULL

The	NULL
probe	NULL
was	NULL
generated	NULL
by	NULL
radiolabeling	NULL
the	NULL
upstream	NULL
primer	NULL
(	NULL
5-GGT	NULL
TTG	NULL
ACA	NULL
GCC	NULL
GCC	NULL
TAG	NULL
CAT	NULL
TTC	NULL
ATC-3	NULL
'	NULL
)	NULL
in	NULL
a	NULL
kinase	NULL
reaction	NULL
using	NULL
y-*°P	NULL
.	NULL

The	NULL
labeled	NULL
primer	NULL
and	NULL
the	NULL
downstream	NULL
primer	NULL
(	NULL
5'-CCA	NULL
GAG	NULL
AGA	NULL
CCC	NULL
AGT	NULL
ACA	NULL
GGC	NULL
AAA	NULL
AAG	NULL
CAG-3	NULL
'	NULL
)	NULL
were	NULL
then	NULL
included	NULL
in	NULL
a	NULL
PCR	NULL
with	NULL
a	NULL
plasmid	NULL
that	NULL
contained	NULL
the	NULL
LAI	NULL
LTR	NULL
.	NULL

The	NULL
resulting	NULL
204-bp	NULL
radiolabeled	NULL
DNA	NULL
product	NULL
was	NULL
isolated	NULL
using	NULL
a	NULL
Qiaquick	NULL
PCR	NULL
purification	NULL
kit	NULL
(	NULL
Qiagen	NULL
)	NULL
.	NULL

The	NULL
DNase	NULL
I	NULL
footprinting	NULL
reactions	NULL
were	NULL
performed	NULL
using	NULL
2,000	NULL
cpm	NULL
of	NULL
radiolabeled	NULL
,	NULL
double-stranded	NULL
oligonucleotide	NULL
,	NULL
six-histidine-tagged	NULL
C/EBP	NULL
B	NULL
(	NULL
estimated	NULL
to	NULL
be	NULL
300	NULL
ng	NULL
per	NULL
reaction	NULL
)	NULL
,	NULL
0.5	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
15	NULL
pg	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
in	NULL
a	NULL
50-4l	NULL
volume	NULL
.	NULL

The	NULL
reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
for	NULL
3	NULL
min	NULL
with	NULL
5	NULL
pl	NULL
of	NULL
CaCl	NULL
,	NULL
(	NULL
2	NULL
mM	NULL
)	NULL
and	NULL
MgCl	NULL
;	NULL
(	NULL
2	NULL
mM	NULL
)	NULL
and	NULL
an	NULL
amount	NULL
of	NULL
a	NULL
1:10	NULL
dilution	NULL
of	NULL
DNase	NULL
(	NULL
Promega	NULL
)	NULL
predetermined	NULL
experimentally	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
terminated	NULL
with	NULL
a	NULL
1	NULL
wl	NULL
volume	NULL
of	NULL
a	NULL
DNase	NULL
I	NULL
stop	NULL
solution	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
removed	NULL
by	NULL
phenol-chloroform	NULL
extraction	NULL
,	NULL
and	NULL
the	NULL
DNA	NULL
was	NULL
reprecipitated	NULL
from	NULL
the	NULL
reactions	NULL
,	NULL
resuspended	NULL
in	NULL
formamide	NULL
loading	NULL
buffer	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
on	NULL
an	NULL
8	NULL
%	NULL
polyacrylamide	NULL
sequencing	NULL
gel	NULL
.	NULL

The	NULL
probes	NULL
were	NULL
also	NULL
sequenced	NULL
by	NULL
the	NULL
Maxam-Gilbert	NULL
chemical	NULL
sequencing	NULL
procedure	NULL
(	NULL
28	NULL
)	NULL
,	NULL
and	NULL
the	NULL
sequencing	NULL
reactions	NULL
were	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
in	NULL
parallel	NULL
with	NULL
the	NULL
DNase	NULL
I	NULL
footprinting	NULL
reactions	NULL
to	NULL
verify	NULL
the	NULL
positions	NULL
of	NULL
protein	NULL
binding	NULL
.	NULL

Plasmids	NULL
and	NULL
site-directed	NULL
mutagenesis	NULL
.	NULL

A	NULL
Psfl/Xbel	NULL
LTR-containing	NULL
DNA	NULL
fragment	NULL
(	NULL
~600	NULL
bp	NULL
)	NULL
derived	NULL
from	NULL
the	NULL
LAI	NULL
strain	NULL
of	NULL
HIV-1	NULL
was	NULL
ligated	NULL
into	NULL
a	NULL
modified	NULL
pGL3-Basic	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
to	NULL
construct	NULL
the	NULL
LAI-Lue	NULL
construct	NULL
.	NULL

LAI-Lue	NULL
was	NULL
used	NULL
as	NULL
a	NULL
template	NULL
for	NULL
site-directed	NULL
mutagenesis	NULL
using	NULL
a	NULL
Quick-Change	NULL
mutagenesis	NULL
kit	NULL
(	NULL
Stratagene	NULL
)	NULL
to	NULL
construct	NULL
the	NULL
chimeric	NULL
LTRs	NULL
that	NULL
contained	NULL
four	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
variants	NULL
next	NULL
to	NULL
the	NULL
low-affinity	NULL
3T	NULL
C/EBP	NULL
binding	NULL
site	NULL
I	NULL
.	NULL

The	NULL
3T	NULL
C/EBP	NULL
variant	NULL
contains	NULL
a	NULL
thymidine	NULL
substitution	NULL
at	NULL
position	NULL
3	NULL
of	NULL
the	NULL
HIV-1	NULL
clade	NULL
B	NULL
C/EBP	NULL
site	NULL
I	NULL
consensus	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
parental	NULL
LAI	NULL
strain	NULL
contains	NULL
the	NULL
clade	NULL
B	NULL
consensus	NULL
sequence	NULL
at	NULL
the	NULL
ATF/CREB	NULL
site	NULL
and	NULL
the	NULL
6G	NULL
(	NULL
thymidine-to-guanosine	NULL
change	NULL
at	NULL
position	NULL
6	NULL
)	NULL
C/EBP	NULL
binding	NULL
site	NULL
(	NULL
ConB/6G	NULL
)	NULL
.	NULL

The	NULL
four	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
configurations	NULL
were	NULL
designated	NULL
ATF/CREB	NULL
variants	NULL
1	NULL
to	NULL
4	NULL
(	NULL
Varl	NULL
to	NULL
Var4	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
mutants	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
.	NULL

All	NULL
plasmids	NULL
used	NULL
in	NULL
these	NULL
studies	NULL
were	NULL
sequenced	NULL
to	NULL
verify	NULL
the	NULL
ATF/CREB	NULL
and	NULL
C/EBP	NULL
binding	NULL
site	NULL
sequence	NULL
configurations	NULL
(	NULL
performed	NULL
in	NULL
the	NULL
Penn	NULL
State	NULL
College	NULL
of	NULL
Medicine	NULL
Macromolecular	NULL
Core	NULL
Facility	NULL
)	NULL
.	NULL

Transient	NULL
expression	NULL
analyses	NULL
.	NULL

Exponentially	NULL
growing	NULL
cultures	NULL
were	NULL
aliquoted	NULL
at	NULL
10°	NULL
cells	NULL
in	NULL
2	NULL
ml	NULL
of	NULL
growth	NULL
medium	NULL
.	NULL

For	NULL
each	NULL
transfection	NULL
,	NULL
6	NULL
pl	NULL
of	NULL
FuGENE	NULL
6	NULL
transfection	NULL
reagent	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
was	NULL
dispensed	NULL
into	NULL
94	NULL
pl	NULL
of	NULL
serum-free	NULL
medium	NULL
.	NULL

After	NULL
5	NULL
min	NULL
,	NULL
DNA	NULL
was	NULL
added	NULL
to	NULL
the	NULL
solution	NULL
,	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
,	NULL
and	NULL
dispensed	NULL
dropwise	NULL
into	NULL
the	NULL
cell	NULL
culture	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
0.5	NULL
ug	NULL
of	NULL
firefly	NULL
luciferase	NULL
construct	NULL
in	NULL
conjunction	NULL
with	NULL
0.04	NULL
pg	NULL
of	NULL
pRL-TK	NULL
Renilla	NULL
luciferase	NULL
internal	NULL
control	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
which	NULL
is	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
.	NULL

Cells	NULL
treated	NULL
with	NULL
recombinant	NULL
human	NULL
IL-6	NULL
(	NULL
Genzyme	NULL
)	NULL
received	NULL
875	NULL
U/ml	NULL
!	NULL

at	NULL
the	NULL
time	NULL
of	NULL
transfection	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
and	NULL
dual	NULL
luciferase	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Firefly	NULL
luminescence	NULL
was	NULL
normalized	NULL
to	NULL
the	NULL
Renilla	NULL
luminescence	NULL
to	NULL
control	NULL
for	NULL
variability	NULL
in	NULL
transfection	NULL
efficiency	NULL
.	NULL

Firefly	NULL
luminescence	NULL
(	NULL
pGL3	NULL
constructs	NULL
)	NULL
is	NULL
presented	NULL
relative	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
J.	NULL
Virou	NULL
.	NULL

A	NULL
Var1	NULL
:	NULL
cre	NULL
ace	NULL
TCG	NULL
ATE/CREB	NULL
Var2	NULL
:	NULL
ATG	NULL
ACC	NULL
TCG	NULL
variants	NULL
:	NULL
Vars	NULL
:	NULL
CTG	NULL
ACA	NULL
GCG	NULL
Vard	NULL
:	NULL
CTG	NULL
ACA	NULL
CAA	NULL
ATEICREB	NULL
(	NULL
P	NULL
HE	NULL
probes	NULL
:	NULL
CTG	NULL
)	NULL
ATE/CREB	NULL
[	NULL
acc	NULL
3T	NULL
C/EBP	NULL
probes	NULL
:	NULL
CTe|	NULL
ATF/CREB	NULL
|act	NULL
TTP	NULL
CTA	NULL
caa	NULL
Gee	NULL
3T	NULL
C/EBP	NULL
B	NULL
Probe	NULL
:	NULL
Varl	NULL
Var2	NULL
Vars	NULL
Var4	NULL
a	NULL
a	NULL
®	NULL
®	NULL
Li	NULL
LJ	NULL
I	NULL
]	NULL
LJ	NULL
Antisera	NULL
_	NULL
,	NULL
8	NULL
51	NULL
,	NULL
8	NULL
51	NULL
.	NULL

8	NULL
61	NULL
.	NULL

8	NULL
5	NULL
,	NULL
PS	NULL
o	NULL
«	NULL
ts	NULL
dik	NULL
«	NULL
»	NULL
o	NULL
wt	NULL
<	NULL
3	NULL
<	NULL
-CREB-1	NULL
complexl	NULL
:	NULL
Extract	NULL
:	NULL
CREB-enriched	NULL
SFo	NULL
Lanesi123456789101112	NULL
C	NULL
Probe	NULL
:	NULL
Varl	NULL
Var2	NULL
Var3	NULL
Vard4	NULL
Antisera	NULL
:	NULL
#	NULL
CREB	NULL
<	NULL
<	NULL
m	NULL
W	NULL
Extract	NULL
:	NULL
iw	NULL
**	NULL
10	NULL
11	NULL
12	NULL
CREB-1	NULL
complex	NULL
I	NULL
*	NULL
2	NULL
3	NULL
4	NULL
50	NULL
60	NULL
7	NULL
8	NULL
9	NULL
Lanes	NULL
:	NULL
-	NULL
1	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

ATF/CREB	NULL
binding	NULL
site	NULL
sequence	NULL
variation	NULL
results	NULL
in	NULL
different	NULL
binding	NULL
reactivities	NULL
with	NULL
respect	NULL
to	NULL
CREB-1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Four	NULL
HIV-1	NULL
ATF/CREB	NULL
sequence	NULL
variants	NULL
that	NULL
differ	NULL
from	NULL
the	NULL
HIV-1	NULL
consensus	NULL
clade	NULL
B	NULL
sequence	NULL
were	NULL
selected	NULL
.	NULL

The	NULL
ATF/CREB	NULL
probes	NULL
(	NULL
15	NULL
bp	NULL
)	NULL
were	NULL
designated	NULL
as	NULL
ATF/CREB	NULL
Varl	NULL
to	NULL
Var4	NULL
(	NULL
divergent	NULL
nucleotides	NULL
are	NULL
underlined	NULL
)	NULL
.	NULL

Probes	NULL
spanning	NULL
27	NULL
nucleotides	NULL
that	NULL
included	NULL
an	NULL
ATF/	NULL
CREB	NULL
variant	NULL
and	NULL
the	NULL
3T	NULL
C/EBP	NULL
site	NULL
I	NULL
sequence	NULL
were	NULL
used	NULL
in	NULL
subsequent	NULL
experimentation	NULL
.	NULL

The	NULL
four	NULL
ATF/CREB	NULL
probes	NULL
were	NULL
used	NULL
in	NULL
EMS	NULL
analyses	NULL
in	NULL
which	NULL
radiolabeled	NULL
oligonucleotides	NULL
spanning	NULL
the	NULL
ATF/CREB	NULL
site	NULL
were	NULL
reacted	NULL
with	NULL
nuclear	NULL
extract	NULL
prepared	NULL
from	NULL
a	NULL
baculovirus-infected	NULL
insect	NULL
SF9	NULL
cell	NULL
line	NULL
which	NULL
overexpressed	NULL
CREB-1	NULL
(	NULL
B	NULL
)	NULL
or	NULL
the	NULL
human	NULL
monocytic	NULL
U-937	NULL
nuclear	NULL
extract	NULL
(	NULL
C	NULL
)	NULL
.	NULL

CREB-1	NULL
antisera	NULL
was	NULL
added	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
and	NULL
12	NULL
)	NULL
to	NULL
demonstrate	NULL
the	NULL
presence	NULL
of	NULL
CREB	NULL
in	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

Control	NULL
rabbit	NULL
immunoglobulin	NULL
(	NULL
CS	NULL
)	NULL
was	NULL
added	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
8	NULL
,	NULL
and	NULL
11	NULL
)	NULL
to	NULL
demonstrate	NULL
the	NULL
specific	NULL
nature	NULL
of	NULL
supershifted	NULL
complexes	NULL
.	NULL

The	NULL
asterisk	NULL
indicates	NULL
potential	NULL
ATF-related	NULL
complexes	NULL
.	NULL

Arrows	NULL
to	NULL
the	NULL
right	NULL
indicate	NULL
supershifted	NULL
CREB-1	NULL
complexes	NULL
,	NULL
and	NULL
the	NULL
bracket	NULL
to	NULL
the	NULL
left	NULL
identifies	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

The	NULL
EMS	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
probe	NULL
excess	NULL
,	NULL
and	NULL
the	NULL
free	NULL
probe	NULL
accounted	NULL
for	NULL
approximately	NULL
75	NULL
to	NULL
90	NULL
%	NULL
of	NULL
the	NULL
total	NULL
probe	NULL
in	NULL
each	NULL
reaction	NULL
at	NULL
completion	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

parental	NULL
construct	NULL
which	NULL
was	NULL
set	NULL
to	NULL
1.0	NULL
for	NULL
each	NULL
experiment	NULL
.	NULL

Each	NULL
value	NULL
shown	NULL
represents	NULL
the	NULL
average	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
performed	NULL
with	NULL
duplicate	NULL
samples	NULL
;	NULL
error	NULL
bars	NULL
indicate	NULL
the	NULL
standard	NULL
deviation	NULL
.	NULL

RESULTS	NULL
Identification	NULL
of	NULL
an	NULL
HIV-1	NULL
C/EBP	NULL
site	NULL
I	NULL
sequence	NULL
variant	NULL
that	NULL
recruits	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
C/EBP	NULL
proteins	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
the	NULL
critical	NULL
importance	NULL
of	NULL
two	NULL
HIV-1	NULL
LTR	NULL
C/EBP	NULL
binding	NULL
sites	NULL
(	NULL
positions	NULL
-107	NULL
to	NULL
-118	NULL
[	NULL
site	NULL
II	NULL
]	NULL
and	NULL
positions	NULL
-167	NULL
to	NULL
-175	NULL
[	NULL
site	NULL
II	NULL
]	NULL
relative	NULL
to	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
)	NULL
to	NULL
viral	NULL
replication	NULL
within	NULL
cells	NULL
of	NULL
the	NULL
monocyte/	NULL
macrophage	NULL
lineage	NULL
(	NULL
17-19	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
these	NULL
two	NULL
bind	NULL
Vor	NULL
.	NULL

75	NULL
,	NULL
2001	NULL
ing	NULL
sites	NULL
are	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
the	NULL
functional	NULL
properties	NULL
of	NULL
C/EBP	NULL
binding	NULL
site	NULL
I	NULL
are	NULL
examined	NULL
along	NULL
with	NULL
the	NULL
impact	NULL
of	NULL
a	NULL
directly	NULL
adjacent	NULL
ATF/CREB	NULL
site	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
this	NULL
NF-	NULL
«	NULL
B-proximal	NULL
cis-acting	NULL
element	NULL
relevant	NULL
to	NULL
LTR-directed	NULL
transcription	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocyte/macrophage	NULL
lineage	NULL
.	NULL

A	NULL
number	NULL
of	NULL
naturally	NULL
occurring	NULL
C/EBP	NULL
site	NULL
I	NULL
sequence	NULL
variants	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
LTRs	NULL
of	NULL
different	NULL
HIV-1	NULL
strains	NULL
.	NULL

EMS	NULL
analyses	NULL
have	NULL
identified	NULL
at	NULL
C/EBP	NULL
sites	NULL
I	NULL
and	NULL
II	NULL
sequence	NULL
variants	NULL
that	NULL
exhibit	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
variation	NULL
in	NULL
the	NULL
ability	NULL
to	NULL
react	NULL
with	NULL
members	NULL
of	NULL
the	NULL
C/EBP	NULL
transcription	NULL
factor	NULL
family	NULL
.	NULL

Two	NULL
of	NULL
the	NULL
site	NULL
I	NULL
sequence	NULL
variants	NULL
,	NULL
3T	NULL
and	NULL
6G	NULL
(	NULL
see	NULL
above	NULL
)	NULL
represent	NULL
opposing	NULL
ends	NULL
of	NULL
the	NULL
spectrum	NULL
with	NULL
respect	NULL
to	NULL
reactivity	NULL
with	NULL
members	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
.	NULL

Both	NULL
sequences	NULL
are	NULL
commonly	NULL
encountered	NULL
configurations	NULL
within	NULL
HIV-1	NULL
sequence	NULL
databases	NULL
.	NULL

The	NULL
reactivity	NULL
of	NULL
both	NULL
sites	NULL
for	NULL
members	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
is	NULL
demonstrated	NULL
in	NULL
the	NULL
EMS	NULL
analysis	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
where	NULL
the	NULL
3T	NULL
and	NULL
6G	NULL
C/EBP	NULL
site	NULL
I	NULL
variants	NULL
were	NULL
reacted	NULL
with	NULL
IL-6-stimulated	NULL
U-937	NULL
nuclear	NULL
extract	NULL
.	NULL

IL-6	NULL
stimulation	NULL
of	NULL
the	NULL
monocytic	NULL
U-937	NULL
cells	NULL
resulted	NULL
in	NULL
increased	NULL
binding	NULL
of	NULL
C/EBP	NULL
«	NULL
and	NULL
B	NULL
to	NULL
cognate	NULL
binding	NULL
sequences	NULL
.	NULL

The	NULL
EMS	NULL
reactions	NULL
were	NULL
conducted	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
5	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
antibodies	NULL
directed	NULL
against	NULL
C/EBP	NULL
«	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
or	NULL
C/EBP	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
,	NULL
a	NULL
greater	NULL
amount	NULL
of	NULL
DNA-protein	NULL
complex	NULL
formation	NULL
was	NULL
observed	NULL
with	NULL
the	NULL
6G	NULL
C/EBP	NULL
site	NULL
I	NULL
variant	NULL
than	NULL
with	NULL
the	NULL
3T	NULL
C/EBP	NULL
site	NULL
I	NULL
.	NULL

While	NULL
abundant	NULL
supershifted	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
observed	NULL
when	NULL
C/EBP	NULL
a	NULL
and	NULL
C/EBP	NULL
B	NULL
antisera	NULL
were	NULL
added	NULL
to	NULL
the	NULL
reactions	NULL
with	NULL
the	NULL
6G	NULL
C/EBP	NULL
site	NULL
I	NULL
probe	NULL
,	NULL
only	NULL
small	NULL
amounts	NULL
of	NULL
supershifted	NULL
complexes	NULL
were	NULL
detected	NULL
with	NULL
the	NULL
3T	NULL
C/EBP	NULL
site	NULL
I	NULL
variant	NULL
.	NULL

These	NULL
results	NULL
were	NULL
not	NULL
due	NULL
to	NULL
different	NULL
specific	NULL
activities	NULL
of	NULL
the	NULL
probes	NULL
,	NULL
as	NULL
the	NULL
probes	NULL
exhibited	NULL
the	NULL
same	NULL
specific	NULL
activities	NULL
.	NULL

These	NULL
results	NULL
demonstrated	NULL
that	NULL
the	NULL
3T	NULL
C/EBP	NULL
site	NULL
I	NULL
variant	NULL
exhibited	NULL
a	NULL
very	NULL
low	NULL
level	NULL
of	NULL
reactivity	NULL
with	NULL
respect	NULL
to	NULL
binding	NULL
of	NULL
C/EBP	NULL
a	NULL
or	NULL
B	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
EMS	NULL
analyses	NULL
indicated	NULL
that	NULL
the	NULL
3T	NULL
C/EBP	NULL
site	NULL
I	NULL
variant	NULL
exhibited	NULL
a	NULL
very	NULL
low	NULL
level	NULL
of	NULL
reactivity	NULL
with	NULL
C/EBP	NULL
8	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

HIV-1	NULL
LTR	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
sequence	NULL
variation	NULL
leads	NULL
to	NULL
alterations	NULL
in	NULL
reactivity	NULL
with	NULL
CREB-1	NULL
.	NULL

Immediately	NULL
adjacent	NULL
to	NULL
C/EBP	NULL
site	NULL
I	NULL
is	NULL
an	NULL
upstream	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
and	NULL
a	NULL
downstream	NULL
NF-KB	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
indicated	NULL
that	NULL
sequence	NULL
variation	NULL
at	NULL
the	NULL
ATF/CREB	NULL
site	NULL
impacts	NULL
ATFE/CREB	NULL
protein	NULL
binding	NULL
and	NULL
HIV-1	NULL
LTR	NULL
activity	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
numerous	NULL
reports	NULL
have	NULL
described	NULL
synergistic	NULL
transactivation	NULL
of	NULL
different	NULL
promoters	NULL
by	NULL
proteins	NULL
from	NULL
the	NULL
ATFE/CREB	NULL
and	NULL
C/EBP	NULL
families	NULL
(	NULL
33	NULL
,	NULL
35	NULL
,	NULL
41	NULL
)	NULL
.	NULL

As	NULL
a	NULL
result	NULL
,	NULL
sequence	NULL
variation	NULL
within	NULL
the	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
was	NULL
examined	NULL
with	NULL
respect	NULL
to	NULL
its	NULL
impact	NULL
on	NULL
factor	NULL
recruitment	NULL
to	NULL
C/EBP	NULL
site	NULL
I	NULL
and	NULL
subsequent	NULL
C/EBP-dependent	NULL
transcription	NULL
.	NULL

ATF/CREB	NULL
binding	NULL
site	NULL
sequence	NULL
variants	NULL
were	NULL
selected	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
HIV-1	NULL
clade	NULL
B	NULL
consensus	NULL
reference	NULL
sequence	NULL
,	NULL
based	NULL
on	NULL
a	NULL
search	NULL
of	NULL
Los	NULL
Alamos	NULL
and	NULL
GenBank	NULL
sequence	NULL
databases	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Four	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
variants	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
were	NULL
selected	NULL
which	NULL
differed	NULL
from	NULL
the	NULL
consensus	NULL
clade	NULL
B	NULL
sequence	NULL
by	NULL
one	NULL
,	NULL
two	NULL
,	NULL
or	NULL
three	NULL
nucleotides	NULL
(	NULL
Varl	NULL
to	NULL
Vard4	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
clade	NULL
B	NULL
sequence	NULL
was	NULL
the	NULL
most	NULL
commonly	NULL
encountered	NULL
sequence	NULL
within	NULL
this	NULL
analysis	NULL
.	NULL

By	NULL
comparison	NULL
,	NULL
the	NULL
naturally	NULL
occurring	NULL
variants	NULL
selected	NULL
for	NULL
study	NULL
were	NULL
C/EBP-CREB-1	NULL
INTERACTION	NULL
REGULATES	NULL
HIV-1	NULL
TRANSCRIPTION	NULL
-	NULL
1845	NULL
less	NULL
frequently	NULL
encountered	NULL
.	NULL

Varl	NULL
was	NULL
observed	NULL
in	NULL
a	NULL
sequence	NULL
database	NULL
of	NULL
HIV-1	NULL
LTRs	NULL
provided	NULL
by	NULL
Maureen	NULL
Goodenow	NULL
,	NULL
University	NULL
of	NULL
Florida	NULL
at	NULL
Gainesville	NULL
(	NULL
23	NULL
)	NULL
.	NULL

VarZ2	NULL
was	NULL
encountered	NULL
in	NULL
the	NULL
HIV-1	NULL
YU-2	NULL
molecular	NULL
clone	NULL
,	NULL
Var3	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
HIV-1	NULL
MANC	NULL
molecular	NULL
clone	NULL
,	NULL
and	NULL
Var4	NULL
was	NULL
encountered	NULL
in	NULL
the	NULL
HIV-1	NULL
SF1701	NULL
molecular	NULL
clone	NULL
.	NULL

Four	NULL
double-stranded	NULL
oligonucleotide	NULL
probes	NULL
(	NULL
15	NULL
nucleotides	NULL
in	NULL
length	NULL
)	NULL
were	NULL
synthesized	NULL
to	NULL
contain	NULL
each	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
variant	NULL
with	NULL
three	NULL
additional	NULL
nucleotides	NULL
on	NULL
either	NULL
side	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
to	NULL
facilitate	NULL
binding	NULL
to	NULL
the	NULL
core	NULL
element	NULL
.	NULL

The	NULL
additional	NULL
flanking	NULL
sequences	NULL
represented	NULL
those	NULL
found	NULL
in	NULL
the	NULL
HIV-1	NULL
clade	NULL
B	NULL
consensus	NULL
sequence	NULL
.	NULL

Radiolabeled	NULL
probes	NULL
were	NULL
examined	NULL
in	NULL
EMS	NULL
reactions	NULL
with	NULL
nuclear	NULL
extract	NULL
prepared	NULL
from	NULL
baculovirus-infected	NULL
insect	NULL
SF9	NULL
cells	NULL
that	NULL
overexpressed	NULL
CREB-1	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
CREB-1	NULL
antisera	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
and	NULL
12	NULL
)	NULL
indicated	NULL
that	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
formed	NULL
with	NULL
each	NULL
of	NULL
the	NULL
ATF/CREB	NULL
variant	NULL
sites	NULL
contained	NULL
CREB-1	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
there	NULL
appeared	NULL
to	NULL
be	NULL
a	NULL
major	NULL
CREB-1-containing	NULL
complex	NULL
,	NULL
visible	NULL
with	NULL
each	NULL
ATF/CREB	NULL
variant	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
faster-migrating	NULL
minor	NULL
CREB-1-containing	NULL
complex	NULL
that	NULL
was	NULL
most	NULL
obvious	NULL
with	NULL
Varl	NULL
.	NULL

It	NULL
was	NULL
readily	NULL
apparent	NULL
that	NULL
the	NULL
four	NULL
sequence	NULL
variants	NULL
had	NULL
different	NULL
relative	NULL
reactivities	NULL
with	NULL
respect	NULL
to	NULL
binding	NULL
CREB-1	NULL
.	NULL

Varl	NULL
exhibited	NULL
the	NULL
highest	NULL
level	NULL
of	NULL
reactivity	NULL
with	NULL
CREB-1	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
Var3	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
7	NULL
to	NULL
9	NULL
)	NULL
.	NULL

Both	NULL
Var2	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
and	NULL
Vard	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
10	NULL
to	NULL
12	NULL
)	NULL
exhibited	NULL
lower	NULL
levels	NULL
of	NULL
CREB-1	NULL
binding	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
the	NULL
four	NULL
ATF/CREB	NULL
site	NULL
variants	NULL
selected	NULL
displayed	NULL
a	NULL
range	NULL
of	NULL
CREB-1	NULL
binding	NULL
capabilities	NULL
.	NULL

The	NULL
most	NULL
commonly	NULL
encountered	NULL
ATF/CREB	NULL
site	NULL
configuration	NULL
,	NULL
the	NULL
clade	NULL
B	NULL
consensus	NULL
sequence	NULL
,	NULL
mimicked	NULL
Var2	NULL
to	NULL
Vard4	NULL
with	NULL
respect	NULL
to	NULL
amounts	NULL
of	NULL
ATF/CREB	NULL
protein	NULL
recruited	NULL
and	NULL
typically	NULL
recruited	NULL
similar	NULL
amounts	NULL
of	NULL
CREB-1	NULL
and	NULL
ATF-related	NULL
proteins	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Since	NULL
subsequent	NULL
experimentation	NULL
will	NULL
focus	NULL
on	NULL
the	NULL
interaction	NULL
of	NULL
C/EBP	NULL
and	NULL
CREB	NULL
factors	NULL
derived	NULL
from	NULL
the	NULL
monocytic	NULL
cell	NULL
line	NULL
U-937	NULL
,	NULL
EMS	NULL
analyses	NULL
were	NULL
also	NULL
performed	NULL
to	NULL
determine	NULL
whether	NULL
ATF	NULL
and	NULL
CREB	NULL
factors	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
these	NULL
cells	NULL
would	NULL
bind	NULL
to	NULL
the	NULL
selected	NULL
site	NULL
variants	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
U-937	NULL
nuclear	NULL
extract	NULL
was	NULL
reacted	NULL
with	NULL
the	NULL
four	NULL
ATF/CREB	NULL
variant	NULL
probes	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
7	NULL
,	NULL
and	NULL
10	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
and	NULL
12	NULL
)	NULL
of	NULL
CREB-1	NULL
antisera	NULL
.	NULL

These	NULL
analyses	NULL
indicated	NULL
very	NULL
strong	NULL
CREB-1	NULL
binding	NULL
using	NULL
Varl	NULL
,	NULL
while	NULL
Var3	NULL
exhibited	NULL
readily	NULL
detectable	NULL
CREB-1	NULL
binding	NULL
when	NULL
reacted	NULL
with	NULL
the	NULL
U-937	NULL
nuclear	NULL
extracts	NULL
.	NULL

Small	NULL
amounts	NULL
of	NULL
CREB-1	NULL
-containing	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
also	NULL
detected	NULL
with	NULL
Var2	NULL
and	NULL
Var4	NULL
.	NULL

Thus	NULL
,	NULL
different	NULL
relative	NULL
reactivities	NULL
with	NULL
respect	NULL
to	NULL
CREB-1	NULL
binding	NULL
were	NULL
observed	NULL
with	NULL
the	NULL
four	NULL
ATF/CREB	NULL
variants	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
nuclear	NULL
extract	NULL
from	NULL
the	NULL
THP-1	NULL
monocytic	NULL
cell	NULL
line	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
THP-1	NULL
cell	NULL
line	NULL
also	NULL
represents	NULL
a	NULL
relatively	NULL
immature	NULL
monocytic	NULL
cell	NULL
but	NULL
is	NULL
morphologically	NULL
more	NULL
mature	NULL
than	NULL
the	NULL
U-937	NULL
cell	NULL
line	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Although	NULL
supershift	NULL
EMS	NULL
analyses	NULL
were	NULL
also	NULL
conducted	NULL
using	NULL
ATF-1	NULL
and	NULL
ATF-2	NULL
antisera	NULL
,	NULL
neither	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
EMS	NULL
analyses	NULL
using	NULL
U-937	NULL
or	NULL
THP	NULL
-1	NULL
nuclear	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Previous	NULL
EMS	NULL
analyses	NULL
using	NULL
Jurkat	NULL
(	NULL
lymphocytic	NULL
)	NULL
and	NULL
U-373	NULL
MG	NULL
(	NULL
astrocytic	NULL
)	NULL
nuclear	NULL
extracts	NULL
demonstrated	NULL
the	NULL
formation	NULL
of	NULL
DNA-protein	NULL
complexes	NULL
similar	NULL
to	NULL
those	NULL
observed	NULL
with	NULL
the	NULL
monocytic	NULL
nuclear	NULL
extract	NULL
in	NULL
Fig	NULL
.	NULL

2C	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
EMS	NULL
analyses	NULL
utilizing	NULL
the	NULL
lymphocytic	NULL
and	NULL
astrocytic	NULL
1846	NULL
ROSS	NULL
ET	NULL
AL	NULL
.	NULL

extracts	NULL
also	NULL
exhibited	NULL
DNA-protein	NULL
complexes	NULL
which	NULL
migrated	NULL
just	NULL
above	NULL
the	NULL
CREB-1	NULL
complexes	NULL
,	NULL
similar	NULL
to	NULL
those	NULL
indicated	NULL
by	NULL
the	NULL
asterisk	NULL
in	NULL
Fig	NULL
.	NULL

2C	NULL
.	NULL

The	NULL
slower-migrating	NULL
complexes	NULL
were	NULL
determined	NULL
to	NULL
be	NULL
composed	NULL
of	NULL
ATF	NULL
family	NULL
members	NULL
by	NULL
supershift	NULL
EMS	NULL
analyses	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
slower-migrating	NULL
DNA-protein	NULL
complexes	NULL
indicated	NULL
by	NULL
the	NULL
asterisk	NULL
in	NULL
Fig	NULL
.	NULL

2C	NULL
are	NULL
composed	NULL
of	NULL
ATF	NULL
family	NULL
members	NULL
that	NULL
do	NULL
not	NULL
contain	NULL
epitopes	NULL
that	NULL
cross-react	NULL
with	NULL
the	NULL
ATF	NULL
monoclonal	NULL
antibodies	NULL
used	NULL
in	NULL
these	NULL
analyses	NULL
.	NULL

The	NULL
experiments	NULL
involving	NULL
the	NULL
lymphocytic	NULL
and	NULL
astrocytic	NULL
extracts	NULL
suggested	NULL
that	NULL
Varl	NULL
and	NULL
Var2	NULL
may	NULL
both	NULL
recruit	NULL
ATF	NULL
proteins	NULL
while	NULL
Var3	NULL
and	NULL
Var4	NULL
do	NULL
not	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
correlate	NULL
with	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
proposed	NULL
ATF-related	NULL
complexes	NULL
observed	NULL
using	NULL
the	NULL
ATF/CREB	NULL
variants	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Sequence	NULL
variation	NULL
at	NULL
the	NULL
ATF/CREB	NULL
site	NULL
alters	NULL
factor	NULL
recruitment	NULL
to	NULL
the	NULL
immediately	NULL
adjacent	NULL
weak	NULL
C/EBP	NULL
binding	NULL
site	NULL
I	NULL
variant	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
impact	NULL
of	NULL
selected	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
variants	NULL
on	NULL
C/EBP	NULL
binding	NULL
to	NULL
the	NULL
adjacent	NULL
cis-acting	NULL
element	NULL
,	NULL
four	NULL
chimeric	NULL
ATF/CREB-C/EBP	NULL
oligonucleotides	NULL
were	NULL
employed	NULL
which	NULL
contained	NULL
the	NULL
weakly	NULL
reactive	NULL
3T	NULL
C/EBP	NULL
binding	NULL
site	NULL
I	NULL
variant	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
adjacent	NULL
to	NULL
each	NULL
of	NULL
the	NULL
four	NULL
ATF/CREB	NULL
sequence	NULL
variants	NULL
.	NULL

We	NULL
hypothesized	NULL
that	NULL
the	NULL
ATFE/CREB	NULL
variant	NULL
sites	NULL
adjacent	NULL
to	NULL
the	NULL
weak	NULL
3T	NULL
C/EBP	NULL
binding	NULL
site	NULL
I	NULL
would	NULL
facilitate	NULL
C/EBP	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
cognate	NULL
C/EBP	NULL
binding	NULL
site	NULL
if	NULL
ATF/CREB	NULL
and	NULL
C/EBP	NULL
factors	NULL
bind	NULL
in	NULL
a	NULL
cooperative	NULL
manner	NULL
.	NULL

Each	NULL
chimeric	NULL
probe	NULL
consisted	NULL
of	NULL
an	NULL
ATF/CREB	NULL
site	NULL
variant	NULL
directly	NULL
adjacent	NULL
to	NULL
the	NULL
weak	NULL
3T	NULL
C/EBP	NULL
binding	NULL
site	NULL
I	NULL
,	NULL
with	NULL
three	NULL
additional	NULL
nucleotides	NULL
from	NULL
the	NULL
HIV-1	NULL
clade	NULL
B	NULL
consensus	NULL
sequence	NULL
on	NULL
each	NULL
end	NULL
of	NULL
the	NULL
chimeric	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

The	NULL
four	NULL
chimeric	NULL
oligonucleotides	NULL
were	NULL
then	NULL
reacted	NULL
with	NULL
three	NULL
monocytic	NULL
nuclear	NULL
extract	NULL
preparations	NULL
(	NULL
U-937	NULL
,	NULL
IL-6-induced	NULL
U-937	NULL
,	NULL
and	NULL
THP	NULL
-1	NULL
)	NULL
in	NULL
EMS	NULL
analyses	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
treatment	NULL
with	NULL
LPS	NULL
or	NULL
inflammatory	NULL
cytokines	NULL
,	NULL
including	NULL
IL-6	NULL
,	NULL
resulted	NULL
in	NULL
an	NULL
upregulation	NULL
of	NULL
C/EBP	NULL
B	NULL
mRNA	NULL
expression	NULL
in	NULL
different	NULL
tissues	NULL
(	NULL
2	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
an	NULL
increase	NULL
in	NULL
C/EBP	NULL
«	NULL
and	NULL
C/EBP	NULL
B	NULL
DNA-binding	NULL
activity	NULL
was	NULL
observed	NULL
in	NULL
response	NULL
to	NULL
IL-6-stimulation	NULL
of	NULL
U-937	NULL
human	NULL
monocytic	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
same	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
formed	NULL
with	NULL
each	NULL
chimeric	NULL
radiolabeled	NULL
oligonucleotide	NULL
,	NULL
there	NULL
was	NULL
a	NULL
striking	NULL
difference	NULL
in	NULL
the	NULL
abundance	NULL
of	NULL
each	NULL
complex	NULL
formed	NULL
between	NULL
the	NULL
four	NULL
chimeric	NULL
probes	NULL
.	NULL

The	NULL
chimeric	NULL
ATF/CREB-C/EBP	NULL
probe	NULL
containing	NULL
the	NULL
highly	NULL
reactive	NULL
Varl	NULL
ATF/CREB	NULL
site	NULL
exhibited	NULL
the	NULL
most	NULL
abundant	NULL
DNA-protein	NULL
complex	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
1	NULL
,	NULL
5	NULL
,	NULL
and	NULL
9	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
Var2/3T	NULL
chimera	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
2	NULL
,	NULL
6	NULL
,	NULL
and	NULL
10	NULL
)	NULL
.	NULL

The	NULL
Var3/3T	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
3	NULL
,	NULL
7	NULL
,	NULL
and	NULL
11	NULL
)	NULL
and	NULL
Var4/3T	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
4	NULL
,	NULL
8	NULL
,	NULL
and	NULL
12	NULL
)	NULL
chimeras	NULL
both	NULL
exhibited	NULL
a	NULL
lower	NULL
level	NULL
of	NULL
reactivity	NULL
for	NULL
nuclear	NULL
factors	NULL
from	NULL
the	NULL
monocytic	NULL
extracts	NULL
(	NULL
even	NULL
when	NULL
higher	NULL
amounts	NULL
of	NULL
extract	NULL
were	NULL
used	NULL
)	NULL
.	NULL

Proteins	NULL
from	NULL
the	NULL
U-937	NULL
and	NULL
THP-1	NULL
nuclear	NULL
extracts	NULL
reacted	NULL
almost	NULL
identically	NULL
with	NULL
regard	NULL
to	NULL
DNA-protein	NULL
complex	NULL
formation	NULL
with	NULL
each	NULL
of	NULL
the	NULL
four	NULL
chimeric	NULL
CREB-C/EBP	NULL
probes	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
observation	NULL
was	NULL
not	NULL
limited	NULL
to	NULL
a	NULL
single	NULL
monocytic	NULL
cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
comparative	NULL
analyses	NULL
revealed	NULL
that	NULL
an	NULL
increase	NULL
in	NULL
C/EBP	NULL
-containing	NULL
DNA-protein	NULL
complex	NULL
formation	NULL
was	NULL
observed	NULL
with	NULL
each	NULL
of	NULL
the	NULL
ATF/CREB	NULL
variants	NULL
when	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
untreated	NULL
and	NULL
IL-6-treated	NULL
U-937	NULL
cells	NULL
J.	NULL
Virou	NULL
.	NULL

were	NULL
used	NULL
in	NULL
the	NULL
EMS	NULL
reactions	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
compared	NULL
to	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
.	NULL

The	NULL
potentially	NULL
ATF-related	NULL
complexes	NULL
appeared	NULL
to	NULL
run	NULL
in	NULL
the	NULL
same	NULL
proximity	NULL
as	NULL
the	NULL
C/EBP	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

This	NULL
may	NULL
explain	NULL
why	NULL
Var2	NULL
appeared	NULL
to	NULL
recruit	NULL
such	NULL
large	NULL
amounts	NULL
of	NULL
C/EBP	NULL
,	NULL
as	NULL
some	NULL
of	NULL
the	NULL
complex	NULL
formed	NULL
may	NULL
have	NULL
been	NULL
due	NULL
to	NULL
ATF-related	NULL
factors	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
proteins	NULL
being	NULL
recruited	NULL
to	NULL
the	NULL
complexes	NULL
formed	NULL
with	NULL
the	NULL
ATF/CREB-C/EBP	NULL
probes	NULL
,	NULL
the	NULL
chimeric	NULL
probes	NULL
were	NULL
reacted	NULL
in	NULL
supershift	NULL
EMS	NULL
analyses	NULL
with	NULL
IL-6-stimulated	NULL
U-937	NULL
nuclear	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Antisera	NULL
directed	NULL
against	NULL
C/EBP	NULL
a	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
3	NULL
,	NULL
7	NULL
,	NULL
11	NULL
,	NULL
15	NULL
,	NULL
19	NULL
,	NULL
and	NULL
23	NULL
)	NULL
and	NULL
C/EBP	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
4	NULL
,	NULL
8	NULL
,	NULL
12	NULL
,	NULL
16	NULL
,	NULL
20	NULL
,	NULL
and	NULL
24	NULL
)	NULL
were	NULL
added	NULL
to	NULL
the	NULL
reactions	NULL
to	NULL
identify	NULL
complexes	NULL
that	NULL
contained	NULL
these	NULL
two	NULL
C/EBP	NULL
family	NULL
members	NULL
.	NULL

For	NULL
comparison	NULL
,	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
only	NULL
the	NULL
weakly	NULL
reactive	NULL
3T	NULL
C/EBP	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
and	NULL
13	NULL
to	NULL
16	NULL
)	NULL
was	NULL
also	NULL
reacted	NULL
with	NULL
the	NULL
nuclear	NULL
extract	NULL
and	NULL
C/EBP	NULL
antisera	NULL
.	NULL

This	NULL
was	NULL
done	NULL
to	NULL
demonstrate	NULL
the	NULL
low	NULL
level	NULL
of	NULL
C/EBP	NULL
factors	NULL
that	NULL
normally	NULL
react	NULL
with	NULL
the	NULL
3T	NULL
C/EBP	NULL
site	NULL
I	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
adjacent	NULL
ATF/	NULL
CREB	NULL
site	NULL
.	NULL

While	NULL
only	NULL
experiments	NULL
using	NULL
IL-6-stimulated	NULL
U-937	NULL
nuclear	NULL
extract	NULL
are	NULL
shown	NULL
,	NULL
similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
unstimulated	NULL
U-937	NULL
and	NULL
THP	NULL
-1	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
four	NULL
chimeric	NULL
probes	NULL
exhibited	NULL
various	NULL
levels	NULL
of	NULL
enhanced	NULL
C/EBP	NULL
binding	NULL
over	NULL
the	NULL
levels	NULL
of	NULL
C/EBP	NULL
protein	NULL
normally	NULL
recruited	NULL
to	NULL
the	NULL
weakly	NULL
reactive	NULL
3T	NULL
C/EBP	NULL
site	NULL
.	NULL

This	NULL
observation	NULL
was	NULL
readily	NULL
apparent	NULL
in	NULL
the	NULL
analyses	NULL
of	NULL
complexes	NULL
formed	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
C/EBP	NULL
«	NULL
and	NULL
B	NULL
antisera	NULL
.	NULL

The	NULL
EMS	NULL
reactions	NULL
conducted	NULL
with	NULL
the	NULL
3T	NULL
C/EBP	NULL
site	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
15	NULL
,	NULL
and	NULL
16	NULL
)	NULL
indicated	NULL
that	NULL
only	NULL
small	NULL
amounts	NULL
of	NULL
C/EBP	NULL
a	NULL
were	NULL
recruited	NULL
to	NULL
site	NULL
I	NULL
(	NULL
consistent	NULL
with	NULL
results	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
C/EBP	NULL
supershift	NULL
EMS	NULL
reactions	NULL
conducted	NULL
with	NULL
the	NULL
chimeric	NULL
ATF/CREB-C/EBP	NULL
probes	NULL
,	NULL
all	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
variants	NULL
exhibited	NULL
modest	NULL
increases	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
C/EBP	NULL
a	NULL
recruitment	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
Varl/3T	NULL
exhibited	NULL
a	NULL
considerable	NULL
increase	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
C/EBP	NULL
«	NULL
recruitment	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Varl/3T	NULL
recruited	NULL
a	NULL
considerable	NULL
amount	NULL
of	NULL
C/EBP	NULL
,	NULL
while	NULL
much	NULL
smaller	NULL
amounts	NULL
of	NULL
C/EBP	NULL
B	NULL
recruitment	NULL
were	NULL
observed	NULL
with	NULL
the	NULL
remaining	NULL
three	NULL
variants	NULL
.	NULL

Phosphorimaging	NULL
analyses	NULL
were	NULL
used	NULL
to	NULL
quantify	NULL
the	NULL
amount	NULL
of	NULL
protein	NULL
in	NULL
each	NULL
of	NULL
the	NULL
supershifted	NULL
C/EBP	NULL
DNA-protein	NULL
complexes	NULL
from	NULL
Fig	NULL
.	NULL

3B	NULL
and	NULL
other	NULL
representative	NULL
experiments	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

It	NULL
was	NULL
apparent	NULL
that	NULL
the	NULL
ATF/CREB	NULL
site	NULL
that	NULL
displayed	NULL
the	NULL
highest	NULL
reactivity	NULL
with	NULL
CREB-1	NULL
(	NULL
Varl	NULL
)	NULL
displayed	NULL
the	NULL
largest	NULL
degree	NULL
of	NULL
enhanced	NULL
C/EBP	NULL
binding	NULL
.	NULL

Var3	NULL
,	NULL
which	NULL
displayed	NULL
the	NULL
second	NULL
highest	NULL
reactivity	NULL
with	NULL
respect	NULL
to	NULL
CREB-1	NULL
,	NULL
appeared	NULL
to	NULL
be	NULL
the	NULL
next	NULL
most	NULL
efficient	NULL
enhancer	NULL
of	NULL
C/EBP	NULL
binding	NULL
.	NULL

Var1/3T	NULL
recruited	NULL
92-fold	NULL
more	NULL
C/EBP	NULL
«	NULL
than	NULL
did	NULL
the	NULL
3T	NULL
C/EBP	NULL
site	NULL
alone	NULL
,	NULL
while	NULL
the	NULL
Var3/3T	NULL
chimeric	NULL
probe	NULL
resulted	NULL
in	NULL
a	NULL
9.8-fold	NULL
increase	NULL
in	NULL
C/EBP	NULL
a	NULL
binding	NULL
over	NULL
3T	NULL
alone	NULL
.	NULL

The	NULL
weakly	NULL
reactive	NULL
Var4/3T	NULL
and	NULL
Var2/3T	NULL
chimeric	NULL
probes	NULL
enhanced	NULL
C/EBP	NULL
«	NULL
binding	NULL
4.5-	NULL
and	NULL
2.1-fold	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
enhancement	NULL
of	NULL
C/EBP	NULL
B	NULL
recruitment	NULL
by	NULL
ATF/CREB	NULL
binding	NULL
was	NULL
even	NULL
greater	NULL
but	NULL
followed	NULL
a	NULL
similar	NULL
relationship	NULL
between	NULL
CREB-1	NULL
binding	NULL
and	NULL
C/EBP	NULL
B	NULL
enhancement	NULL
.	NULL

Varl/	NULL
3T	NULL
recruited	NULL
295-fold	NULL
more	NULL
C/EBP	NULL
B	NULL
protein	NULL
than	NULL
did	NULL
the	NULL
3T	NULL
probe	NULL
alone	NULL
,	NULL
while	NULL
the	NULL
Var3/3T	NULL
probe	NULL
enhanced	NULL
C/EBP	NULL
B	NULL
binding	NULL
approximately	NULL
18-fold	NULL
.	NULL

The	NULL
Var2/3T	NULL
probe	NULL
enhanced	NULL
C/EBP	NULL
B	NULL
binding	NULL
sevenfold	NULL
over	NULL
that	NULL
observed	NULL
with	NULL
the	NULL
3T	NULL
Vor	NULL
.	NULL

75	NULL
,	NULL
2001	NULL
A	NULL
Extract	NULL
:	NULL
U-937	NULL
IL-6-induced	NULL
THP-1	NULL
U-937	NULL
5	NULL
8	NULL
g	NULL
I	NULL
%	NULL
©	NULL
2	NULL
tit	NULL
@	NULL
g	NULL
f	NULL
Probe	NULL
:	NULL
S	NULL
$	NULL
$	NULL
S	NULL
$	NULL
|S	NULL
S	NULL
$	NULL
$	NULL
S|S	NULL
$	NULL
S	NULL
$	NULL
$	NULL
won	NULL
oon	NULL
ats	NULL
wun	NULL
ds	NULL
win	NULL
win	NULL
din	NULL
die	NULL
dit	NULL
«	NULL
*	NULL
th	NULL
C/EBP	NULL
complex	NULL
I	NULL
:	NULL
CREB	NULL
complex	NULL
E	NULL
Lanes	NULL
:	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
Probes	NULL
:	NULL
[	NULL
CREB	NULL
Varl	NULL
3T	NULL
Vara	NULL
Vars	NULL
Var4	NULL
B	NULL
Probe	NULL
:	NULL
3T	NULL
only	NULL
Varl/3T	NULL
Var2/3T	NULL
5	NULL
«	NULL
ol	NULL
5	NULL
ua	NULL
3	NULL
un	NULL
88	NULL
L858	NULL
)	NULL
,58	NULL
Antisera	NULL
:	NULL
_	NULL
.	NULL

8	NULL
5	NULL
S1	NULL
.	NULL

8	NULL
5	NULL
61	NULL
.	NULL

8	NULL
5	NULL
8	NULL
»	NULL
w	NULL
«	NULL
tb	NULL
ty	NULL
h	NULL
Ab	NULL
say	NULL
@	NULL
C/EBP	NULL
complex	NULL
]	NULL
:	NULL
4	NULL
H	NULL
h	NULL
CREB	NULL
complexl	NULL
:	NULL
EE	NULL
Bi	NULL
,	NULL
Efgfiigguced	NULL
*	NULL
chimeric	NULL
probes	NULL
U-937	NULL
only	NULL
Lanes	NULL
:	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
1011	NULL
12	NULL
Probe	NULL
:	NULL
3T	NULL
on	NULL
!	NULL

Var3/3T	NULL
.	NULL

Vard4f3T	NULL
8	NULL
a.	NULL
t	NULL
a	NULL
Antisera	NULL
:	NULL
.	NULL

8	NULL
o	NULL
ol	NULL
.	NULL

8	NULL
.	NULL

86	NULL
6	NULL
0	NULL
w	NULL
»	NULL
wn	NULL
on	NULL
a	NULL
»	NULL
dh	NULL
d	NULL
cog	NULL
.	NULL

»	NULL
-**	NULL
@	NULL
®	NULL
P4	NULL
C/EBP	NULL
complex	NULL
I	NULL
:	NULL
CREB	NULL
complex	NULL
|	NULL
_|	NULL
_-	NULL
Extract	NULL
:	NULL
*	NULL
chimeric	NULL
probes	NULL
IL-6-induced	NULL
only	NULL
U-937	NULL
Lanes	NULL
:	NULL
13	NULL
1415	NULL
16	NULL
17	NULL
18	NULL
19	NULL
20	NULL
2122	NULL
23	NULL
24	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Probes	NULL
containing	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
sequence	NULL
variants	NULL
adjacent	NULL
to	NULL
a	NULL
weakly	NULL
reactive	NULL
C/EBP	NULL
binding	NULL
site	NULL
can	NULL
differentially	NULL
enhance	NULL
binding	NULL
of	NULL
C/EBP	NULL
nuclear	NULL
factors	NULL
derived	NULL
from	NULL
monocytic	NULL
cell	NULL
lines	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Chimeric	NULL
probes	NULL
containing	NULL
the	NULL
Varl	NULL
,	NULL
Var2	NULL
,	NULL
Var3	NULL
,	NULL
and	NULL
Vard	NULL
ATF/	NULL
CREB	NULL
binding	NULL
sites	NULL
adjacent	NULL
to	NULL
the	NULL
3T	NULL
C/EBP	NULL
site	NULL
I	NULL
were	NULL
reacted	NULL
with	NULL
U-937	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
)	NULL
,	NULL
IL-6-induced	NULL
U-937	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
,	NULL
and	NULL
THP-1	NULL
(	NULL
lanes	NULL
9	NULL
to	NULL
12	NULL
)	NULL
nuclear	NULL
extracts	NULL
.	NULL

Brackets	NULL
to	NULL
the	NULL
left	NULL
identify	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Probes	NULL
containing	NULL
the	NULL
Varl	NULL
and	NULL
Var2	NULL
ATF/CREB	NULL
binding	NULL
sites	NULL
adjacent	NULL
to	NULL
the	NULL
weakly	NULL
reactive	NULL
3T	NULL
C/EBP	NULL
binding	NULL
site	NULL
were	NULL
reacted	NULL
with	NULL
nuclear	NULL
extract	NULL
from	NULL
IL-6-induced	NULL
U-937	NULL
cells	NULL
in	NULL
EMS	NULL
analyses	NULL
.	NULL

Antisera	NULL
to	NULL
C/EBP	NULL
a	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
7	NULL
,	NULL
11	NULL
,	NULL
15	NULL
,	NULL
19	NULL
,	NULL
and	NULL
23	NULL
)	NULL
and	NULL
C/EBP	NULL
f	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
8	NULL
,	NULL
12	NULL
,	NULL
16	NULL
,	NULL
20	NULL
,	NULL
and	NULL
24	NULL
)	NULL
were	NULL
added	NULL
to	NULL
identify	NULL
the	NULL
quantities	NULL
of	NULL
these	NULL
proteins	NULL
recruited	NULL
to	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

A	NULL
probe	NULL
containing	NULL
the	NULL
single	NULL
3T	NULL
C/EBP	NULL
binding	NULL
site	NULL
was	NULL
included	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
and	NULL
13	NULL
to	NULL
16	NULL
)	NULL
to	NULL
demonstrate	NULL
the	NULL
level	NULL
of	NULL
C/EBP	NULL
recruited	NULL
to	NULL
the	NULL
weakly	NULL
reactive	NULL
site	NULL
alone	NULL
.	NULL

Control	NULL
rabbit	NULL
immunoglobulin	NULL
(	NULL
CS	NULL
)	NULL
was	NULL
added	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
6	NULL
,	NULL
10	NULL
,	NULL
14	NULL
,	NULL
18	NULL
,	NULL
and	NULL
22	NULL
)	NULL
to	NULL
demonstrate	NULL
the	NULL
specific	NULL
nature	NULL
of	NULL
supershifted	NULL
complexes	NULL
.	NULL

Arrows	NULL
to	NULL
the	NULL
right	NULL
indicate	NULL
supershifted	NULL
C/EBP	NULL
complexes	NULL
,	NULL
and	NULL
brackets	NULL
to	NULL
the	NULL
left	NULL
identify	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

The	NULL
EMS	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
probe	NULL
excess	NULL
,	NULL
and	NULL
the	NULL
free	NULL
probe	NULL
accounted	NULL
for	NULL
approximately	NULL
75	NULL
to	NULL
90	NULL
%	NULL
of	NULL
the	NULL
total	NULL
probe	NULL
in	NULL
each	NULL
reaction	NULL
at	NULL
completion	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

C/EBP-CREB-1	NULL
INTERACTION	NULL
REGULATES	NULL
HIV-1	NULL
TRANSCRIPTION	NULL
-	NULL
1847	NULL
probe	NULL
,	NULL
and	NULL
Var4/3T	NULL
enhanced	NULL
binding	NULL
of	NULL
C/EBP	NULL
B	NULL
about	NULL
two-fold	NULL
.	NULL

Based	NULL
on	NULL
these	NULL
results	NULL
,	NULL
the	NULL
level	NULL
of	NULL
enhanced	NULL
binding	NULL
of	NULL
both	NULL
C/EBP	NULL
«	NULL
and	NULL
C/EBP	NULL
B	NULL
appeared	NULL
to	NULL
correlate	NULL
with	NULL
the	NULL
relative	NULL
reactivity	NULL
of	NULL
the	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
for	NULL
CREB-1	NULL
.	NULL

The	NULL
placement	NULL
of	NULL
the	NULL
ATF/CREB	NULL
sites	NULL
adjacent	NULL
to	NULL
the	NULL
weakly	NULL
reactive	NULL
C/EBP	NULL
site	NULL
I	NULL
led	NULL
to	NULL
the	NULL
recruitment	NULL
of	NULL
different	NULL
C/EBP	NULL
factors	NULL
depending	NULL
on	NULL
the	NULL
ATF/CREB	NULL
sequence	NULL
.	NULL

Only	NULL
C/EBP	NULL
a	NULL
proteins	NULL
were	NULL
detected	NULL
with	NULL
the	NULL
weakly	NULL
reactive	NULL
3T	NULL
C/EBP	NULL
binding	NULL
site	NULL
I	NULL
.	NULL

However	NULL
,	NULL
when	NULL
the	NULL
strong	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
variants	NULL
were	NULL
placed	NULL
adjacent	NULL
to	NULL
the	NULL
weakly	NULL
reactive	NULL
C/EBP	NULL
site	NULL
,	NULL
both	NULL
C/EBP	NULL
a	NULL
and	NULL
B	NULL
proteins	NULL
were	NULL
detected	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
mobilities	NULL
of	NULL
the	NULL
supershifted	NULL
C/EBP	NULL
B	NULL
complexes	NULL
appeared	NULL
to	NULL
differ	NULL
,	NULL
dependent	NULL
on	NULL
which	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
was	NULL
placed	NULL
adjacent	NULL
to	NULL
3T	NULL
.	NULL

The	NULL
C/EBP	NULL
B-related	NULL
complex	NULL
detected	NULL
with	NULL
the	NULL
Var1l/3T	NULL
chimera	NULL
appeared	NULL
to	NULL
have	NULL
the	NULL
same	NULL
mobility	NULL
as	NULL
the	NULL
C/EBP	NULL
a	NULL
«	NULL
-related	NULL
complex	NULL
.	NULL

Conversely	NULL
,	NULL
the	NULL
C/EBP	NULL
B-related	NULL
complex	NULL
that	NULL
binds	NULL
to	NULL
Var3/3T	NULL
and	NULL
Var4/3T	NULL
appeared	NULL
to	NULL
have	NULL
a	NULL
much	NULL
lower	NULL
mobility	NULL
than	NULL
the	NULL
C/EBP	NULL
«	NULL
-related	NULL
complex	NULL
,	NULL
most	NULL
likely	NULL
indicative	NULL
of	NULL
differences	NULL
in	NULL
dimerization	NULL
partners	NULL
between	NULL
the	NULL
C/EBP	NULL
family	NULL
members	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
containing	NULL
the	NULL
ATF/CREB	NULL
variants	NULL
exhibit	NULL
differential	NULL
abilities	NULL
to	NULL
compete	NULL
for	NULL
C/EBP	NULL
proteins	NULL
derived	NULL
from	NULL
U-937	NULL
nuclear	NULL
extract	NULL
.	NULL

While	NULL
EMS	NULL
analyses	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
indicated	NULL
that	NULL
the	NULL
four	NULL
ATF/CREB	NULL
variants	NULL
exhibited	NULL
different	NULL
abilities	NULL
to	NULL
enhance	NULL
C/EBP	NULL
binding	NULL
to	NULL
an	NULL
immediately	NULL
adjacent	NULL
weak	NULL
3T	NULL
C/EBP	NULL
binding	NULL
site	NULL
,	NULL
cold	NULL
(	NULL
unlabeled	NULL
)	NULL
competitor	NULL
EMS	NULL
analyses	NULL
were	NULL
performed	NULL
to	NULL
quantitate	NULL
the	NULL
differences	NULL
in	NULL
relative	NULL
C/EBP	NULL
recruitment	NULL
.	NULL

In	NULL
these	NULL
analyses	NULL
,	NULL
a	NULL
radiolabeled	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
strong	NULL
Varl	NULL
ATF/CREB	NULL
and	NULL
weakly	NULL
reactive	NULL
3T	NULL
C/EBP	NULL
binding	NULL
sites	NULL
was	NULL
reacted	NULL
with	NULL
U-937	NULL
nuclear	NULL
extract	NULL
.	NULL

Increasing	NULL
amounts	NULL
of	NULL
unlabeled	NULL
competitor	NULL
oligonucleotides	NULL
Varl/3T	NULL
,	NULL
Var2/3T	NULL
,	NULL
Var3¥/3T	NULL
,	NULL
and	NULL
Var4/3T	NULL
were	NULL
also	NULL
added	NULL
to	NULL
the	NULL
reactions	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
C/EBP	NULL
binding	NULL
(	NULL
C/EBP	NULL
«	NULL
and	NULL
B	NULL
combined	NULL
)	NULL
was	NULL
quantitated	NULL
in	NULL
each	NULL
experiment	NULL
by	NULL
phosphorimaging	NULL
analyses	NULL
.	NULL

Since	NULL
Varl/3T	NULL
appeared	NULL
to	NULL
possess	NULL
the	NULL
highest	NULL
reactivity	NULL
with	NULL
respect	NULL
to	NULL
C/EBP	NULL
factors	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
,	NULL
it	NULL
was	NULL
not	NULL
surprising	NULL
that	NULL
Varl/3T	NULL
exhibited	NULL
the	NULL
highest	NULL
relative	NULL
affinity	NULL
for	NULL
C/EBP	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
,	NULL
with	NULL
about	NULL
a	NULL
40-fold	NULL
molar	NULL
excess	NULL
competitor	NULL
required	NULL
to	NULL
reduce	NULL
the	NULL
C/EBP	NULL
complex	NULL
formation	NULL
by	NULL
50	NULL
%	NULL
.	NULL

However	NULL
,	NULL
under	NULL
most	NULL
circum-stances	NULL
,	NULL
competition	NULL
EMS	NULL
studies	NULL
performed	NULL
with	NULL
a	NULL
single	NULL
protein	NULL
and	NULL
the	NULL
corresponding	NULL
binding	NULL
site	NULL
would	NULL
result	NULL
in	NULL
a	NULL
50	NULL
%	NULL
reduction	NULL
in	NULL
DNA-protein	NULL
complex	NULL
formation	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
fivefold	NULL
excess	NULL
unlabeled	NULL
homologous	NULL
competitor	NULL
oligonucleotide	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
a	NULL
result	NULL
,	NULL
the	NULL
larger	NULL
amount	NULL
of	NULL
excess	NULL
competitor	NULL
required	NULL
to	NULL
obtain	NULL
a	NULL
50	NULL
%	NULL
reduction	NULL
with	NULL
the	NULL
chimeric	NULL
V1/3T	NULL
probe	NULL
in	NULL
homologous	NULL
competition	NULL
suggests	NULL
that	NULL
complex	NULL
interactions	NULL
between	NULL
the	NULL
ATF/CREB	NULL
and	NULL
C/EBP	NULL
factors	NULL
at	NULL
these	NULL
two	NULL
binding	NULL
sites	NULL
are	NULL
required	NULL
to	NULL
enhance	NULL
binding	NULL
of	NULL
C/EBP	NULL
«	NULL
and	NULL
B	NULL
.	NULL

Given	NULL
the	NULL
apparent	NULL
low	NULL
relative	NULL
reactivity	NULL
of	NULL
Var2/3T	NULL
and	NULL
Vard4/3T	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
for	NULL
C/EBP	NULL
proteins	NULL
,	NULL
it	NULL
was	NULL
not	NULL
surprising	NULL
that	NULL
unlabeled	NULL
oligonucleotides	NULL
containing	NULL
both	NULL
Var2/3T	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
and	NULL
Vard4/3T	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
competed	NULL
with	NULL
Varl/3T	NULL
for	NULL
C/EBP	NULL
binding	NULL
very	NULL
poorly	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
the	NULL
highest	NULL
amount	NULL
of	NULL
Var2/3T	NULL
competitor	NULL
(	NULL
100	NULL
%	NULL
)	NULL
decreased	NULL
C/EBP	NULL
recruitment	NULL
to	NULL
the	NULL
labeled	NULL
Varl/3T	NULL
probe	NULL
only	NULL
about	NULL
30	NULL
%	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

The	NULL
Var4/3T	NULL
competitor	NULL
decreased	NULL
C/EBP	NULL
recruitment	NULL
about	NULL
40	NULL
%	NULL
.	NULL

The	NULL
situation	NULL
became	NULL
much	NULL
more	NULL
complex	NULL
,	NULL
however	NULL
,	NULL
when	NULL
1848	NULL
ROSS	NULL
ET	NULL
AL	NULL
.	NULL

Labeled	NULL
Probe	NULL
:	NULL
A	NULL
f	NULL
competitor	NULL
:	NULL
Var1/3T	NULL
%	NULL
1.8	NULL
w	NULL
5	NULL
0	NULL
%	NULL
1.4	NULL
¥€	NULL
©	NULL
°	NULL
2	NULL
x	NULL
E0	NULL
se	NULL
22	NULL
0	NULL
*	NULL
02	NULL
f	NULL
20	NULL
_	NULL
40	NULL
60	NULL
so	NULL
_	NULL
100	NULL
Fold	NULL
competition	NULL
B	NULL
.	NULL

competitor	NULL
:	NULL
Var2/3T	NULL
1.8	NULL
&	NULL
u	NULL
5	NULL
0	NULL
%	NULL
x	NULL
E	NULL
©	NULL
°	NULL
2	NULL
x	NULL
E	NULL
®	NULL
58	NULL
a	NULL
100	NULL
20	NULL
40	NULL
60	NULL
80	NULL
Fold	NULL
competition	NULL
J.	NULL
Virou	NULL
.	NULL

CREB	NULL
C/EBP	NULL
Vari	NULL
3T	NULL
C	NULL
competitor	NULL
:	NULL
Var3/3T	NULL
ax	NULL
co	NULL
s	NULL
B	NULL
o	NULL
&	NULL
%	NULL
uncompeted	NULL
C/EBP	NULL
complex	NULL
formation	NULL
=	NULL
o	NULL
ho	NULL
20	NULL
-	NULL
40	NULL
_	NULL
60	NULL
_	NULL
80	NULL
_	NULL
100	NULL
Fold	NULL
competition	NULL
O	NULL
competitor	NULL
:	NULL
Var4/3T	NULL
sa	NULL
co	NULL
M	NULL
B	NULL
complex	NULL
formation	NULL
o	NULL
st	NULL
&	NULL
0	NULL
%	NULL
uncompeted	NULL
C/EBP	NULL
mg	NULL
ho	NULL
100	NULL
20	NULL
40	NULL
60	NULL
80	NULL
Fold	NULL
competition	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

ATF/CREB	NULL
variants	NULL
adjacent	NULL
to	NULL
the	NULL
weakly	NULL
reactive	NULL
3T	NULL
C/EBP	NULL
binding	NULL
site	NULL
exhibit	NULL
differential	NULL
abilities	NULL
to	NULL
compete	NULL
for	NULL
C/EBP	NULL
proteins	NULL
derived	NULL
from	NULL
U-937	NULL
monocytic	NULL
nuclear	NULL
extract	NULL
.	NULL

Radiolabeled	NULL
Varl/3T	NULL
probe	NULL
was	NULL
reacted	NULL
with	NULL
U-937	NULL
nuclear	NULL
extract	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
unlabeled	NULL
competitor	NULL
oligonucleotide	NULL
Varl/3T	NULL
(	NULL
A	NULL
)	NULL
,	NULL
Var2/3T	NULL
(	NULL
B	NULL
)	NULL
,	NULL
Var3/3T	NULL
(	NULL
C	NULL
)	NULL
,	NULL
or	NULL
Var	NULL
4/3T	NULL
(	NULL
D	NULL
)	NULL
in	NULL
EMS	NULL
analyses	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
remaining	NULL
radioactive	NULL
C/EBP	NULL
complex	NULL
was	NULL
quantitated	NULL
by	NULL
phosphorimaging	NULL
analyses	NULL
.	NULL

The	NULL
fold	NULL
amount	NULL
of	NULL
competitor	NULL
required	NULL
to	NULL
decrease	NULL
C/EBP	NULL
binding	NULL
by	NULL
50	NULL
%	NULL
is	NULL
illustrated	NULL
with	NULL
a	NULL
dashed	NULL
line	NULL
.	NULL

Each	NULL
graph	NULL
is	NULL
the	NULL
summary	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

The	NULL
EMS	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
probe	NULL
excess	NULL
,	NULL
and	NULL
the	NULL
free	NULL
probe	NULL
accounted	NULL
for	NULL
approximately	NULL
75	NULL
to	NULL
90	NULL
%	NULL
of	NULL
the	NULL
total	NULL
probe	NULL
in	NULL
each	NULL
reaction	NULL
at	NULL
completion	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Var3/3T	NULL
competitor	NULL
was	NULL
added	NULL
to	NULL
the	NULL
EMS	NULL
reactions	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
C/EBP	NULL
binding	NULL
to	NULL
the	NULL
radiolabeled	NULL
Var1l/3T	NULL
oligonucleotide	NULL
was	NULL
actually	NULL
enhanced	NULL
,	NULL
rather	NULL
than	NULL
reduced	NULL
.	NULL

C/EBP	NULL
binding	NULL
was	NULL
increased	NULL
up	NULL
to	NULL
50	NULL
%	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
about	NULL
30-fold-excess	NULL
unlabeled	NULL
competitor	NULL
,	NULL
while	NULL
unlabeled	NULL
competitor	NULL
levels	NULL
greater	NULL
than	NULL
50-fold	NULL
excess	NULL
did	NULL
not	NULL
result	NULL
in	NULL
enhancement	NULL
or	NULL
reduction	NULL
in	NULL
reactive	NULL
C/EBP	NULL
-containing	NULL
complex	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
the	NULL
enhancement	NULL
of	NULL
C/EBP	NULL
binding	NULL
was	NULL
likely	NULL
due	NULL
to	NULL
the	NULL
high	NULL
relative	NULL
affinity	NULL
of	NULL
Var3/3T	NULL
for	NULL
CREB	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
with	NULL
the	NULL
Var3/3T	NULL
cold	NULL
competitor	NULL
oligonucleotide	NULL
binding	NULL
specific	NULL
CREB-related	NULL
proteins	NULL
that	NULL
may	NULL
normally	NULL
be	NULL
recruited	NULL
to	NULL
Var1	NULL
,	NULL
which	NULL
exhibits	NULL
a	NULL
very	NULL
high	NULL
relative	NULL
affinity	NULL
for	NULL
CREB	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Some	NULL
of	NULL
these	NULL
CREB-related	NULL
proteins	NULL
may	NULL
inhibit	NULL
enhancement	NULL
of	NULL
C/EBP	NULL
binding	NULL
.	NULL

With	NULL
the	NULL
addition	NULL
of	NULL
Var3/3T	NULL
competitor	NULL
,	NULL
these	NULL
CREB-related	NULL
proteins	NULL
were	NULL
sequestered	NULL
from	NULL
the	NULL
radiolabeled	NULL
Var1/3T	NULL
,	NULL
and	NULL
allowed	NULL
additional	NULL
levels	NULL
of	NULL
CREB-1	NULL
to	NULL
bind	NULL
Var1/3T	NULL
.	NULL

This	NULL
resulted	NULL
in	NULL
an	NULL
even	NULL
greater	NULL
enhancement	NULL
of	NULL
C/EBP	NULL
binding	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
illustrate	NULL
enhanced	NULL
binding	NULL
of	NULL
C/EBP	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CREB	NULL
but	NULL
were	NULL
unsuccessful	NULL
at	NULL
this	NULL
point	NULL
,	NULL
due	NULL
in	NULL
part	NULL
to	NULL
the	NULL
apparent	NULL
complexities	NULL
of	NULL
the	NULL
DNA-protein	NULL
and	NULL
protein-protein	NULL
interactions	NULL
involved	NULL
in	NULL
the	NULL
observed	NULL
enhancement	NULL
.	NULL

Specifically	NULL
,	NULL
these	NULL
studies	NULL
were	NULL
performed	NULL
with	NULL
partially	NULL
purified	NULL
,	NULL
bacterially	NULL
ex-pressed	NULL
,	NULL
six-histidine-tagged	NULL
C/EBP	NULL
B	NULL
and	NULL
CREB-1	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
U-937	NULL
nuclear	NULL
extract	NULL
.	NULL

Although	NULL
footprints	NULL
with	NULL
C/EBP	NULL
B	NULL
and	NULL
CREB-1	NULL
were	NULL
readily	NULL
formed	NULL
in	NULL
the	NULL
appropriate	NULL
region	NULL
of	NULL
the	NULL
LTR	NULL
,	NULL
enhanced	NULL
binding	NULL
of	NULL
bacterially	NULL
expressed	NULL
six-histidine-tagged	NULL
C/EBP	NULL
B	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
to	NULL
a	NULL
radiolabeled	NULL
LTR	NULL
204-bp	NULL
probe	NULL
containing	NULL
the	NULL
3T	NULL
C/EBP	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
bacterially	NULL
expressed	NULL
six-histidine-tagged	NULL
CREB-1	NULL
capable	NULL
of	NULL
a	NULL
high-affinity	NULL
interaction	NULL
with	NULL
the	NULL
immediately	NULL
adjacent	NULL
ATF/CREB	NULL
site	NULL
(	NULL
Varl	NULL
)	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
the	NULL
DNA-protein	NULL
and	NULL
protein-protein	NULL
interactions	NULL
are	NULL
too	NULL
complex	NULL
to	NULL
enable	NULL
us	NULL
to	NULL
illustrate	NULL
enhanced	NULL
C/EBP	NULL
binding	NULL
by	NULL
interaction	NULL
with	NULL
ATF/CREB	NULL
factors	NULL
using	NULL
purified	NULL
proteins	NULL
at	NULL
this	NULL
time	NULL
.	NULL

As	NULL
reported	NULL
by	NULL
other	NULL
investiga-tors	NULL
,	NULL
CREB-1	NULL
likely	NULL
interacts	NULL
with	NULL
other	NULL
proteins	NULL
by	NULL
bridging	NULL
with	NULL
CREB	NULL
binding	NULL
protein	NULL
(	NULL
CBP	NULL
)	NULL
(	NULL
5	NULL
,	NULL
10	NULL
,	NULL
11	NULL
,	NULL
20	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
these	NULL
studies	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
the	NULL
enhancement	NULL
of	NULL
C/EBP	NULL
binding	NULL
by	NULL
CREB-1	NULL
is	NULL
due	NULL
to	NULL
interactions	NULL
with	NULL
CBP	NULL
or	NULL
its	NULL
homologue	NULL
,	NULL
p300	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
CREB-1	NULL
with	NULL
CBP	NULL
that	NULL
may	NULL
be	NULL
required	NULL
to	NULL
enhance	NULL
C/EBP	NULL
binding	NULL
may	NULL
entail	NULL
specific	NULL
phosphorylation	NULL
of	NULL
CREB-1	NULL
that	NULL
does	NULL
not	NULL
occur	NULL
in	NULL
the	NULL
bacterial	NULL
system	NULL
.	NULL

At	NULL
present	NULL
,	NULL
we	NULL
do	NULL
not	NULL
have	NULL
enough	NULL
information	NULL
concerning	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
the	NULL
proteins	NULL
required	NULL
for	NULL
the	NULL
interactions	NULL
leading	NULL
to	NULL
enhanced	NULL
C/EBP	NULL
binding	NULL
.	NULL

Ad-ditional	NULL
,	NULL
extensive	NULL
experimentation	NULL
is	NULL
needed	NULL
to	NULL
address	NULL
the	NULL
apparent	NULL
complexities	NULL
of	NULL
these	NULL
interactions	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
DNase	NULL
I	NULL
footprinting	NULL
analyses	NULL
were	NULL
performed	NULL
with	NULL
LTR	NULL
probes	NULL
containing	NULL
the	NULL
C/EBP	NULL
and	NULL
ATF/CREB	NULL
region	NULL
with	NULL
U-937	NULL
nuclear	NULL
extract	NULL
.	NULL

These	NULL
experiments	NULL
were	NULL
also	NULL
unsuccessful	NULL
in	NULL
demonstrating	NULL
the	NULL
sequence-specific	NULL
enhancement	NULL
of	NULL
C/EBP	NULL
binding	NULL
by	NULL
ATF/CREB	NULL
factors	NULL
.	NULL

However	NULL
,	NULL
this	NULL
was	NULL
not	NULL
surprising	NULL
since	NULL
a	NULL
number	NULL
of	NULL
other	NULL
investigators	NULL
have	NULL
Vor	NULL
.	NULL

75	NULL
,	NULL
2001	NULL
reported	NULL
difficulties	NULL
in	NULL
forming	NULL
footprints	NULL
in	NULL
DNase	NULL
I	NULL
footprinting	NULL
analyses	NULL
when	NULL
examining	NULL
interactions	NULL
of	NULL
nuclear	NULL
proteins	NULL
present	NULL
in	NULL
lower	NULL
abundances	NULL
(	NULL
14	NULL
,	NULL
43	NULL
)	NULL
,	NULL
compared	NULL
to	NULL
readily	NULL
demonstrable	NULL
footprints	NULL
at	NULL
the	NULL
binding	NULL
sites	NULL
and	NULL
Sp	NULL
GC	NULL
box	NULL
array	NULL
with	NULL
the	NULL
corresponding	NULL
factors	NULL
present	NULL
in	NULL
U-937	NULL
nuclear	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Enhanced	NULL
C/EBP	NULL
binding	NULL
is	NULL
due	NULL
in	NULL
part	NULL
to	NULL
heterodimerization	NULL
with	NULL
CREB-1	NULL
and	NULL
subsequent	NULL
binding	NULL
to	NULL
a	NULL
hybrid	NULL
site	NULL
consisting	NULL
of	NULL
adjacent	NULL
ATF/CREB	NULL
and	NULL
C/EBP	NULL
half	NULL
sites	NULL
.	NULL

At	NULL
least	NULL
three	NULL
possible	NULL
mechanisms	NULL
might	NULL
explain	NULL
how	NULL
CREB	NULL
proteins	NULL
enhance	NULL
the	NULL
recruitment	NULL
of	NULL
C/EBP	NULL
proteins	NULL
to	NULL
an	NULL
adjacent	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

First	NULL
,	NULL
CREB	NULL
and	NULL
C/EBP	NULL
could	NULL
heterodimerize	NULL
and	NULL
bind	NULL
to	NULL
the	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
model	NULL
1	NULL
)	NULL
.	NULL

The	NULL
second	NULL
possible	NULL
mechanism	NULL
also	NULL
involves	NULL
heterodimerization	NULL
between	NULL
the	NULL
two	NULL
families	NULL
of	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
model	NULL
2	NULL
)	NULL
.	NULL

In	NULL
this	NULL
scenario	NULL
,	NULL
CREB-C/EBP	NULL
heterodimers	NULL
bind	NULL
to	NULL
a	NULL
hybrid	NULL
site	NULL
created	NULL
by	NULL
CREB	NULL
and	NULL
C/EBP	NULL
half	NULL
sites	NULL
.	NULL

Heterodimerization	NULL
between	NULL
these	NULL
two	NULL
families	NULL
of	NULL
proteins	NULL
has	NULL
been	NULL
reported	NULL
previously	NULL
,	NULL
as	NULL
has	NULL
binding	NULL
of	NULL
such	NULL
heterodimers	NULL
to	NULL
unique	NULL
CREB	NULL
binding	NULL
site	NULL
sequences	NULL
or	NULL
hybrid	NULL
sites	NULL
consisting	NULL
of	NULL
CREB	NULL
and	NULL
C/EBP	NULL
half	NULL
sites	NULL
(	NULL
35	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Lastly	NULL
,	NULL
CREB	NULL
homodimers	NULL
could	NULL
bind	NULL
to	NULL
their	NULL
cognate	NULL
sequence	NULL
and	NULL
recruit	NULL
C/EBP	NULL
dimers	NULL
to	NULL
the	NULL
adjacent	NULL
weakly	NULL
reactive	NULL
C/EBP	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
model	NULL
3	NULL
)	NULL
.	NULL

To	NULL
distinguish	NULL
between	NULL
the	NULL
three	NULL
possible	NULL
mechanisms	NULL
by	NULL
which	NULL
C/EBP	NULL
binding	NULL
was	NULL
enhanced	NULL
,	NULL
we	NULL
first	NULL
proceeded	NULL
to	NULL
determine	NULL
whether	NULL
heterodimers	NULL
of	NULL
CREB	NULL
and	NULL
C/EBP	NULL
proteins	NULL
could	NULL
be	NULL
recruited	NULL
to	NULL
a	NULL
hybrid	NULL
binding	NULL
site	NULL
as	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

SA	NULL
,	NULL
model	NULL
2	NULL
.	NULL

This	NULL
binding	NULL
site	NULL
consists	NULL
of	NULL
one	NULL
half	NULL
of	NULL
the	NULL
ATF/CREB	NULL
site	NULL
and	NULL
the	NULL
adjacent	NULL
half	NULL
of	NULL
the	NULL
weakly	NULL
reactive	NULL
3T	NULL
C/EBP	NULL
binding	NULL
site	NULL
.	NULL

First	NULL
,	NULL
a	NULL
chimeric	NULL
oligonucleotide	NULL
probe	NULL
consisting	NULL
of	NULL
the	NULL
adjacent	NULL
half	NULL
sites	NULL
from	NULL
both	NULL
the	NULL
Varl	NULL
ATF/	NULL
CREB	NULL
site	NULL
and	NULL
the	NULL
3T	NULL
C/EBP	NULL
binding	NULL
site	NULL
was	NULL
constructed	NULL
.	NULL

This	NULL
probe	NULL
was	NULL
reacted	NULL
with	NULL
U-937	NULL
and	NULL
IL-6-induced	NULL
U-937	NULL
nuclear	NULL
extracts	NULL
in	NULL
EMS	NULL
analyses	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

The	NULL
DNA-protein	NULL
complexes	NULL
that	NULL
formed	NULL
with	NULL
this	NULL
hybrid	NULL
binding	NULL
site	NULL
did	NULL
not	NULL
differ	NULL
significantly	NULL
between	NULL
the	NULL
U-937	NULL
and	NULL
IL-6-stimulated	NULL
U-937	NULL
nuclear	NULL
extracts	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
C/EBP	NULL
«	NULL
-specific	NULL
antibody	NULL
to	NULL
the	NULL
EMS	NULL
reactions	NULL
with	NULL
both	NULL
nuclear	NULL
extracts	NULL
indicated	NULL
that	NULL
C/EBP	NULL
a	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
8	NULL
)	NULL
and	NULL
a	NULL
small	NULL
amount	NULL
of	NULL
C/EBP	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
9	NULL
)	NULL
were	NULL
recruited	NULL
to	NULL
the	NULL
hybrid	NULL
site	NULL
.	NULL

Supershift	NULL
EMS	NULL
reactions	NULL
containing	NULL
CREB-1	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
10	NULL
)	NULL
also	NULL
indicated	NULL
that	NULL
CREB-1	NULL
was	NULL
recruited	NULL
to	NULL
the	NULL
hybrid	NULL
site	NULL
with	NULL
the	NULL
U-937	NULL
and	NULL
IL-6-stimulated	NULL
U-937	NULL
nuclear	NULL
extracts	NULL
.	NULL

The	NULL
CREB-1-containing	NULL
supershifted	NULL
complex	NULL
migrated	NULL
at	NULL
the	NULL
same	NULL
rate	NULL
as	NULL
a	NULL
faint	NULL
C/EBP	NULL
a	NULL
supershift	NULL
(	NULL
the	NULL
faster	NULL
migrating	NULL
of	NULL
the	NULL
two	NULL
supershifted	NULL
complexes	NULL
observed	NULL
with	NULL
C/EBP	NULL
«	NULL
antisera	NULL
and	NULL
most	NULL
noticeable	NULL
with	NULL
the	NULL
IL-6-induced	NULL
extract	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
these	NULL
two	NULL
family	NULL
members	NULL
were	NULL
likely	NULL
heterodimerizing	NULL
at	NULL
this	NULL
hybrid	NULL
binding	NULL
site	NULL
in	NULL
very	NULL
small	NULL
amounts	NULL
.	NULL

The	NULL
remainder	NULL
of	NULL
the	NULL
proteins	NULL
recognizing	NULL
the	NULL
binding	NULL
site	NULL
were	NULL
likely	NULL
binding	NULL
as	NULL
homodimers	NULL
.	NULL

However	NULL
,	NULL
when	NULL
the	NULL
quantities	NULL
of	NULL
supershifted	NULL
C/EBP	NULL
proteins	NULL
recruited	NULL
to	NULL
the	NULL
hybrid	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9	NULL
)	NULL
were	NULL
compared	NULL
to	NULL
the	NULL
quantities	NULL
of	NULL
supershifted	NULL
C/EBP	NULL
proteins	NULL
that	NULL
were	NULL
recruited	NULL
to	NULL
the	NULL
entire	NULL
Var1l/3T	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
it	NULL
appeared	NULL
that	NULL
CREB-C/EBP	NULL
heterodimer	NULL
formation	NULL
at	NULL
the	NULL
hybrid	NULL
binding	NULL
site	NULL
accounted	NULL
for	NULL
only	NULL
a	NULL
small	NULL
amount	NULL
of	NULL
the	NULL
enhanced	NULL
C/EBP	NULL
binding	NULL
detected	NULL
with	NULL
the	NULL
C/EBP-CREB-1	NULL
INTERACTION	NULL
REGULATES	NULL
HIV-1	NULL
TRANSCRIPTION	NULL
-	NULL
1849	NULL
Var1/3T	NULL
probe	NULL
.	NULL

This	NULL
indicated	NULL
that	NULL
only	NULL
a	NULL
small	NULL
quantity	NULL
of	NULL
the	NULL
enhanced	NULL
C/EBP	NULL
binding	NULL
that	NULL
occurred	NULL
at	NULL
C/EBP	NULL
site	NULL
I	NULL
was	NULL
likely	NULL
due	NULL
to	NULL
heterodimerization	NULL
between	NULL
CREB-1	NULL
and	NULL
C/EBP	NULL
a	NULL
at	NULL
a	NULL
hybrid	NULL
site	NULL
created	NULL
by	NULL
the	NULL
directly	NULL
adjacent	NULL
cis-acting	NULL
elements	NULL
.	NULL

The	NULL
remaining	NULL
enhancement	NULL
was	NULL
due	NULL
to	NULL
one	NULL
of	NULL
the	NULL
other	NULL
two	NULL
mechanisms	NULL
detailed	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
.	NULL

As	NULL
previously	NULL
indicated	NULL
,	NULL
the	NULL
four	NULL
chimeric	NULL
CREB-C/EBP	NULL
probes	NULL
have	NULL
different	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
sequence	NULL
configurations	NULL
adjacent	NULL
to	NULL
the	NULL
weakly	NULL
reactive	NULL
3T	NULL
binding	NULL
site	NULL
.	NULL

As	NULL
a	NULL
result	NULL
,	NULL
all	NULL
four	NULL
ATF/CREB	NULL
variants	NULL
potentially	NULL
have	NULL
different	NULL
hybrid	NULL
binding	NULL
sites	NULL
.	NULL

Results	NULL
similar	NULL
to	NULL
those	NULL
observed	NULL
with	NULL
the	NULL
Varl	NULL
half	NULL
site	NULL
were	NULL
also	NULL
observed	NULL
with	NULL
the	NULL
Var2	NULL
and	NULL
Var3	NULL
half	NULL
sites	NULL
in	NULL
that	NULL
small	NULL
quantities	NULL
of	NULL
C/EBP	NULL
protein	NULL
were	NULL
detected	NULL
in	NULL
EMS	NULL
supershift	NULL
analyses	NULL
sites	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
hybrid	NULL
binding	NULL
site	NULL
created	NULL
by	NULL
the	NULL
adjacent	NULL
Var4	NULL
ATF/CREB	NULL
and	NULL
3T	NULL
C/EBP	NULL
binding	NULL
sites	NULL
was	NULL
quite	NULL
different	NULL
.	NULL

When	NULL
the	NULL
Var4/3T	NULL
hybrid	NULL
half	NULL
site	NULL
probe	NULL
was	NULL
reacted	NULL
in	NULL
supershift	NULL
EMS	NULL
reactions	NULL
with	NULL
nuclear	NULL
extract	NULL
prepared	NULL
from	NULL
IL-6-stimulated	NULL
U-937	NULL
cells	NULL
,	NULL
C/EBP	NULL
a	NULL
was	NULL
readily	NULL
detectable	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

As	NULL
a	NULL
comparison	NULL
,	NULL
similar	NULL
reactions	NULL
were	NULL
conducted	NULL
with	NULL
the	NULL
strong	NULL
6G	NULL
C/EBP	NULL
binding	NULL
site	NULL
I	NULL
(	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
Var4/3T	NULL
hybrid	NULL
half	NULL
site	NULL
probe	NULL
recruited	NULL
even	NULL
greater	NULL
amounts	NULL
of	NULL
C/EBP	NULL
than	NULL
did	NULL
the	NULL
highly	NULL
reactive	NULL
6G	NULL
full-length	NULL
binding	NULL
site	NULL
alone	NULL
.	NULL

This	NULL
difference	NULL
was	NULL
not	NULL
due	NULL
to	NULL
differences	NULL
in	NULL
the	NULL
specific	NULL
activities	NULL
of	NULL
the	NULL
probes	NULL
,	NULL
as	NULL
the	NULL
two	NULL
probes	NULL
exhibited	NULL
the	NULL
same	NULL
specific	NULL
activity	NULL
.	NULL

Thus	NULL
,	NULL
while	NULL
three	NULL
of	NULL
the	NULL
hybrid	NULL
half	NULL
sites	NULL
(	NULL
those	NULL
including	NULL
Varl	NULL
,	NULL
Var2	NULL
,	NULL
and	NULL
Var3	NULL
)	NULL
bound	NULL
only	NULL
very	NULL
small	NULL
amounts	NULL
of	NULL
C/EBP	NULL
factors	NULL
,	NULL
the	NULL
Var4	NULL
half	NULL
site	NULL
adjacent	NULL
to	NULL
half	NULL
of	NULL
the	NULL
3T	NULL
binding	NULL
site	NULL
appeared	NULL
to	NULL
recruit	NULL
abundant	NULL
levels	NULL
of	NULL
both	NULL
C/EBP	NULL
«	NULL
.	NULL

However	NULL
,	NULL
no	NULL
CREB	NULL
proteins	NULL
were	NULL
detected	NULL
in	NULL
supershift	NULL
EMS	NULL
analysis	NULL
involving	NULL
the	NULL
Var4/3T	NULL
hybrid	NULL
half	NULL
site	NULL
probe	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
adjacent	NULL
half	NULL
sites	NULL
of	NULL
Var	NULL
4	NULL
and	NULL
the	NULL
3T	NULL
C/EBP	NULL
site	NULL
created	NULL
a	NULL
strong	NULL
C/EBP	NULL
binding	NULL
site	NULL
(	NULL
instead	NULL
of	NULL
a	NULL
weak	NULL
binding	NULL
site	NULL
enhanced	NULL
by	NULL
CREB	NULL
binding	NULL
[	NULL
data	NULL
not	NULL
shown	NULL
]	NULL
)	NULL
.	NULL

In	NULL
this	NULL
instance	NULL
,	NULL
sequence	NULL
variation	NULL
appears	NULL
to	NULL
lead	NULL
to	NULL
a	NULL
new	NULL
binding	NULL
site	NULL
that	NULL
would	NULL
be	NULL
present	NULL
in	NULL
a	NULL
subset	NULL
of	NULL
HIV-1	NULL
LTRs	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
C/EBP	NULL
proteins	NULL
were	NULL
indeed	NULL
being	NULL
recruited	NULL
to	NULL
a	NULL
hybrid	NULL
Var4/3T	NULL
binding	NULL
site	NULL
,	NULL
DNase	NULL
I	NULL
footprinting	NULL
analyses	NULL
were	NULL
conducted	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
)	NULL
.	NULL

A	NULL
204-bp	NULL
radiolabeled	NULL
probe	NULL
was	NULL
generated	NULL
that	NULL
contained	NULL
the	NULL
Var4	NULL
ATF/CREB	NULL
site	NULL
and	NULL
the	NULL
3T	NULL
C/EBP	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

This	NULL
probe	NULL
was	NULL
reacted	NULL
with	NULL
DNase	NULL
I	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
with	NULL
DNase	NULL
I	NULL
and	NULL
purified	NULL
six-histidine-tagged	NULL
C/EBP	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

As	NULL
a	NULL
comparison	NULL
,	NULL
similar	NULL
reactions	NULL
were	NULL
prepared	NULL
using	NULL
a	NULL
radiolabeled	NULL
probe	NULL
that	NULL
contained	NULL
a	NULL
strong	NULL
6G	NULL
C/EBP	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
to	NULL
visualize	NULL
the	NULL
region	NULL
of	NULL
DNase	NULL
I	NULL
footprinting	NULL
observed	NULL
with	NULL
a	NULL
highly	NULL
reactive	NULL
C/EBP	NULL
site	NULL
.	NULL

As	NULL
shown	NULL
,	NULL
the	NULL
region	NULL
of	NULL
DNase	NULL
I	NULL
footprinting	NULL
with	NULL
the	NULL
Var4/3T	NULL
binding	NULL
sites	NULL
spanned	NULL
approximately	NULL
half	NULL
of	NULL
the	NULL
C/EBP	NULL
and	NULL
ATF/CREB	NULL
binding	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
C/EBP	NULL
binding	NULL
to	NULL
the	NULL
probe	NULL
containing	NULL
the	NULL
highly	NULL
reactive	NULL
6G	NULL
C/EBP	NULL
site	NULL
was	NULL
limited	NULL
to	NULL
the	NULL
region	NULL
encompassing	NULL
the	NULL
C/EBP	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
adjacent	NULL
Var4	NULL
ATF/CREB	NULL
and	NULL
the	NULL
3T	NULL
C/EBP	NULL
binding	NULL
sites	NULL
do	NULL
indeed	NULL
create	NULL
a	NULL
hybrid	NULL
binding	NULL
site	NULL
with	NULL
increased	NULL
affinity	NULL
for	NULL
C/EBP	NULL
protein	NULL
.	NULL

CREB-1-containing	NULL
dimers	NULL
,	NULL
bound	NULL
to	NULL
their	NULL
cognate	NULL
sequence	NULL
,	NULL
also	NULL
recruit	NULL
C/EBP	NULL
dimers	NULL
to	NULL
the	NULL
weakly	NULL
reactive	NULL
C/EBP	NULL
site	NULL
I	NULL
.	NULL

To	NULL
further	NULL
distinguish	NULL
between	NULL
the	NULL
mechanisms	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
binding	NULL
to	NULL
the	NULL
Var1l/3T	NULL
oligonucleotide	NULL
1850	NULL
ROSS	NULL
ET	NULL
AL	NULL
.	NULL

J.	NULL
VirRou	NULL
.	NULL

A	NULL
C/EBP	NULL
|	NULL
C/EBP	NULL
3	NULL
.	NULL

C/EBP	NULL
binding	NULL
site	NULL
B	NULL
Extract	NULL
:	NULL
U-937	NULL
IL-6-induced	NULL
D	NULL
U-937	NULL
CREB-C/EBP	NULL
configuration	NULL
:	NULL
Var4/3T	NULL
Var1/6G	NULL
s	NULL
C/EBP	NULL
a	NULL
C/EBP	NULL
Antisera	NULL
:	NULL
-	NULL
i	NULL
}	NULL
Lanes	NULL
:	NULL
10	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
b	NULL
#	NULL
~	NULL
DNase	NULL
only	NULL
roe	NULL
-	NULL
Oeil	NULL
+	NULL
ccer	NULL
3	NULL
DNase	NULL
only	NULL
a	NULL
ow	NULL
-	NULL
+	NULL
orer	NULL
c	NULL
Probe	NULL
:	NULL
half	NULL
Var	NULL
?	NULL

/haif	NULL
3T	NULL
-	NULL
-C-	NULL
%	NULL
#	NULL
4	NULL
CREB	NULL
C/EBP	NULL
me	NULL
.	NULL

**	NULL
w-§	NULL
]	NULL
5	NULL
p	NULL
®	NULL
C	NULL
Probe	NULL
:	NULL
6G	NULL
C/EBP	NULL
site	NULL
|	NULL
half	NULL
Var4/half	NULL
8T	NULL
L	NULL
hnd	NULL
ma	NULL
GO	NULL
t	NULL
«	NULL
»	NULL
we	NULL
Antisera	NULL
:	NULL
3	NULL
pet	NULL
f	NULL
oo	NULL
«	NULL
thts	NULL
LL	NULL
.	NULL

S	NULL
*	NULL
t	NULL
5	NULL
«	NULL
»	NULL
am	NULL
*	NULL
LL	NULL
C/EBP	NULL
complex	NULL
[	NULL
_	NULL
Extract	NULL
:	NULL
<	NULL
«	NULL
»	NULL
IL-6-induced	NULL
U-937	NULL
Lanes	NULL
:	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
-	NULL
1	NULL
:	NULL
i	NULL
~	NULL
make	NULL
co	NULL
Wts	NULL
4	NULL
~~	NULL
Wile	NULL
Lanes	NULL
:	NULL
Probe	NULL
:	NULL
half	NULL
Var4/haif	NULL
3T	NULL
-	NULL
-C-	NULL
CREB	NULL
C/EBP	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Recruitment	NULL
of	NULL
different	NULL
levels	NULL
of	NULL
CREB-C/EBP	NULL
heterodimers	NULL
and	NULL
C/EBP	NULL
homodimers	NULL
in	NULL
EMS	NULL
analyses	NULL
is	NULL
dependent	NULL
on	NULL
ATF/CREB	NULL
sequence	NULL
variation	NULL
at	NULL
hybrid	NULL
binding	NULL
sites	NULL
containing	NULL
adjacent	NULL
half	NULL
sites	NULL
of	NULL
the	NULL
ATF/CREB	NULL
and	NULL
C/EBP	NULL
binding	NULL
sites	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Several	NULL
mechanisms	NULL
may	NULL
explain	NULL
CREB	NULL
enhancement	NULL
of	NULL
C/EBP	NULL
recruitment	NULL
.	NULL

CREB/C/EBP	NULL
heterodimers	NULL
may	NULL
bind	NULL
to	NULL
the	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
(	NULL
model	NULL
1	NULL
)	NULL
,	NULL
or	NULL
CREB/C/EBP	NULL
heterodimers	NULL
may	NULL
bind	NULL
to	NULL
a	NULL
chimeric	NULL
binding	NULL
site	NULL
created	NULL
by	NULL
half	NULL
sites	NULL
from	NULL
the	NULL
ATF/CREB	NULL
and	NULL
C/EBP	NULL
binding	NULL
sites	NULL
(	NULL
model	NULL
2	NULL
)	NULL
.	NULL

CREB	NULL
homodimers	NULL
may	NULL
bind	NULL
to	NULL
the	NULL
ATF/CREB	NULL
site	NULL
and	NULL
recruit	NULL
C/EBP	NULL
dimers	NULL
to	NULL
their	NULL
cognate	NULL
sequence	NULL
(	NULL
model	NULL
3	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
Varl/3T	NULL
hybrid	NULL
half-site	NULL
probe	NULL
was	NULL
reacted	NULL
with	NULL
U-937	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
and	NULL
IL-6-induced	NULL
U-937	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
nuclear	NULL
extracts	NULL
.	NULL

Monoclonal	NULL
antisera	NULL
directed	NULL
against	NULL
C/EBP	NULL
proteins	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9	NULL
)	NULL
and	NULL
CREB-1	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
10	NULL
)	NULL
were	NULL
added	NULL
to	NULL
the	NULL
EMS	NULL
reactions	NULL
to	NULL
identify	NULL
the	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
hybrid	NULL
half	NULL
sites	NULL
.	NULL

Control	NULL
rabbit	NULL
immunoglobulin	NULL
(	NULL
CS	NULL
)	NULL
was	NULL
added	NULL
to	NULL
lanes	NULL
2	NULL
and	NULL
7	NULL
to	NULL
demonstrate	NULL
the	NULL
specific	NULL
nature	NULL
of	NULL
supershifted	NULL
complexes	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
Var4/3T	NULL
hybrid	NULL
half	NULL
site	NULL
was	NULL
reacted	NULL
with	NULL
IL-6-stimulated	NULL
U-937	NULL
nuclear	NULL
extract	NULL
.	NULL

Antisera	NULL
to	NULL
C/EBP	NULL
proteins	NULL
were	NULL
added	NULL
to	NULL
lanes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
7	NULL
,	NULL
and	NULL
8	NULL
.	NULL

Control	NULL
rabbit	NULL
immunoglobulin	NULL
(	NULL
CS	NULL
)	NULL
was	NULL
also	NULL
added	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
to	NULL
demonstrate	NULL
the	NULL
specific	NULL
nature	NULL
of	NULL
supershifted	NULL
complexes	NULL
.	NULL

Arrows	NULL
to	NULL
the	NULL
right	NULL
indicate	NULL
supershifted	NULL
C/EBP	NULL
complexes	NULL
(	NULL
filled	NULL
)	NULL
and	NULL
CREB-1	NULL
complexes	NULL
(	NULL
open	NULL
)	NULL
,	NULL
and	NULL
brackets	NULL
to	NULL
the	NULL
left	NULL
identify	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

The	NULL
EMS	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
probe	NULL
excess	NULL
,	NULL
and	NULL
the	NULL
free	NULL
probe	NULL
accounted	NULL
for	NULL
approximately	NULL
75	NULL
to	NULL
90	NULL
%	NULL
of	NULL
the	NULL
total	NULL
probe	NULL
in	NULL
each	NULL
reaction	NULL
Vor	NULL
.	NULL

75	NULL
,	NULL
2001	NULL
probe	NULL
was	NULL
compared	NULL
to	NULL
binding	NULL
to	NULL
a	NULL
similar	NULL
probe	NULL
in	NULL
which	NULL
a	NULL
10-bp	NULL
nonsense	NULL
sequence	NULL
was	NULL
placed	NULL
between	NULL
the	NULL
Varl	NULL
ATF/	NULL
CREB	NULL
and	NULL
3T	NULL
C/EBP	NULL
binding	NULL
sites	NULL
.	NULL

These	NULL
probes	NULL
were	NULL
reacted	NULL
with	NULL
IL-6-stimulated	NULL
U-937	NULL
extracts	NULL
in	NULL
EMS	NULL
analyses	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

If	NULL
CREB-C/EBP	NULL
heterodimers	NULL
were	NULL
bound	NULL
to	NULL
the	NULL
ATF/CREB	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
model	NULL
1	NULL
)	NULL
,	NULL
accounting	NULL
for	NULL
the	NULL
majority	NULL
of	NULL
enhanced	NULL
C/EBP	NULL
binding	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
linker	NULL
between	NULL
the	NULL
two	NULL
sites	NULL
should	NULL
not	NULL
disrupt	NULL
enhanced	NULL
C/EBP	NULL
binding	NULL
.	NULL

However	NULL
,	NULL
if	NULL
CREB	NULL
dimers	NULL
recruit	NULL
C/EBP	NULL
dimers	NULL
to	NULL
the	NULL
adjacent	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
model	NULL
3	NULL
)	NULL
,	NULL
then	NULL
a	NULL
10-bp	NULL
linker	NULL
between	NULL
these	NULL
sites	NULL
should	NULL
disrupt	NULL
enhanced	NULL
C/EBP	NULL
binding	NULL
.	NULL

The	NULL
Varl/3T	NULL
and	NULL
Varl/linker/3T	NULL
probes	NULL
were	NULL
reacted	NULL
with	NULL
IL-6-induced	NULL
U-937	NULL
nuclear	NULL
extract	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
antisera	NULL
directed	NULL
against	NULL
C/EBP	NULL
«	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
7	NULL
)	NULL
,	NULL
C/EBP	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
8	NULL
)	NULL
,	NULL
and	NULL
CREB-1	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
9	NULL
)	NULL
.	NULL

As	NULL
demonstrated	NULL
previously	NULL
,	NULL
the	NULL
Varl/3T	NULL
probe	NULL
recruited	NULL
C/EBP	NULL
«	NULL
and	NULL
B	NULL
,	NULL
and	NULL
CREB-1	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
the	NULL
linker	NULL
was	NULL
placed	NULL
between	NULL
the	NULL
two	NULL
sites	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
C/EBP	NULL
protein	NULL
recruited	NULL
to	NULL
the	NULL
probe	NULL
was	NULL
decreased	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

The	NULL
only	NULL
apparent	NULL
mobility	NULL
shift	NULL
was	NULL
a	NULL
faint	NULL
C/EBP	NULL
a	NULL
supershift	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
an	NULL
abundant	NULL
CREB-1-containing	NULL
supershifted	NULL
complex	NULL
was	NULL
also	NULL
detected	NULL
with	NULL
the	NULL
Varl/linker/3T	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
C/EBP	NULL
protein	NULL
that	NULL
was	NULL
detectable	NULL
appeared	NULL
similar	NULL
to	NULL
the	NULL
small	NULL
quantity	NULL
of	NULL
C/EBP	NULL
a	NULL
that	NULL
was	NULL
normally	NULL
recruited	NULL
to	NULL
the	NULL
3T	NULL
site	NULL
.	NULL

Consequently	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
CREB	NULL
and	NULL
C/EBP	NULL
proteins	NULL
detected	NULL
with	NULL
the	NULL
Varl/linker/3T	NULL
binding	NULL
site	NULL
probably	NULL
only	NULL
reflect	NULL
the	NULL
binding	NULL
affinities	NULL
of	NULL
the	NULL
individual	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
proteins	NULL
detected	NULL
were	NULL
likely	NULL
not	NULL
the	NULL
result	NULL
of	NULL
any	NULL
cooperative	NULL
binding	NULL
between	NULL
the	NULL
two	NULL
sites	NULL
,	NULL
and	NULL
CREB-C/EBP	NULL
heterodimers	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
binding	NULL
to	NULL
the	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
alone	NULL
(	NULL
as	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
model	NULL
1	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
observed	NULL
when	NULL
identical	NULL
experiments	NULL
were	NULL
conducted	NULL
using	NULL
a	NULL
5-bp	NULL
linker	NULL
placed	NULL
between	NULL
the	NULL
Varl	NULL
CREB	NULL
and	NULL
3T	NULL
C/EBP	NULL
binding	NULL
sites	NULL
and	NULL
when	NULL
the	NULL
same	NULL
experiments	NULL
were	NULL
conducted	NULL
with	NULL
THP-1	NULL
nuclear	NULL
extract	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Parallel	NULL
experiments	NULL
were	NULL
also	NULL
performed	NULL
to	NULL
quantitate	NULL
by	NULL
phosphorimager	NULL
analysis	NULL
the	NULL
amount	NULL
of	NULL
supershifted	NULL
CREB-1-containing	NULL
DNA-protein	NULL
complex	NULL
formed	NULL
with	NULL
the	NULL
Varl/3T	NULL
and	NULL
Varl/linker/3T	NULL
probes	NULL
.	NULL

A	NULL
3.2-fold	NULL
higher	NULL
amount	NULL
of	NULL
CREB-1	NULL
recruitment	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
complexes	NULL
formed	NULL
with	NULL
the	NULL
Var1/3T	NULL
oligonucleotide	NULL
than	NULL
when	NULL
the	NULL
linker	NULL
was	NULL
placed	NULL
between	NULL
the	NULL
two	NULL
binding	NULL
sites	NULL
.	NULL

This	NULL
indicated	NULL
that	NULL
not	NULL
only	NULL
does	NULL
CREB-1	NULL
lead	NULL
to	NULL
enhanced	NULL
binding	NULL
at	NULL
the	NULL
weakly	NULL
reactive	NULL
C/EBP	NULL
site	NULL
I	NULL
,	NULL
but	NULL
additional	NULL
CREB-1	NULL
was	NULL
recruited	NULL
to	NULL
the	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
as	NULL
well	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
that	NULL
the	NULL
two	NULL
families	NULL
of	NULL
proteins	NULL
mutually	NULL
facilitate	NULL
the	NULL
binding	NULL
of	NULL
one	NULL
another	NULL
to	NULL
their	NULL
respective	NULL
sites	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
observed	NULL
when	NULL
identical	NULL
experiments	NULL
were	NULL
conducted	NULL
with	NULL
THP-1	NULL
nuclear	NULL
extract	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
CREB-1	NULL
enhancement	NULL
of	NULL
C/EBP	NULL
protein	NULL
binding	NULL
to	NULL
a	NULL
weakly	NULL
reactive	NULL
C/EBP	NULL
site	NULL
I	NULL
appears	NULL
to	NULL
occur	NULL
via	NULL
two	NULL
C/EBP-CREB-1	NULL
INTERACTION	NULL
REGULATES	NULL
HIV-1	NULL
TRANSCRIPTION	NULL
-	NULL
1851	NULL
mechanisms	NULL
.	NULL

First	NULL
,	NULL
different	NULL
levels	NULL
of	NULL
enhanced	NULL
C/EBP	NULL
binding	NULL
occur	NULL
through	NULL
dimerization	NULL
at	NULL
a	NULL
hybrid	NULL
site	NULL
created	NULL
by	NULL
the	NULL
adjacent	NULL
ATF/CREB	NULL
and	NULL
C/EBP	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Levels	NULL
of	NULL
enhancement	NULL
and	NULL
dimer	NULL
identities	NULL
(	NULL
C/EBP	NULL
homodimers	NULL
or	NULL
C/EBP-CREB	NULL
heterodimers	NULL
)	NULL
are	NULL
dependent	NULL
on	NULL
sequence	NULL
variation	NULL
at	NULL
the	NULL
two	NULL
sites	NULL
.	NULL

Second	NULL
,	NULL
C/EBP	NULL
binding	NULL
enhancement	NULL
also	NULL
occurs	NULL
by	NULL
binding	NULL
of	NULL
CREB-containing	NULL
dimers	NULL
to	NULL
their	NULL
cognate	NULL
ATF/CREB	NULL
site	NULL
,	NULL
which	NULL
leads	NULL
to	NULL
the	NULL
recruitment	NULL
of	NULL
C/EBP	NULL
dimers	NULL
to	NULL
the	NULL
adjacent	NULL
weakly	NULL
reactive	NULL
3T	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Sequence	NULL
variation	NULL
at	NULL
the	NULL
ATF/CREB	NULL
site	NULL
affects	NULL
C/EBP-dependent	NULL
transcription	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
sequence	NULL
variation	NULL
at	NULL
the	NULL
ATF/CREB	NULL
site	NULL
could	NULL
impact	NULL
C/EBP	NULL
-dependent	NULL
tran-scription	NULL
,	NULL
chimeric	NULL
LTRs	NULL
were	NULL
constructed	NULL
for	NULL
use	NULL
in	NULL
transient	NULL
expression	NULL
analyses	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

The	NULL
chimeric	NULL
LTRs	NULL
contained	NULL
the	NULL
variant	NULL
ATF/CREB	NULL
binding	NULL
sites	NULL
(	NULL
Var1l	NULL
,	NULL
Var2	NULL
,	NULL
Var3	NULL
,	NULL
and	NULL
Vard4	NULL
)	NULL
and	NULL
the	NULL
weakly	NULL
reactive	NULL
3T	NULL
C/EBP	NULL
site	NULL
within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
(	NULL
strain	NULL
LAI	NULL
)	NULL
.	NULL

For	NULL
comparative	NULL
purposes	NULL
,	NULL
the	NULL
parental	NULL
HIV-1	NULL
LAI	NULL
LTR	NULL
(	NULL
containing	NULL
the	NULL
ConB/6G	NULL
ATF/CREB-C/EBP	NULL
binding	NULL
site	NULL
combination	NULL
)	NULL
was	NULL
also	NULL
used	NULL
in	NULL
the	NULL
transient	NULL
analyses	NULL
.	NULL

Basal	NULL
activity	NULL
and	NULL
IL-6-induced	NULL
activity	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
and	NULL
B	NULL
,	NULL
respectively	NULL
.	NULL

Sequence	NULL
variation	NULL
at	NULL
the	NULL
ATF/CREB	NULL
site	NULL
affected	NULL
both	NULL
basal	NULL
and	NULL
IL-6-induced	NULL
activity	NULL
.	NULL

LTRs	NULL
containing	NULL
Varl	NULL
to	NULL
Var3	NULL
all	NULL
exhibited	NULL
reduced	NULL
basal	NULL
activity	NULL
compared	NULL
to	NULL
the	NULL
parental	NULL
construct	NULL
.	NULL

Var3	NULL
,	NULL
in	NULL
particular	NULL
,	NULL
exhibited	NULL
the	NULL
largest	NULL
reduction	NULL
in	NULL
basal	NULL
activity	NULL
.	NULL

Only	NULL
Var4	NULL
exhibited	NULL
a	NULL
basal	NULL
activity	NULL
level	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
parental	NULL
LAI	NULL
LTR	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
sequence	NULL
variation	NULL
at	NULL
the	NULL
ATF/CREB	NULL
site	NULL
also	NULL
affected	NULL
LTR	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
IL-6	NULL
stimulation	NULL
,	NULL
a	NULL
treatment	NULL
that	NULL
activates	NULL
C/EBP	NULL
family	NULL
members	NULL
.	NULL

Var4/3T	NULL
and	NULL
LAI	NULL
(	NULL
ConB/6G	NULL
)	NULL
exhibited	NULL
the	NULL
highest	NULL
levels	NULL
of	NULL
activity	NULL
following	NULL
IL-6	NULL
stimulation	NULL
compared	NULL
to	NULL
LAI	NULL
(	NULL
ConB/6G	NULL
)	NULL
basal	NULL
activity	NULL
.	NULL

Vard4/3T	NULL
was	NULL
particularly	NULL
responsive	NULL
to	NULL
IL-6	NULL
,	NULL
with	NULL
a	NULL
14-fold	NULL
increase	NULL
in	NULL
activity	NULL
.	NULL

Var3/3T	NULL
appeared	NULL
to	NULL
exhibit	NULL
the	NULL
lowest	NULL
increase	NULL
in	NULL
activity	NULL
following	NULL
IL-6	NULL
stimulation	NULL
.	NULL

The	NULL
chimeric	NULL
Vard4/3T	NULL
LTR	NULL
exhibited	NULL
the	NULL
highest	NULL
overall	NULL
activity	NULL
following	NULL
IL-6-stimulation	NULL
,	NULL
which	NULL
was	NULL
even	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
the	NULL
parental	NULL
LAI	NULL
LTR	NULL
(	NULL
which	NULL
contains	NULL
both	NULL
a	NULL
strong	NULL
ATF/CREB	NULL
site	NULL
and	NULL
a	NULL
C/EBP	NULL
site	NULL
I	NULL
)	NULL
.	NULL

This	NULL
may	NULL
indicate	NULL
that	NULL
C/EBP	NULL
protein	NULL
binding	NULL
at	NULL
a	NULL
new	NULL
C/EBP	NULL
binding	NULL
site	NULL
created	NULL
by	NULL
half	NULL
sites	NULL
of	NULL
the	NULL
Var4	NULL
ATF/CREB	NULL
and	NULL
3T	NULL
C/EBP	NULL
binding	NULL
site	NULL
(	NULL
as	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
is	NULL
more	NULL
efficient	NULL
than	NULL
when	NULL
C/EBP	NULL
proteins	NULL
are	NULL
recruited	NULL
to	NULL
the	NULL
weak	NULL
3T	NULL
binding	NULL
site	NULL
as	NULL
a	NULL
result	NULL
of	NULL
CREB-1	NULL
binding	NULL
to	NULL
a	NULL
strong	NULL
ATF/CREB	NULL
site	NULL
.	NULL

While	NULL
basal	NULL
activities	NULL
and	NULL
overall	NULL
levels	NULL
of	NULL
activity	NULL
following	NULL
IL-6	NULL
stimulation	NULL
were	NULL
impacted	NULL
by	NULL
the	NULL
ATF/CREB	NULL
sequence	NULL
variation	NULL
,	NULL
the	NULL
magnitude	NULL
of	NULL
IL-6	NULL
stimulation	NULL
appeared	NULL
constant	NULL
between	NULL
all	NULL
of	NULL
the	NULL
chimeras	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Recruitment	NULL
of	NULL
CREB-1	NULL
to	NULL
an	NULL
ATF/CREB	NULL
site	NULL
can	NULL
be	NULL
enhanced	NULL
by	NULL
an	NULL
immediately	NULL
adjacent	NULL
C/EBP	NULL
site	NULL
I	NULL
that	NULL
is	NULL
highly	NULL
reactive	NULL
with	NULL
respect	NULL
to	NULL
binding	NULL
C/EBP	NULL
proteins	NULL
.	NULL

Having	NULL
dem	NULL
at	NULL
completion	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

(	NULL
D	NULL
)	NULL
DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
was	NULL
conducted	NULL
using	NULL
two	NULL
204-bp	NULL
probes	NULL
which	NULL
contained	NULL
either	NULL
the	NULL
Var4	NULL
ATF/CREB	NULL
and	NULL
3T	NULL
C/EBP	NULL
binding	NULL
sites	NULL
within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
HIV-1	NULL
strain	NULL
LAI	NULL
backbone	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
the	NULL
Varl	NULL
ATF/CREB	NULL
and	NULL
highly	NULL
reactive	NULL
6G	NULL
C/EBP	NULL
binding	NULL
sites	NULL
within	NULL
the	NULL
LAI	NULL
backbone	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

The	NULL
probes	NULL
were	NULL
reacted	NULL
with	NULL
purified	NULL
six-histidine-tagged	NULL
C/EBP	NULL
B	NULL
{	NULL
Janes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
,	NULL
and	NULL
regions	NULL
of	NULL
DNase	NULL
I	NULL
footprinting	NULL
were	NULL
compared	NULL
with	NULL
probe	NULL
incubated	NULL
with	NULL
DNase	NULL
I	NULL
only	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Sequencing	NULL
ladders	NULL
of	NULL
the	NULL
probes	NULL
were	NULL
also	NULL
included	NULL
during	NULL
electrophoresis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
to	NULL
confirm	NULL
the	NULL
regions	NULL
of	NULL
DNase	NULL
I	NULL
footprint	NULL
,	NULL
and	NULL
the	NULL
confirmed	NULL
binding	NULL
sites	NULL
are	NULL
illustrated	NULL
to	NULL
the	NULL
left	NULL
.	NULL

1852	NULL
ROSS	NULL
ET	NULL
AL	NULL
.	NULL

Probes	NULL
:	NULL
Varl/dT	NULL
Vari	NULL
Ainker/3T	NULL
.	NULL

Y	NULL
aa	NULL
x	NULL
8	NULL
«	NULL
a	NULL
.	NULL

#	NULL
&	NULL
©	NULL
&	NULL
&	NULL
©	NULL
.	NULL

o	NULL
4	NULL
&	NULL
c	NULL
o	NULL
&	NULL
W	NULL
or	NULL
Antisera	NULL
:	NULL
.	NULL

O	NULL
0G	NULL
G	NULL
O|	NULL
.	NULL

0	NULL
G	NULL
G	NULL
0	NULL
C/EBP	NULL
complex	NULL
C	NULL
#	NULL
#	NULL
<	NULL
-Extract	NULL
:	NULL
CREB	NULL
complex	NULL
[	NULL
IL-6-induced	NULL
U-937	NULL
lanes	NULL
:	NULL
10	NULL
2	NULL
3	NULL
40	NULL
50	NULL
60	NULL
7	NULL
8	NULL
9	NULL
10	NULL
Vart/3T	NULL
:	NULL
[	NULL
Var	NULL
CREB	NULL
C/EBP	NULL
Vari	NULL
/inker/3T	NULL
:	NULL
var	NULL
+-	NULL
.	NULL

Eo	NULL
CREB	NULL
ako	NULL
,	NULL
-	NULL
C/EBP	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

EMS	NULL
analyses	NULL
with	NULL
a	NULL
Varl/linker/3T	NULL
probe	NULL
indicate	NULL
that	NULL
the	NULL
majority	NULL
of	NULL
enhanced	NULL
C/EBP	NULL
binding	NULL
to	NULL
Varl/3T	NULL
depends	NULL
on	NULL
CREB	NULL
dimers	NULL
binding	NULL
to	NULL
their	NULL
cognate	NULL
sequences	NULL
.	NULL

The	NULL
Var1/3T	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
and	NULL
Varl/linker/3T	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
probes	NULL
were	NULL
reacted	NULL
with	NULL
IL-6-stimulated	NULL
U-937	NULL
nuclear	NULL
extract	NULL
.	NULL

Antisera	NULL
directed	NULL
against	NULL
C/EBP	NULL
a	NULL
{	NULL
Janes	NULL
2	NULL
and	NULL
7	NULL
)	NULL
and	NULL
C/EBP	NULL
B	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
8	NULL
)	NULL
as	NULL
well	NULL
as	NULL
CREB-1	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
9	NULL
)	NULL
were	NULL
all	NULL
used	NULL
to	NULL
identify	NULL
these	NULL
proteins	NULL
in	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

Control	NULL
rabbit	NULL
immunoglobulin	NULL
(	NULL
CS	NULL
)	NULL
was	NULL
added	NULL
to	NULL
lanes	NULL
5	NULL
and	NULL
10	NULL
to	NULL
demonstrate	NULL
the	NULL
specific	NULL
nature	NULL
of	NULL
supershifted	NULL
complexes	NULL
.	NULL

Arrows	NULL
to	NULL
the	NULL
right	NULL
indicate	NULL
the	NULL
supershifted	NULL
C/EBP	NULL
complexes	NULL
(	NULL
filled	NULL
)	NULL
and	NULL
supershifted	NULL
CREB-1	NULL
complexes	NULL
(	NULL
open	NULL
)	NULL
,	NULL
and	NULL
brackets	NULL
to	NULL
the	NULL
left	NULL
identify	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

The	NULL
EMS	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
probe	NULL
excess	NULL
,	NULL
and	NULL
the	NULL
free	NULL
probe	NULL
accounted	NULL
for	NULL
approximately	NULL
75	NULL
to	NULL
90	NULL
%	NULL
of	NULL
the	NULL
total	NULL
probe	NULL
in	NULL
each	NULL
reaction	NULL
at	NULL
completion	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

onstrated	NULL
that	NULL
CREB-1	NULL
binding	NULL
to	NULL
a	NULL
strong	NULL
ATF/CREB	NULL
site	NULL
can	NULL
lead	NULL
to	NULL
enhanced	NULL
binding	NULL
to	NULL
a	NULL
weak	NULL
C/EBP	NULL
binding	NULL
site	NULL
,	NULL
we	NULL
proceeded	NULL
to	NULL
determine	NULL
the	NULL
impact	NULL
of	NULL
ATF/CREB	NULL
sequence	NULL
variation	NULL
on	NULL
C/EBP	NULL
protein	NULL
binding	NULL
to	NULL
a	NULL
highly	NULL
reactive	NULL
C/EBP	NULL
site	NULL
and	NULL
the	NULL
impact	NULL
of	NULL
this	NULL
binding	NULL
on	NULL
CREB-1	NULL
binding	NULL
to	NULL
the	NULL
array	NULL
of	NULL
ATF/CREB	NULL
variant	NULL
sites	NULL
under	NULL
study	NULL
.	NULL

The	NULL
probes	NULL
containing	NULL
the	NULL
ATF/CREB	NULL
variants	NULL
adjacent	NULL
to	NULL
the	NULL
weak	NULL
3T	NULL
C/EBP	NULL
site	NULL
were	NULL
reacted	NULL
with	NULL
IL-6-induced	NULL
U-937	NULL
nuclear	NULL
extract	NULL
in	NULL
EMS	NULL
analyses	NULL
,	NULL
along	NULL
with	NULL
similar	NULL
probes	NULL
that	NULL
contained	NULL
the	NULL
ATF/CREB	NULL
variants	NULL
adjacent	NULL
to	NULL
the	NULL
highly	NULL
reactive	NULL
6G	NULL
C/EBP	NULL
site	NULL
I	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
characterized	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
probes	NULL
was	NULL
reacted	NULL
with	NULL
control	NULL
serum	NULL
(	NULL
Janes	NULL
2	NULL
,	NULL
7	NULL
,	NULL
12	NULL
,	NULL
and	NULL
17	NULL
)	NULL
and	NULL
antisera	NULL
directed	NULL
against	NULL
C/EBP	NULL
a	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
8	NULL
,	NULL
13	NULL
,	NULL
and	NULL
18	NULL
)	NULL
,	NULL
C/EBP	NULL
B	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
9	NULL
,	NULL
14	NULL
,	NULL
and	NULL
19	NULL
)	NULL
,	NULL
and	NULL
CREB-1	NULL
(	NULL
lanes	NULL
5	NULL
,	NULL
10	NULL
,	NULL
15	NULL
,	NULL
and	NULL
20	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
C/EBP	NULL
protein	NULL
recruitment	NULL
was	NULL
higher	NULL
with	NULL
each	NULL
of	NULL
the	NULL
ATF/CREB	NULL
variants	NULL
when	NULL
placed	NULL
adjacent	NULL
to	NULL
the	NULL
6G	NULL
C/EBP	NULL
site	NULL
compared	NULL
to	NULL
an	NULL
adjacent	NULL
3T	NULL
C/EBP	NULL
site	NULL
.	NULL

Thus	NULL
,	NULL
even	NULL
if	NULL
a	NULL
highly	NULL
reactive	NULL
ATF/CREB	NULL
site	NULL
leads	NULL
to	NULL
increased	NULL
binding	NULL
of	NULL
C/EBP	NULL
proteins	NULL
to	NULL
a	NULL
weak	NULL
C/EBP	NULL
site	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
C/EBP	NULL
binding	NULL
is	NULL
still	NULL
less	NULL
than	NULL
that	NULL
which	NULL
is	NULL
recruited	NULL
to	NULL
a	NULL
very	NULL
strong	NULL
C/EBP	NULL
site	NULL
I.	NULL
Interestingly	NULL
,	NULL
enhanced	NULL
CREB	NULL
binding	NULL
was	NULL
observed	NULL
with	NULL
Var2	NULL
and	NULL
Var4	NULL
when	NULL
placed	NULL
adjacent	NULL
to	NULL
a	NULL
strong	NULL
6G	NULL
C/EBP	NULL
site	NULL
compared	NULL
to	NULL
a	NULL
weak	NULL
3T	NULL
C/EBP	NULL
site	NULL
.	NULL

This	NULL
would	NULL
indicate	NULL
that	NULL
strong	NULL
C/EBP	NULL
binding	NULL
at	NULL
an	NULL
adjacent	NULL
site	NULL
can	NULL
also	NULL
lead	NULL
to	NULL
enhanced	NULL
CREB-1	NULL
binding	NULL
to	NULL
a	NULL
weak	NULL
ATF/CREB	NULL
site	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
proteins	NULL
from	NULL
these	NULL
two	NULL
families	NULL
of	NULL
proteins	NULL
is	NULL
intimately	NULL
connected	NULL
,	NULL
and	NULL
they	NULL
appear	NULL
able	NULL
to	NULL
enhance	NULL
the	NULL
binding	NULL
of	NULL
one	NULL
another	NULL
,	NULL
dependent	NULL
on	NULL
sequence	NULL
variation	NULL
at	NULL
both	NULL
sites	NULL
.	NULL

J.	NULL
Virou	NULL
.	NULL

DISCUSSION	NULL
Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
C/EBP	NULL
-dependent	NULL
transcription	NULL
is	NULL
critical	NULL
to	NULL
replication	NULL
of	NULL
HIV-1	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocyte/macrophage	NULL
lineage	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Studies	NULL
detailed	NULL
herein	NULL
indicate	NULL
that	NULL
complex	NULL
interactions	NULL
occur	NULL
between	NULL
two	NULL
families	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
interact	NULL
with	NULL
an	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
and	NULL
the	NULL
NF-	NULL
«	NULL
B-proximal	NULL
C/EBP	NULL
site	NULL
I	NULL
within	NULL
the	NULL
HIV-1	NULL
LTR	NULL
,	NULL
which	NULL
may	NULL
affect	NULL
C/EBP-dependent	NULL
transactivation	NULL
in	NULL
monocytic	NULL
cell	NULL
populations	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
enhanced	NULL
C/EBP	NULL
factor	NULL
binding	NULL
at	NULL
a	NULL
naturally	NULL
occurring	NULL
weakly	NULL
reactive	NULL
C/EBP	NULL
binding	NULL
site	NULL
(	NULL
3T	NULL
)	NULL
due	NULL
to	NULL
interactions	NULL
A	NULL
Basal	NULL
Activity	NULL
=	NULL
o	NULL
-	NULL
-	NULL
-_	NULL
o	NULL
N	NULL
&	NULL
Variant	NULL
LTR	NULL
Basal	NULL
Activity	NULL
Relative	NULL
to	NULL
6G	NULL
(	NULL
LAI	NULL
)	NULL
Basal	NULL
Activity	NULL
o	NULL
&	NULL
0.6	NULL
0.4	NULL
0.2	NULL
0.0	NULL
z	NULL
E	NULL
E	NULL
E	NULL
©	NULL
5	NULL
°o	NULL
g	NULL
$	NULL
0	NULL
f	NULL
S	NULL
$	NULL
$	NULL
S	NULL
B	NULL
IL-6-induced	NULL
Activity	NULL
20	NULL
2	NULL
{	NULL
g	NULL
18	NULL
S	NULL
é	NULL
)	NULL
?	NULL

16	NULL
©§	NULL
$	NULL
8	NULL
14	NULL
+9	NULL
§§	NULL
12	NULL
€3	NULL
10	NULL
<	NULL
3	NULL
es	NULL
f	NULL
$	NULL
0	NULL
6	NULL
§	NULL
4	NULL
2	NULL
i	NULL
E	NULL
m	NULL
E	NULL
m	NULL
%	NULL
a	NULL
&	NULL
o	NULL
©	NULL
m	NULL
<	NULL
a	NULL
a	NULL
#	NULL
©	NULL
G	NULL
&	NULL
>	NULL
>	NULL
>	NULL
>	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

ATF/CREB	NULL
sequence	NULL
variation	NULL
affects	NULL
basal	NULL
and	NULL
IL-6-induced	NULL
activity	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
with	NULL
the	NULL
weakly	NULL
reactive	NULL
C/EBP	NULL
site	NULL
I.	NULL
Chimeric	NULL
LTRs	NULL
were	NULL
constructed	NULL
to	NULL
contain	NULL
the	NULL
ATF/CREB	NULL
variants	NULL
adjacent	NULL
to	NULL
a	NULL
weakly	NULL
reactive	NULL
3T	NULL
binding	NULL
site	NULL
within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
LAI	NULL
LTR	NULL
backbone	NULL
.	NULL

The	NULL
parental	NULL
LAI	NULL
LTR	NULL
(	NULL
containing	NULL
the	NULL
clade	NULL
B	NULL
consensus	NULL
sequence	NULL
at	NULL
the	NULL
ATF/CREB	NULL
site	NULL
and	NULL
the	NULL
6G	NULL
C/EBP	NULL
binding	NULL
site	NULL
)	NULL
was	NULL
also	NULL
included	NULL
in	NULL
the	NULL
analyses	NULL
.	NULL

The	NULL
LTRs	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
the	NULL
U-937	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
the	NULL
cultures	NULL
were	NULL
treated	NULL
with	NULL
IL-6	NULL
for	NULL
a	NULL
24-h	NULL
interval	NULL
.	NULL

Firefly	NULL
luminescence	NULL
was	NULL
normalized	NULL
to	NULL
the	NULL
Renilla	NULL
luminescence	NULL
to	NULL
control	NULL
for	NULL
variations	NULL
in	NULL
transfection	NULL
efficiency	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
of	NULL
each	NULL
of	NULL
the	NULL
chimeric	NULL
LTRs	NULL
was	NULL
normalized	NULL
to	NULL
an	NULL
arbitrary	NULL
activity	NULL
level	NULL
of	NULL
1.0	NULL
for	NULL
the	NULL
parental	NULL
LAI	NULL
LTR	NULL
.	NULL

Basal	NULL
(	NULL
A	NULL
)	NULL
activity	NULL
and	NULL
IL-6-induced	NULL
(	NULL
B	NULL
)	NULL
activities	NULL
were	NULL
plotted	NULL
separately	NULL
.	NULL

Each	NULL
transient	NULL
transfection	NULL
was	NULL
done	NULL
in	NULL
duplicate	NULL
,	NULL
with	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

The	NULL
average	NULL
luciferase	NULL
count	NULL
for	NULL
the	NULL
LAI	NULL
LTR	NULL
was	NULL
3,265	NULL
+	NULL
1,075	NULL
,	NULL
and	NULL
the	NULL
average	NULL
background	NULL
count	NULL
was	NULL
66	NULL
+	NULL
16	NULL
.	NULL

C/EBP-CREB-1	NULL
INTERACTION	NULL
REGULATES	NULL
HIV-1	NULL
TRANSCRIPTION	NULL
Vor	NULL
.	NULL

75	NULL
,	NULL
2001	NULL
A	NULL
Probe	NULL
:	NULL
Var1/6G	NULL
Var2/31T	NULL
Var2/6G	NULL
toa	NULL
r	NULL
toa	NULL
t	NULL
5	NULL
oo	NULL
t	NULL
80	NULL
o	NULL
t	NULL
ga.	NULL
o.	NULL
mM	NULL
o.	NULL
o.	NULL
m	NULL
ga.	NULL
o.	NULL
mM	NULL
o.	NULL
o.	NULL
m	NULL
a	NULL
§	NULL
7	NULL
8	NULL
§	NULL
7	NULL
a	NULL
5	NULL
#	NULL
)	NULL
,	NULL
§	NULL
0	NULL
E	NULL
Antisera	NULL
:	NULL
a	NULL
8	NULL
a	NULL
as	NULL
5	NULL
)	NULL
.	NULL

8	NULL
a	NULL
a	NULL
6	NULL
]	NULL
,	NULL
8	NULL
a	NULL
a	NULL
S|	NULL
.	NULL

8	NULL
a	NULL
o	NULL
o	NULL
«	NULL
ea	NULL
dh	NULL
ain	NULL
dth	NULL
dh	NULL
sth	NULL
«	NULL
lis	NULL
«	NULL
r	NULL
»	NULL
3	NULL
C/EBP	NULL
complex	NULL
I	NULL
:	NULL
CREB	NULL
complex	NULL
I	NULL
:	NULL
Extract	NULL
IL-6-induced	NULL
U-937	NULL
Lanes	NULL
:	NULL
10	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
19	NULL
20	NULL
B	NULL
Probe	NULL
:	NULL
Var3/3T	NULL
Var3/6G	NULL
Vard4/3T	NULL
Var4/6G	NULL
80	NULL
ca	NULL
v	NULL
8	NULL
ca	NULL
r	NULL
8	NULL
ca	NULL
r	NULL
8	NULL
o	NULL
t	NULL
oA	NULL
.	NULL

t.	NULL
M	NULL
g	NULL
t.	NULL
m	NULL
o	NULL
o.	NULL
m	NULL
o	NULL
.	NULL

A.	NULL
M	NULL
mo	NULL
o	NULL
m	NULL
®	NULL
m	NULL
®	NULL
w	NULL
m	NULL
m	NULL
w	NULL
.	NULL

o	NULL
W	NULL
W	NULL
r	NULL
o	NULL
WoW	NULL
o	NULL
o	NULL
WoW	NULL
C	NULL
q	NULL
WoW	NULL
C	NULL
Antisera	NULL
:	NULL
1	NULL
o	NULL
G	NULL
G	NULL
G|1|	NULL
6	NULL
d	NULL
Go	NULL
G|i|	NULL
6	NULL
G	NULL
G	NULL
G|1	NULL
0	NULL
G	NULL
G	NULL
O	NULL
am	NULL
dh	NULL
gin	NULL
dh	NULL
din	NULL
dt	NULL
t	NULL
»	NULL
«	NULL
in	NULL
dik	NULL
wn	NULL
an	NULL
e	NULL
``	NULL
C/EBP	NULL
complex	NULL
I	NULL
:	NULL
'	NULL
CREB	NULL
complex	NULL
I	NULL
:	NULL
Extract	NULL
:	NULL
IL-6-induced	NULL
U-937	NULL
Lanes	NULL
:	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
19	NULL
20	NULL
Probes	NULL
:	NULL
1853	NULL
Varl	NULL
3T	NULL
Var2	NULL
6G	NULL
Vars	NULL
Vard4	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Highly	NULL
reactive	NULL
C/EBP	NULL
binding	NULL
sites	NULL
can	NULL
enhance	NULL
binding	NULL
of	NULL
CREB-1	NULL
to	NULL
an	NULL
adjacent	NULL
weakly	NULL
reactive	NULL
ATF/CREB	NULL
site	NULL
.	NULL

Chimeric	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
Varl	NULL
(	NULL
A	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
10	NULL
)	NULL
,	NULL
Var2	NULL
(	NULL
A	NULL
,	NULL
lanes	NULL
11	NULL
to	NULL
20	NULL
)	NULL
,	NULL
Var3	NULL
(	NULL
B	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
10	NULL
)	NULL
,	NULL
and	NULL
Var4	NULL
(	NULL
B	NULL
,	NULL
lanes	NULL
11	NULL
to	NULL
20	NULL
)	NULL
ATF/CREB	NULL
binding	NULL
sites	NULL
adjacent	NULL
to	NULL
either	NULL
a	NULL
weak	NULL
3T	NULL
C/EBP	NULL
site	NULL
(	NULL
A	NULL
and	NULL
B	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
and	NULL
11	NULL
to	NULL
15	NULL
)	NULL
or	NULL
a	NULL
strong	NULL
6G	NULL
C/EBP	NULL
binding	NULL
site	NULL
(	NULL
A	NULL
and	NULL
B	NULL
,	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
and	NULL
16	NULL
to	NULL
20	NULL
)	NULL
were	NULL
reacted	NULL
with	NULL
IL-6-induced	NULL
U-937	NULL
nuclear	NULL
extract	NULL
in	NULL
EMS	NULL
analyses	NULL
.	NULL

Antisera	NULL
specific	NULL
for	NULL
C/EBP	NULL
a	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
8	NULL
,	NULL
13	NULL
,	NULL
and	NULL
18	NULL
)	NULL
and	NULL
C/EBP	NULL
B	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
9	NULL
,	NULL
14	NULL
,	NULL
and	NULL
19	NULL
)	NULL
were	NULL
added	NULL
to	NULL
the	NULL
indicated	NULL
reactions	NULL
.	NULL

Control	NULL
rabbit	NULL
immunoglobulin	NULL
(	NULL
CS	NULL
)	NULL
was	NULL
added	NULL
(	NULL
Janes	NULL
2	NULL
,	NULL
7	NULL
,	NULL
12	NULL
,	NULL
and	NULL
17	NULL
)	NULL
to	NULL
demonstrate	NULL
the	NULL
specific	NULL
nature	NULL
of	NULL
any	NULL
supershifted	NULL
complexes	NULL
.	NULL

Arrows	NULL
to	NULL
the	NULL
right	NULL
indicate	NULL
supershifted	NULL
C/EBP	NULL
complexes	NULL
(	NULL
filled	NULL
)	NULL
and	NULL
supershifted	NULL
CREB-1	NULL
complexes	NULL
(	NULL
open	NULL
)	NULL
and	NULL
brackets	NULL
to	NULL
the	NULL
left	NULL
identify	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

The	NULL
EMS	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
probe	NULL
excess	NULL
,	NULL
and	NULL
the	NULL
free	NULL
probe	NULL
accounted	NULL
for	NULL
approximately	NULL
75	NULL
to	NULL
90	NULL
%	NULL
of	NULL
the	NULL
total	NULL
probe	NULL
in	NULL
each	NULL
reaction	NULL
at	NULL
completion	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

with	NULL
CREB-1	NULL
(	NULL
and	NULL
possibly	NULL
additional	NULL
ATF/CREB	NULL
family	NULL
members	NULL
)	NULL
at	NULL
an	NULL
immediately	NULL
adjacent	NULL
ATF/CREB	NULL
sequence	NULL
.	NULL

The	NULL
level	NULL
of	NULL
enhanced	NULL
binding	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
reactivity	NULL
of	NULL
the	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
for	NULL
CREB-1	NULL
.	NULL

The	NULL
strength	NULL
of	NULL
the	NULL
recruitment	NULL
of	NULL
particular	NULL
ATF/CREB	NULL
proteins	NULL
at	NULL
the	NULL
cognate	NULL
sequence	NULL
affected	NULL
not	NULL
only	NULL
the	NULL
level	NULL
of	NULL
enhanced	NULL
C/EBP	NULL
binding	NULL
but	NULL
also	NULL
the	NULL
identity	NULL
of	NULL
C/EBP	NULL
family	NULL
members	NULL
re-cruited	NULL
.	NULL

Furthermore	NULL
,	NULL
sequence	NULL
variation	NULL
at	NULL
the	NULL
ATF/CREB	NULL
site	NULL
can	NULL
impact	NULL
C/EBP	NULL
-dependent	NULL
transactivation	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
ATF/CREB	NULL
binding	NULL
sites	NULL
with	NULL
relatively	NULL
high	NULL
reactivity	NULL
with	NULL
respect	NULL
to	NULL
binding	NULL
CREB-1	NULL
(	NULL
Varl	NULL
and	NULL
Var3	NULL
[	NULL
Fig	NULL
.	NULL

2B	NULL
and	NULL
CJ	NULL
)	NULL
enhanced	NULL
the	NULL
binding	NULL
of	NULL
both	NULL
C/EBP	NULL
«	NULL
and	NULL
C/EBP	NULL
B	NULL
to	NULL
the	NULL
greatest	NULL
extent	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

The	NULL
weakly	NULL
reactive	NULL
CREB	NULL
binding	NULL
sites	NULL
,	NULL
Var2	NULL
and	NULL
Vard4	NULL
,	NULL
however	NULL
,	NULL
did	NULL
not	NULL
exhibit	NULL
nearly	NULL
the	NULL
same	NULL
level	NULL
of	NULL
enhanced	NULL
binding	NULL
of	NULL
C/EBP	NULL
B	NULL
to	NULL
the	NULL
neighboring	NULL
weakly	NULL
reactive	NULL
C/EBP	NULL
site	NULL
I	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
ATF/CREB	NULL
sites	NULL
highly	NULL
reactive	NULL
with	NULL
CREB-1	NULL
should	NULL
increase	NULL
C/EBP	NULL
-dependent	NULL
transcription	NULL
more	NULL
efficiently	NULL
than	NULL
weakly	NULL
reactive	NULL
ATF/CREB	NULL
sites	NULL
,	NULL
since	NULL
C/EBP	NULL
B	NULL
is	NULL
a	NULL
better	NULL
transac-tivator	NULL
than	NULL
C/EBP	NULL
«	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

While	NULL
ATF/CREB	NULL
variation	NULL
did	NULL
affect	NULL
C/EBP-dependent	NULL
transactivation	NULL
,	NULL
those	NULL
with	NULL
higher	NULL
reactivities	NULL
for	NULL
CREB	NULL
(	NULL
Varl	NULL
and	NULL
Var3	NULL
)	NULL
did	NULL
not	NULL
give	NULL
the	NULL
highest	NULL
levels	NULL
of	NULL
activity	NULL
.	NULL

Several	NULL
explanations	NULL
can	NULL
account	NULL
for	NULL
this	NULL
discrepancy	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
ATF	NULL
family	NULL
members	NULL
could	NULL
also	NULL
influence	NULL
C/EBP	NULL
-dependent	NULL
transactivation	NULL
,	NULL
since	NULL
previous	NULL
studies	NULL
have	NULL
indicated	NULL
that	NULL
these	NULL
ATF/CREB	NULL
variants	NULL
,	NULL
particularly	NULL
Varl	NULL
and	NULL
Var2	NULL
,	NULL
bind	NULL
ATF	NULL
family	NULL
members	NULL
to	NULL
differing	NULL
degrees	NULL
with	NULL
lymphocytic	NULL
nuclear	NULL
extract	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

While	NULL
it	NULL
was	NULL
not	NULL
possible	NULL
in	NULL
these	NULL
studies	NULL
to	NULL
supershift	NULL
any	NULL
ATF-related	NULL
complexes	NULL
,	NULL
we	NULL
can	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
ATF	NULL
proteins	NULL
or	NULL
other	NULL
CREB-related	NULL
proteins	NULL
are	NULL
recruited	NULL
to	NULL
the	NULL
ATF/CREB	NULL
variants	NULL
to	NULL
different	NULL
degrees	NULL
in	NULL
the	NULL
monocytic	NULL
extracts	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
epitopes	NULL
recognized	NULL
by	NULL
the	NULL
ATF-specific	NULL
monoclonal	NULL
antibodies	NULL
used	NULL
in	NULL
these	NULL
studies	NULL
were	NULL
masked	NULL
or	NULL
not	NULL
present	NULL
during	NULL
dimerization	NULL
,	NULL
preventing	NULL
detection	NULL
in	NULL
the	NULL
1854	NULL
ROSS	NULL
ET	NULL
AL	NULL
.	NULL

supershift	NULL
EMS	NULL
analyses	NULL
.	NULL

Thus	NULL
,	NULL
while	NULL
CREB-1	NULL
was	NULL
shown	NULL
to	NULL
affect	NULL
C/EBP	NULL
protein	NULL
recruitment	NULL
and	NULL
C/EBP-dependent	NULL
tran-scription	NULL
,	NULL
CREB-1	NULL
may	NULL
be	NULL
homodimerizing	NULL
or	NULL
heterodimerizing	NULL
with	NULL
other	NULL
yet	NULL
to	NULL
be	NULL
identified	NULL
ATF/CREB	NULL
family	NULL
members	NULL
.	NULL

Our	NULL
competition	NULL
EMS	NULL
analyses	NULL
with	NULL
Var3/3T	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
also	NULL
indicate	NULL
that	NULL
other	NULL
CREB-related	NULL
proteins	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
interactions	NULL
at	NULL
the	NULL
ATF/CREB	NULL
and	NULL
C/EBP	NULL
binding	NULL
sites	NULL
.	NULL

With	NULL
the	NULL
addition	NULL
of	NULL
this	NULL
relatively	NULL
high	NULL
affinity	NULL
CREB	NULL
binding	NULL
site	NULL
,	NULL
enhanced	NULL
C/EBP	NULL
binding	NULL
was	NULL
observed	NULL
with	NULL
the	NULL
labeled	NULL
Varl/	NULL
3T	NULL
oligonucleotide	NULL
.	NULL

We	NULL
hypothesize	NULL
that	NULL
Var3/3T	NULL
recruited	NULL
additional	NULL
CREB-related	NULL
proteins	NULL
,	NULL
sequestering	NULL
these	NULL
from	NULL
the	NULL
Var1/3T	NULL
probe	NULL
,	NULL
allowing	NULL
additional	NULL
CREB-1	NULL
binding	NULL
to	NULL
Varl/	NULL
3T	NULL
and	NULL
enhancement	NULL
of	NULL
C/EBP	NULL
binding	NULL
.	NULL

Similarly	NULL
,	NULL
C/EBP	NULL
-dependent	NULL
transcription	NULL
may	NULL
be	NULL
affected	NULL
by	NULL
the	NULL
composition	NULL
of	NULL
dimers	NULL
with	NULL
different	NULL
ATF/CREB	NULL
and	NULL
C/EBP	NULL
family	NULL
members	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
mobilities	NULL
of	NULL
the	NULL
supershifted	NULL
C/EBP	NULL
B-containing	NULL
complexes	NULL
which	NULL
bound	NULL
to	NULL
the	NULL
probes	NULL
containing	NULL
the	NULL
ATF/CREB	NULL
variants	NULL
adjacent	NULL
to	NULL
the	NULL
3T	NULL
C/EBP	NULL
site	NULL
appeared	NULL
to	NULL
be	NULL
different	NULL
,	NULL
dependent	NULL
on	NULL
the	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
used	NULL
in	NULL
the	NULL
EMS	NULL
analyses	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

The	NULL
C/EBP	NULL
B-related	NULL
complex	NULL
that	NULL
was	NULL
detected	NULL
with	NULL
the	NULL
Var1l/3T	NULL
chimera	NULL
appeared	NULL
to	NULL
have	NULL
the	NULL
same	NULL
mobility	NULL
as	NULL
the	NULL
C/EBP	NULL
«	NULL
-related	NULL
complex	NULL
.	NULL

Conversely	NULL
,	NULL
the	NULL
C/EBP	NULL
B-related	NULL
complex	NULL
that	NULL
bound	NULL
to	NULL
Var3/3T	NULL
and	NULL
Var4/3T	NULL
appeared	NULL
to	NULL
have	NULL
a	NULL
much	NULL
faster	NULL
mobility	NULL
than	NULL
the	NULL
C/EBP	NULL
«	NULL
-related	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

This	NULL
could	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
different	NULL
sizes	NULL
of	NULL
the	NULL
two	NULL
C/EBP	NULL
proteins	NULL
.	NULL

C/EBP	NULL
«	NULL
is	NULL
approximately	NULL
42	NULL
kDa	NULL
(	NULL
26	NULL
,	NULL
31	NULL
,	NULL
37	NULL
)	NULL
,	NULL
while	NULL
C/EBP	NULL
f	NULL
is	NULL
a	NULL
38-kDa	NULL
protein	NULL
(	NULL
2	NULL
,	NULL
16	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
mobilities	NULL
of	NULL
the	NULL
different	NULL
C/EBP	NULL
B-related	NULL
complexes	NULL
,	NULL
the	NULL
observations	NULL
suggest	NULL
that	NULL
the	NULL
Var1/3T	NULL
chimeric	NULL
probe	NULL
recruits	NULL
heterodimers	NULL
of	NULL
C/EBP	NULL
a	NULL
and	NULL
C/EBP	NULL
B.	NULL
Conversely	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
the	NULL
chimeric	NULL
probes	NULL
containing	NULL
the	NULL
Var3	NULL
and	NULL
Var4	NULL
binding	NULL
sites	NULL
recruit	NULL
primarily	NULL
C/EBP	NULL
«	NULL
and	NULL
B	NULL
homodimers	NULL
.	NULL

The	NULL
Var2/3T	NULL
chimeric	NULL
probe	NULL
appeared	NULL
to	NULL
recruit	NULL
primarily	NULL
C/EBP	NULL
«	NULL
homo-dimers	NULL
,	NULL
since	NULL
a	NULL
supershifted	NULL
complex	NULL
containing	NULL
C/EBP	NULL
B	NULL
was	NULL
difficult	NULL
to	NULL
detect	NULL
.	NULL

Finally	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
truncated	NULL
members	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
which	NULL
act	NULL
as	NULL
transcriptional	NULL
repressors	NULL
are	NULL
recruited	NULL
differentially	NULL
to	NULL
the	NULL
sequence	NULL
variants	NULL
,	NULL
thereby	NULL
complicating	NULL
interactions	NULL
between	NULL
the	NULL
ATF/CREB	NULL
and	NULL
C/EBP	NULL
proteins	NULL
.	NULL

While	NULL
synergistic	NULL
interactions	NULL
between	NULL
the	NULL
ATF/CREB	NULL
and	NULL
C/EBP	NULL
protein	NULL
families	NULL
have	NULL
previously	NULL
been	NULL
observed	NULL
(	NULL
33	NULL
,	NULL
35	NULL
,	NULL
41	NULL
)	NULL
,	NULL
they	NULL
have	NULL
not	NULL
been	NULL
defined	NULL
within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

The	NULL
interaction	NULL
between	NULL
the	NULL
two	NULL
protein	NULL
families	NULL
and	NULL
the	NULL
HIV-1	NULL
LTR	NULL
appears	NULL
to	NULL
occur	NULL
via	NULL
a	NULL
combination	NULL
of	NULL
mechanisms	NULL
.	NULL

A	NULL
small	NULL
fraction	NULL
of	NULL
the	NULL
enhanced	NULL
C/EBP	NULL
«	NULL
binding	NULL
may	NULL
occur	NULL
via	NULL
homodimerization	NULL
or	NULL
dimerization	NULL
with	NULL
CREB-1	NULL
(	NULL
depending	NULL
on	NULL
the	NULL
ATF/CREB	NULL
variant	NULL
configura-tion	NULL
)	NULL
.	NULL

These	NULL
heterodimers	NULL
are	NULL
then	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
a	NULL
hybrid	NULL
binding	NULL
site	NULL
created	NULL
by	NULL
adjacent	NULL
half	NULL
sites	NULL
from	NULL
the	NULL
ATF/CREB	NULL
and	NULL
C/EBP	NULL
binding	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

While	NULL
the	NULL
level	NULL
of	NULL
C/EBP	NULL
recruited	NULL
via	NULL
this	NULL
mechanism	NULL
was	NULL
small	NULL
with	NULL
the	NULL
Varl	NULL
,	NULL
Var2	NULL
,	NULL
and	NULL
Var3	NULL
ATF/CREB	NULL
binding	NULL
sites	NULL
,	NULL
significant	NULL
levels	NULL
of	NULL
C/EBP	NULL
proteins	NULL
were	NULL
recruited	NULL
when	NULL
the	NULL
Var4	NULL
half	NULL
site	NULL
was	NULL
placed	NULL
adjacent	NULL
to	NULL
the	NULL
3T	NULL
half	NULL
site	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
rather	NULL
than	NULL
recruiting	NULL
CREB-C/EBP	NULL
heterodimers	NULL
,	NULL
the	NULL
hybrid	NULL
binding	NULL
site	NULL
Vard4/3T	NULL
led	NULL
to	NULL
increased	NULL
C/EBP	NULL
dimer	NULL
recruitment	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

Most	NULL
likely	NULL
,	NULL
this	NULL
mechanism	NULL
of	NULL
recruitment	NULL
explains	NULL
the	NULL
high	NULL
level	NULL
of	NULL
LTR	NULL
activity	NULL
observed	NULL
with	NULL
the	NULL
Vard4/3T	NULL
chimeric	NULL
LTR	NULL
upon	NULL
IL-6	NULL
induction	NULL
,	NULL
with	NULL
the	NULL
hidden	NULL
C/EBP	NULL
site	NULL
J.	NULL
Virou	NULL
.	NULL

recruiting	NULL
more	NULL
C/EBP	NULL
factors	NULL
than	NULL
are	NULL
recruited	NULL
to	NULL
a	NULL
low-affinity	NULL
C/EBP	NULL
site	NULL
during	NULL
enhancement	NULL
of	NULL
C/EBP	NULL
binding	NULL
by	NULL
a	NULL
strong	NULL
ATF/CREB	NULL
site	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
high	NULL
levels	NULL
of	NULL
C/EBP	NULL
recruitment	NULL
were	NULL
not	NULL
observed	NULL
when	NULL
the	NULL
two	NULL
full-length	NULL
binding	NULL
sites	NULL
were	NULL
adjacent	NULL
to	NULL
one	NULL
another	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
under	NULL
certain	NULL
conditions	NULL
,	NULL
CREB-1	NULL
binding	NULL
to	NULL
its	NULL
cognate	NULL
sequence	NULL
prevents	NULL
access	NULL
to	NULL
this	NULL
hybrid	NULL
binding	NULL
site	NULL
.	NULL

Under	NULL
conditions	NULL
where	NULL
the	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
is	NULL
unoccupied	NULL
,	NULL
perhaps	NULL
it	NULL
is	NULL
then	NULL
possible	NULL
to	NULL
observe	NULL
enhanced	NULL
recruitment	NULL
of	NULL
C/EBP	NULL
proteins	NULL
at	NULL
the	NULL
adjacent	NULL
ATF/CREB	NULL
and	NULL
C/EBP	NULL
half	NULL
sites	NULL
.	NULL

Alternative-ly	NULL
,	NULL
in	NULL
instances	NULL
where	NULL
C/EBP	NULL
proteins	NULL
undergo	NULL
modification	NULL
(	NULL
for	NULL
example	NULL
,	NULL
following	NULL
IL-6	NULL
stimulation	NULL
)	NULL
,	NULL
perhaps	NULL
increased	NULL
C/EBP	NULL
affinity	NULL
for	NULL
the	NULL
hybrid	NULL
binding	NULL
site	NULL
is	NULL
greater	NULL
than	NULL
the	NULL
affinity	NULL
of	NULL
CREB-1	NULL
for	NULL
its	NULL
cognate	NULL
sequence	NULL
,	NULL
forcing	NULL
the	NULL
displacement	NULL
of	NULL
CREB-1	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
composition	NULL
and	NULL
quantity	NULL
of	NULL
proteins	NULL
recruited	NULL
to	NULL
the	NULL
hybrid	NULL
sites	NULL
created	NULL
between	NULL
the	NULL
adjacent	NULL
ATF/CREB	NULL
and	NULL
C/EBP	NULL
binding	NULL
sites	NULL
can	NULL
fluctuate	NULL
greatly	NULL
.	NULL

Under	NULL
most	NULL
instances	NULL
examined	NULL
,	NULL
the	NULL
majority	NULL
of	NULL
C/EBP	NULL
«	NULL
enhancement	NULL
as	NULL
well	NULL
as	NULL
the	NULL
enhanced	NULL
binding	NULL
of	NULL
C/EBP	NULL
B	NULL
appears	NULL
to	NULL
occur	NULL
by	NULL
a	NULL
second	NULL
mechanism	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
dimers	NULL
containing	NULL
CREB-1	NULL
appear	NULL
to	NULL
bind	NULL
to	NULL
their	NULL
cognate	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
and	NULL
recruit	NULL
C/EBP	NULL
dimers	NULL
to	NULL
the	NULL
weakly	NULL
reactive	NULL
3T	NULL
binding	NULL
site	NULL
(	NULL
which	NULL
does	NULL
not	NULL
efficiently	NULL
recruit	NULL
these	NULL
proteins	NULL
on	NULL
its	NULL
own	NULL
)	NULL
.	NULL

Interactions	NULL
between	NULL
ATF/CREB	NULL
and	NULL
C/EBP	NULL
proteins	NULL
may	NULL
involve	NULL
direct	NULL
contact	NULL
between	NULL
these	NULL
factors	NULL
or	NULL
an	NULL
intermediary	NULL
protein	NULL
that	NULL
links	NULL
factors	NULL
bound	NULL
to	NULL
these	NULL
two	NULL
sites	NULL
.	NULL

We	NULL
hypothesize	NULL
that	NULL
CREB-1	NULL
probably	NULL
enhances	NULL
C/EBP	NULL
binding	NULL
using	NULL
CBP	NULL
as	NULL
a	NULL
molecular	NULL
bridge	NULL
.	NULL

A	NULL
recent	NULL
study	NULL
demonstrated	NULL
a	NULL
similar	NULL
cooperation	NULL
between	NULL
Myb	NULL
and	NULL
C/EBP	NULL
B	NULL
(	NULL
29	NULL
)	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
Myb	NULL
bound	NULL
to	NULL
its	NULL
cognate	NULL
DNA	NULL
sequence	NULL
and	NULL
recruited	NULL
C/EBP	NULL
proteins	NULL
to	NULL
an	NULL
adjacent	NULL
site	NULL
via	NULL
interactions	NULL
with	NULL
p300	NULL
,	NULL
a	NULL
coactivator	NULL
protein	NULL
homologous	NULL
to	NULL
CBP	NULL
.	NULL

Myb	NULL
binds	NULL
to	NULL
p300	NULL
through	NULL
the	NULL
CREB	NULL
binding	NULL
domain	NULL
on	NULL
the	NULL
p300	NULL
protein	NULL
.	NULL

The	NULL
p300	NULL
protein	NULL
then	NULL
acts	NULL
as	NULL
a	NULL
bridge	NULL
between	NULL
Myb	NULL
and	NULL
the	NULL
adjacent	NULL
C/EBP	NULL
binding	NULL
site	NULL
,	NULL
as	NULL
p300	NULL
also	NULL
possesses	NULL
a	NULL
C/EBP	NULL
binding	NULL
domain	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
a	NULL
similar	NULL
mechanism	NULL
may	NULL
be	NULL
involved	NULL
between	NULL
the	NULL
ATF/CREB	NULL
and	NULL
C/EBP	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

In	NULL
this	NULL
scenario	NULL
,	NULL
CREB	NULL
dimers	NULL
bind	NULL
to	NULL
their	NULL
cognate	NULL
binding	NULL
site	NULL
and	NULL
recruit	NULL
CBP	NULL
,	NULL
the	NULL
major	NULL
coactivator	NULL
for	NULL
CREB	NULL
.	NULL

CBP	NULL
then	NULL
forms	NULL
a	NULL
bridge	NULL
between	NULL
the	NULL
two	NULL
binding	NULL
sites	NULL
and	NULL
leads	NULL
to	NULL
enhanced	NULL
binding	NULL
of	NULL
C/EBP	NULL
proteins	NULL
at	NULL
the	NULL
adjacent	NULL
C/EBP	NULL
site	NULL
I	NULL
,	NULL
due	NULL
to	NULL
interactions	NULL
between	NULL
C/EBP	NULL
and	NULL
the	NULL
E1A	NULL
domain	NULL
of	NULL
CBP	NULL
.	NULL

We	NULL
have	NULL
found	NULL
support	NULL
for	NULL
this	NULL
hypothesis	NULL
in	NULL
EMS	NULL
analyses	NULL
that	NULL
indicated	NULL
that	NULL
disruption	NULL
of	NULL
p300/	NULL
CBP	NULL
binding	NULL
(	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
antisera	NULL
reactive	NULL
for	NULL
CBP	NULL
and	NULL
p300	NULL
)	NULL
caused	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
C/EBP	NULL
proteins	NULL
recruited	NULL
to	NULL
Var1/3T	NULL
,	NULL
with	NULL
a	NULL
concomitant	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
of	NULL
CREB-1	NULL
recruited	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Future	NULL
studies	NULL
must	NULL
be	NULL
conducted	NULL
to	NULL
determine	NULL
if	NULL
ATF/CREB-enhanced	NULL
binding	NULL
of	NULL
C/EBP	NULL
is	NULL
dependent	NULL
on	NULL
CBP	NULL
or	NULL
p300	NULL
.	NULL

If	NULL
this	NULL
is	NULL
the	NULL
case	NULL
,	NULL
it	NULL
must	NULL
then	NULL
be	NULL
determined	NULL
whether	NULL
this	NULL
interaction	NULL
is	NULL
specific	NULL
for	NULL
C/EBP	NULL
B	NULL
,	NULL
or	NULL
if	NULL
it	NULL
is	NULL
applicable	NULL
to	NULL
all	NULL
C/EBP	NULL
family	NULL
members	NULL
.	NULL

We	NULL
have	NULL
been	NULL
unable	NULL
to	NULL
demonstrate	NULL
enhanced	NULL
binding	NULL
of	NULL
six-histidine-tagged	NULL
C/EBP	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
six-histidine-tagged	NULL
CREB-1	NULL
using	NULL
DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
believe	NULL
that	NULL
this	NULL
is	NULL
due	NULL
to	NULL
the	NULL
requirement	NULL
for	NULL
CBP/p300	NULL
as	NULL
a	NULL
molecular	NULL
bridge	NULL
leading	NULL
to	NULL
enhanced	NULL
C/EBP	NULL
binding	NULL
.	NULL

Future	NULL
studies	NULL
will	NULL
address	NULL
the	NULL
requirement	NULL
for	NULL
CBP/	NULL
Vor	NULL
.	NULL

75	NULL
,	NULL
2001	NULL
p300	NULL
in	NULL
ATF/CREB-dependent	NULL
enhancement	NULL
of	NULL
C/EBP	NULL
binding	NULL
and	NULL
the	NULL
necessary	NULL
phosphorylation	NULL
states	NULL
of	NULL
the	NULL
proteins	NULL
involved	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
that	NULL
CREB-1	NULL
binding	NULL
also	NULL
appeared	NULL
to	NULL
be	NULL
increased	NULL
with	NULL
enhanced	NULL
C/EBP	NULL
binding	NULL
.	NULL

When	NULL
the	NULL
high-affinity	NULL
Varl	NULL
ATF/CREB	NULL
site	NULL
was	NULL
immediately	NULL
adjacent	NULL
to	NULL
the	NULL
weakly	NULL
reactive	NULL
C/EBP	NULL
site	NULL
,	NULL
CREB	NULL
binding	NULL
was	NULL
threefold	NULL
higher	NULL
than	NULL
when	NULL
the	NULL
CREB	NULL
site	NULL
was	NULL
separated	NULL
from	NULL
the	NULL
C/EBP	NULL
site	NULL
by	NULL
10	NULL
nucleotides	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
CREB-1	NULL
enhances	NULL
C/EBP	NULL
binding	NULL
to	NULL
the	NULL
weakly	NULL
reactive	NULL
3T	NULL
site	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
enhances	NULL
CREB-1	NULL
binding	NULL
.	NULL

If	NULL
CBP	NULL
is	NULL
responsible	NULL
for	NULL
much	NULL
of	NULL
the	NULL
enhanced	NULL
C/EBP	NULL
binding	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
CREB-1	NULL
and	NULL
C/EBP	NULL
to	NULL
their	NULL
respective	NULL
domains	NULL
on	NULL
CBP	NULL
forms	NULL
a	NULL
much	NULL
more	NULL
stable	NULL
complex	NULL
than	NULL
does	NULL
CREB-1	NULL
binding	NULL
to	NULL
CBP	NULL
alone	NULL
.	NULL

Future	NULL
studies	NULL
will	NULL
examine	NULL
this	NULL
hypothesis	NULL
in	NULL
detail	NULL
.	NULL

However	NULL
,	NULL
enhancement	NULL
of	NULL
C/EBP	NULL
binding	NULL
by	NULL
CREB-1	NULL
appeared	NULL
limited	NULL
to	NULL
instances	NULL
when	NULL
highly	NULL
reactive	NULL
ATF/CREB	NULL
binding	NULL
sites	NULL
were	NULL
adjacent	NULL
to	NULL
a	NULL
weakly	NULL
reactive	NULL
C/EBP	NULL
site	NULL
I	NULL
.	NULL

When	NULL
a	NULL
highly	NULL
reactive	NULL
6G	NULL
C/EBP	NULL
site	NULL
I	NULL
was	NULL
placed	NULL
adjacent	NULL
to	NULL
the	NULL
ATF/CREB	NULL
binding	NULL
site	NULL
variants	NULL
,	NULL
strong	NULL
C/EBP	NULL
binding	NULL
was	NULL
observed	NULL
above	NULL
the	NULL
enhanced	NULL
recruitment	NULL
to	NULL
the	NULL
weak	NULL
3T	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
while	NULL
CREB	NULL
binding	NULL
can	NULL
lead	NULL
to	NULL
enhanced	NULL
C/EBP	NULL
recruitment	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
protein	NULL
binding	NULL
were	NULL
still	NULL
lower	NULL
than	NULL
the	NULL
amounts	NULL
of	NULL
protein	NULL
recruited	NULL
to	NULL
a	NULL
very	NULL
strong	NULL
C/EBP	NULL
site	NULL
I.	NULL
Interestingly	NULL
,	NULL
CREB-1	NULL
binding	NULL
to	NULL
a	NULL
weak	NULL
ATF/CREB	NULL
site	NULL
can	NULL
also	NULL
be	NULL
enhanced	NULL
by	NULL
C/EBP	NULL
binding	NULL
to	NULL
a	NULL
strong	NULL
C/EBP	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
the	NULL
recruitment	NULL
of	NULL
proteins	NULL
to	NULL
these	NULL
two	NULL
sites	NULL
is	NULL
highly	NULL
dependent	NULL
on	NULL
sequence	NULL
variation	NULL
at	NULL
both	NULL
sites	NULL
and	NULL
that	NULL
binding	NULL
of	NULL
proteins	NULL
from	NULL
these	NULL
two	NULL
families	NULL
of	NULL
proteins	NULL
is	NULL
highly	NULL
interrelated	NULL
and	NULL
interdependent	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
complex	NULL
interactions	NULL
appear	NULL
to	NULL
occur	NULL
between	NULL
ATF/CREB	NULL
and	NULL
C/EBP	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

C/EBP	NULL
and	NULL
CREB	NULL
dimers	NULL
impact	NULL
one	NULL
another	NULL
in	NULL
a	NULL
manner	NULL
dependent	NULL
on	NULL
the	NULL
strength	NULL
of	NULL
the	NULL
two	NULL
binding	NULL
sites	NULL
,	NULL
which	NULL
is	NULL
governed	NULL
by	NULL
sequence	NULL
variation	NULL
at	NULL
each	NULL
site	NULL
.	NULL

Given	NULL
the	NULL
integral	NULL
role	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Sp	NULL
family	NULL
members	NULL
play	NULL
with	NULL
respect	NULL
to	NULL
HIV-1	NULL
replication	NULL
and	NULL
the	NULL
immediate	NULL
proximity	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Sp	NULL
binding	NULL
sites	NULL
to	NULL
the	NULL
ATF/CREB	NULL
and	NULL
C/EBP	NULL
sites	NULL
,	NULL
an	NULL
important	NULL
focus	NULL
of	NULL
future	NULL
studies	NULL
will	NULL
be	NULL
to	NULL
determine	NULL
the	NULL
impact	NULL
of	NULL
NF-kB	NULL
and	NULL
Sp	NULL
binding	NULL
on	NULL
ATF/CREB	NULL
and	NULL
C/EBP	NULL
within	NULL
the	NULL
context	NULL
of	NULL
replication	NULL
within	NULL
cells	NULL
of	NULL
the	NULL
monocyte/	NULL
macrophage	NULL
lineage	NULL
.	NULL

Future	NULL
studies	NULL
will	NULL
continue	NULL
to	NULL
examine	NULL
the	NULL
intricate	NULL
biochemical	NULL
interactions	NULL
between	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
ATF/CREB	NULL
,	NULL
and	NULL
C/EBP	NULL
transcription	NULL
families	NULL
,	NULL
the	NULL
coactiva-tors	NULL
CBP	NULL
and	NULL
p300	NULL
,	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
the	NULL
involved	NULL
proteins	NULL
,	NULL
and	NULL
their	NULL
role	NULL
in	NULL
regulating	NULL
HIV-1	NULL
LTR-directed	NULL
transcription	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocyte/macrophage	NULL
lineage	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
This	NULL
study	NULL
was	NULL
performed	NULL
in	NULL
the	NULL
laboratory	NULL
of	NULL
Brian	NULL
Wigdahl	NULL
and	NULL
was	NULL
supported	NULL
by	NULL
Public	NULL
Health	NULL
Service	NULL
grant	NULL
NS	NULL
32092	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Abrink	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
E.	NULL
Gobl	NULL
,	NULL
R.	NULL
Huang	NULL
,	NULL
K.	NULL
Nilsson	NULL
,	NULL
and	NULL
L.	NULL
Hellman	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
cell	NULL
lines	NULL
U-937	NULL
,	NULL
THP-1	NULL
and	NULL
Mono	NULL
Mac	NULL
6	NULL
represent	NULL
relatively	NULL
immature	NULL
cells	NULL
of	NULL
the	NULL
monocyte-macrophage	NULL
cell	NULL
lineage	NULL
Leukemia	NULL
8:1579-1584	NULL
.	NULL

2	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Isshiki	NULL
,	NULL
T.	NULL
Sugita	NULL
,	NULL
O.	NULL
Tanabe	NULL
,	NULL
S.	NULL
Kinoshita	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
T.	NULL
Nakajima	NULL
,	NULL
T.	NULL
Hirano	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
nuclear	NULL
factor	NULL
for	NULL
IL-6	NULL
expression	NULL
(	NULL
NF-IL6	NULL
)	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
C/EBP	NULL
family	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:1897-1906	NULL
.	NULL

3	NULL
.	NULL

Altschul	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
T.	NULL
L.	NULL
Madden	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Schaffer	NULL
,	NULL
J.	NULL
Zhang	NULL
,	NULL
Z.	NULL
Zhang	NULL
,	NULL
W.	NULL
Miller	NULL
,	NULL
C/EBP-CREB-1	NULL
INTERACTION	NULL
REGULATES	NULL
HIV-1	NULL
TRANSCRIPTION	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

1855	NULL
and	NULL
D.	NULL
J.	NULL
Lipman	NULL
.	NULL

1997	NULL
.	NULL

Gapped	NULL
BLAST	NULL
and	NULL
PSI-BLAST	NULL
:	NULL
a	NULL
new	NULL
generation	NULL
of	NULL
protein	NULL
database	NULL
search	NULL
programs	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

25:3389-3402.	NULL
.	NULL

Birkenmeier	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
B.	NULL
Gwynn	NULL
,	NULL
S.	NULL
Howard	NULL
,	NULL
J.	NULL
Jerry	NULL
,	NULL
J.	NULL
I.	NULL
Gordon	NULL
,	NULL
W.	NULL
H.	NULL
Landschulz	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1989	NULL
.	NULL

Tissue-specific	NULL
expression	NULL
,	NULL
developmental	NULL
regulation	NULL
,	NULL
and	NULL
genetic	NULL
mapping	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
CCAAT/	NULL
enhancer	NULL
binding	NULL
protein	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1146-1156.	NULL
.	NULL

Bisotto	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Minorgan	NULL
,	NULL
and	NULL
R.	NULL
P.	NULL
Rehfuss	NULL
.	NULL

1996	NULL
.	NULL

Identification	NULL
and	NULL
char	NULL
acterization	NULL
of	NULL
a	NULL
novel	NULL
transcriptional	NULL
activation	NULL
domain	NULL
in	NULL
the	NULL
CREB-bind-ing	NULL
protein	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:17746-17750.	NULL
.	NULL

Bretz	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
S.	NULL
C.	NULL
Williams	NULL
,	NULL
M.	NULL
Baer	NULL
,	NULL
P.	NULL
F.	NULL
Johnson	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Schwartz	NULL
.	NULL

1994	NULL
.	NULL

C/EBP	NULL
related	NULL
protein	NULL
2	NULL
confers	NULL
lipopolysaccharide-inducible	NULL
expression	NULL
of	NULL
interleukin	NULL
6	NULL
and	NULL
monocyte	NULL
chemoattractant	NULL
protein	NULL
1	NULL
to	NULL
a	NULL
lympho-blastic	NULL
cell	NULL
line	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:7306-7310.	NULL
.	NULL

Bronstein	NULL
,	NULL
L.	NULL
,	NULL
J.	NULL
C.	NULL
Voyta	NULL
,	NULL
O.	NULL
J.	NULL
Murphy	NULL
,	NULL
L.	NULL
Bresnick	NULL
,	NULL
and	NULL
L.	NULL
J.	NULL
Kricka	NULL
.	NULL

1992	NULL
.	NULL

Improved	NULL
chemiluminescent	NULL
western	NULL
blotting	NULL
procedure	NULL
.	NULL

BioTechniques	NULL
12	NULL
;	NULL
748-753.	NULL
.	NULL

Burnette	NULL
,	NULL
W.	NULL
N.	NULL
1981	NULL
.	NULL

``	NULL
Western	NULL
blotting	NULL
``	NULL
:	NULL
electrophoretic	NULL
transfer	NULL
of	NULL
pro	NULL
teins	NULL
from	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gels	NULL
to	NULL
unmodified	NULL
nitro-cellulose	NULL
and	NULL
radiographic	NULL
detection	NULL
with	NULL
antibody	NULL
and	NULL
radioiodinated	NULL
protein	NULL
A.	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

112:195-203.	NULL
.	NULL

Chang	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
T.	NULL
T.	NULL
Chen	NULL
,	NULL
H.	NULL
Y.	NULL
Lei	NULL
,	NULL
D.	NULL
S.	NULL
Chen	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Lee	NULL
.	NULL

1990	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
,	NULL
AGP/EBP	NULL
,	NULL
that	NULL
belongs	NULL
to	NULL
members	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:6642-6653	NULL
.	NULL

Chrivia	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
R.	NULL
P.	NULL
Kwok	NULL
,	NULL
N.	NULL
Lamb	NULL
,	NULL
M.	NULL
Hagiwara	NULL
,	NULL
M.	NULL
R.	NULL
Montminy	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Goodman	NULL
.	NULL

1993	NULL
.	NULL

Phosphorylated	NULL
CREB	NULL
binds	NULL
specifically	NULL
to	NULL
the	NULL
nuclear	NULL
protein	NULL
CBP	NULL
.	NULL

Nature	NULL
365:855-859	NULL
.	NULL

Dallas	NULL
,	NULL
P.	NULL
B.	NULL
,	NULL
P.	NULL
Yaciuk	NULL
,	NULL
and	NULL
E.	NULL
Moran	NULL
.	NULL

1997	NULL
.	NULL

Characterization	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
raised	NULL
against	NULL
p300	NULL
:	NULL
both	NULL
p300	NULL
and	NULL
CBP	NULL
are	NULL
present	NULL
in	NULL
intra-cellular	NULL
TBP	NULL
complexes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:1726-1731	NULL
.	NULL

Descombes	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Chojkier	NULL
,	NULL
S.	NULL
Lichtsteiner	NULL
,	NULL
E.	NULL
Falvey	NULL
,	NULL
and	NULL
U.	NULL
Schibler	NULL
.	NULL

1990	NULL
.	NULL

LAP	NULL
,	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
C/EBP	NULL
gene	NULL
family	NULL
,	NULL
encodes	NULL
a	NULL
liver-enriched	NULL
transcriptional	NULL
activator	NULL
protein	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

41541-1551	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebovitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

Garcia	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
F.	NULL
K.	NULL
Wu	NULL
,	NULL
R.	NULL
Mitsuyasu	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Gaynor	NULL
.	NULL

1987	NULL
.	NULL

Interactions	NULL
of	NULL
cellular	NULL
proteins	NULL
involved	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

6:3761-3770	NULL
.	NULL

Gillespie	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
and	NULL
A.	NULL
J.	NULL
Hudspeth	NULL
.	NULL

1991	NULL
.	NULL

Chemiluminescence	NULL
detection	NULL
of	NULL
proteins	NULL
from	NULL
single	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:2563-2567	NULL
.	NULL

Haas	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
M.	NULL
Strobel	NULL
,	NULL
A.	NULL
Leutz	NULL
,	NULL
P.	NULL
Wendelgass	NULL
,	NULL
C.	NULL
Muller	NULL
,	NULL
E.	NULL
Sterneck	NULL
,	NULL
G.	NULL
Ricthmuller	NULL
,	NULL
and	NULL
H.	NULL
W.	NULL
Ziegler-Heitbrock	NULL
.	NULL

1992	NULL
.	NULL

Constitutive	NULL
monocyte-restricted	NULL
activity	NULL
of	NULL
NF-M	NULL
,	NULL
a	NULL
nuclear	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
a	NULL
C/EBP	NULL
motif	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:237-243	NULL
.	NULL

Henderson	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
and	NULL
K.	NULL
L.	NULL
Calame	NULL
.	NULL

1997	NULL
.	NULL

CCAAT/enhancer	NULL
binding	NULL
protein	NULL
(	NULL
C/EBP	NULL
)	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
HIV-1	NULL
replication	NULL
in	NULL
primary	NULL
macrophages	NULL
but	NULL
not	NULL
CD4	NULL
(	NULL
+	NULL
)	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:8714-8719	NULL
.	NULL

Henderson	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
R.	NULL
I	NULL
Connor	NULL
,	NULL
and	NULL
K.	NULL
L.	NULL
Calame	NULL
.	NULL

1996	NULL
.	NULL

C/EBP	NULL
activators	NULL
are	NULL
required	NULL
for	NULL
HIV-1	NULL
replication	NULL
and	NULL
proviral	NULL
induction	NULL
in	NULL
monocytic	NULL
cell	NULL
lines	NULL
.	NULL

Immunity	NULL
5:91-101	NULL
.	NULL

Henderson	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
X.	NULL
Zou	NULL
,	NULL
and	NULL
K.	NULL
L.	NULL
Calame	NULL
.	NULL

1995	NULL
.	NULL

C/EBP	NULL
proteins	NULL
activate	NULL
transcription	NULL
from	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
in	NULL
macrophages/monocytes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:5337-5344	NULL
.	NULL

Kee	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
J.	NULL
Arias	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Montminy	NULL
.	NULL

1996	NULL
.	NULL

Adaptor-mediated	NULL
recruitment	NULL
of	NULL
RNA	NULL
polymerase	NULL
II	NULL
to	NULL
a	NULL
signal-dependent	NULL
activator	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:2373-2375	NULL
.	NULL

Kinoshita	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Akira	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
member	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
,	NULL
NF-IL6	NULL
beta	NULL
,	NULL
forms	NULL
a	NULL
heterodimer	NULL
and	NULL
transcriptionally	NULL
synergizes	NULL
with	NULL
NF-IL6	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:1473-1476	NULL
.	NULL

Krebs	NULL
,	NULL
F.	NULL
C.	NULL
,	NULL
M.	NULL
M.	NULL
Goodenow	NULL
,	NULL
and	NULL
B.	NULL
Wigdahl	NULL
.	NULL

1997	NULL
.	NULL

Ncuroglial	NULL
ATF/	NULL
CREB	NULL
factors	NULL
interact	NULL
with	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

J.	NULL
Neurovirol	NULL
.	NULL

3	NULL
(	NULL
Suppl	NULL
.	NULL

1	NULL
)	NULL
:	NULL
$	NULL
28-S32	NULL
.	NULL

Krebs	NULL
,	NULL
F.	NULL
C.	NULL
,	NULL
D.	NULL
Mebhrens	NULL
,	NULL
S.	NULL
Pomeroy	NULL
,	NULL
M.	NULL
M.	NULL
Goodenow	NULL
,	NULL
and	NULL
B.	NULL
Wigdahl	NULL
.	NULL

1998	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
quasispe-cies	NULL
differ	NULL
in	NULL
basal	NULL
transcription	NULL
and	NULL
nuclear	NULL
factor	NULL
recruitment	NULL
in	NULL
human	NULL
glial	NULL
cells	NULL
and	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Biomed	NULL
.	NULL

Sci	NULL
.	NULL

5:31-44	NULL
.	NULL

Krebs	NULL
,	NULL
F.	NULL
C.	NULL
,	NULL
H.	NULL
Ross	NULL
,	NULL
J.	NULL
McAllister	NULL
,	NULL
and	NULL
B.	NULL
Wigdahl	NULL
.	NULL

2000	NULL
.	NULL

HIV-associated	NULL
neurologic	NULL
dysfunction	NULL
.	NULL

Adv	NULL
.	NULL

Pharmacol	NULL
.	NULL

49:315-385	NULL
.	NULL

Kwok	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
J.	NULL
R.	NULL
Lundblad	NULL
,	NULL
J.	NULL
C.	NULL
Chrivia	NULL
,	NULL
J.	NULL
P.	NULL
Richards	NULL
,	NULL
H.	NULL
P.	NULL
Bachinger	NULL
,	NULL
R.	NULL
G.	NULL
Brennan	NULL
,	NULL
S.	NULL
G.	NULL
Roberts	NULL
,	NULL
M.	NULL
R.	NULL
Green	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Goodman	NULL
.	NULL

1994	NULL
.	NULL

Nuclear	NULL
protein	NULL
CBP	NULL
is	NULL
a	NULL
coactivator	NULL
for	NULL
the	NULL
transcription	NULL
factor	NULL
CREB	NULL
.	NULL

Nature	NULL
370:223-226	NULL
.	NULL

Landschulz	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
P.	NULL
F.	NULL
Johnson	NULL
,	NULL
E.	NULL
Y.	NULL
Adashi	NULL
,	NULL
B.	NULL
J.	NULL
Graves	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1988	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
recombinant	NULL
copy	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
C/EBP	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

2786-800	NULL
.	NULL

(	NULL
Erratum	NULL
,	NULL
8:1131	NULL
,	NULL
1994	NULL
.	NULL
)	NULL

Matsusaka	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Fujikawa	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
N.	NULL
Mukaida	NULL
,	NULL
K.	NULL
Matsushima	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
and	NULL
S.	NULL
Akira	NULL
.	NULL

1993	NULL
.	NULL

Transcription	NULL
factors	NULL
NF-IL6	NULL
and	NULL
NF-kappa	NULL
B	NULL
synergistically	NULL
activate	NULL
transcription	NULL
of	NULL
the	NULL
inflammatory	NULL
cytokines	NULL
,	NULL
interleukin	NULL
6	NULL
and	NULL
interleukin	NULL
8	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:10193-10197	NULL
.	NULL

Maxam	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
and	NULL
W.	NULL
Gilbert	NULL
.	NULL

1980	NULL
.	NULL

Sequencing	NULL
end-labeled	NULL
DNA	NULL
with	NULL
base-specific	NULL
chemical	NULL
cleavages	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

65:499-560	NULL
.	NULL

Mink	NULL
,	NULL
S.	NULL
,	NULL
B.	NULL
Haenig	NULL
,	NULL
and	NULL
K.	NULL
H.	NULL
Klempnauner	NULL
.	NULL

1997	NULL
.	NULL

Interaction	NULL
and	NULL
func-	NULL
1856	NULL
30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

ROSS	NULL
ET	NULL
AL	NULL
.	NULL

tional	NULL
collaboration	NULL
of	NULL
p300	NULL
and	NULL
C/EBPRB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:6609-6617	NULL
.	NULL

Natsuka	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Akira	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
S.	NULL
Hashimoto	NULL
,	NULL
T.	NULL
Sugita	NULL
,	NULL
H.	NULL
Isshiki	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1992	NULL
.	NULL

Macrophage	NULL
differentiation-specific	NULL
expression	NULL
of	NULL
NF-IL6	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
for	NULL
interleukin-6	NULL
.	NULL

Blood	NULL
79:460-466	NULL
.	NULL

Ossipow	NULL
,	NULL
V.	NULL
,	NULL
P.	NULL
D	NULL
bes	NULL
,	NULL
and	NULL
U.	NULL
Schibler	NULL
.	NULL

1993	NULL
.	NULL

CCAAT/enhancer-binding	NULL
protein	NULL
mRNA	NULL
is	NULL
translated	NULL
into	NULL
multiple	NULL
proteins	NULL
with	NULL
different	NULL
transcription	NULL
activation	NULL
potentials	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:8219-8223	NULL
.	NULL

Pope	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
A.	NULL
Leutz	NULL
,	NULL
and	NULL
S.	NULL
A.	NULL
Ness	NULL
.	NULL

1994	NULL
.	NULL

C/EBP	NULL
beta	NULL
regulation	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
gene	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Investig	NULL
.	NULL

94:1449-1455	NULL
.	NULL

Roesler	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
S.	NULL
M.	NULL
Crosson	NULL
,	NULL
C.	NULL
Vinson	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
MecFie	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
alpha-isoform	NULL
of	NULL
the	NULL
CCAAT/enhancer-binding	NULL
protein	NULL
is	NULL
required	NULL
for	NULL
mediating	NULL
cAMP	NULL
responsiveness	NULL
of	NULL
the	NULL
phosphoenolpyruvate	NULL
carboxykinase	NULL
promoter	NULL
in	NULL
hepatoma	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:8068-8074	NULL
.	NULL

Sandhu	NULL
,	NULL
G.	NULL
S.	NULL
,	NULL
B.	NULL
W.	NULL
Eckloff	NULL
,	NULL
and	NULL
B.	NULL
C.	NULL
Kline	NULL
.	NULL

1991	NULL
.	NULL

Chemiluminescent	NULL
substrates	NULL
increase	NULL
sensitivity	NULL
of	NULL
antigen	NULL
detection	NULL
in	NULL
western	NULL
blots	NULL
.	NULL

BioTechniques	NULL
11:14-16	NULL
.	NULL

Shuman	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
J.	NULL
Cheong	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Coligan	NULL
.	NULL

1997	NULL
.	NULL

ATF-2	NULL
and	NULL
C/EBPalpha	NULL
can	NULL
form	NULL
a	NULL
heterodimeric	NULL
DNA	NULL
binding	NULL
complex	NULL
in	NULL
vitro	NULL
.	NULL

Functional	NULL
implications	NULL
for	NULL
transcriptional	NULL
regulation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:12793-12800	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

Distinct	NULL
mechanisms	NULL
for	NULL
regulation	NULL
of	NULL
the	NULL
interleukin-8	NULL
gene	NULL
involve	NULL
synergism	NULL
and	NULL
cooperativity	NULL
between	NULL
C/EBP	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:7191-7198	NULL
.	NULL

Swart	NULL
,	NULL
G.	NULL
W.	NULL
,	NULL
J.	NULL
J.	NULL
van	NULL
Groningen	NULL
,	NULL
F.	NULL
van	NULL
Ruissen	NULL
,	NULL
M.	NULL
Bergers	NULL
,	NULL
and	NULL
J.	NULL
Schalkwijk	NULL
.	NULL

1997	NULL
.	NULL

Transcription	NULL
factor	NULL
C/EBPalpha	NULL
:	NULL
novel	NULL
sites	NULL
of	NULL
expression	NULL
and	NULL
cloning	NULL
of	NULL
the	NULL
human	NULL
gene	NULL
.	NULL

Biol	NULL
.	NULL

Chem	NULL
.	NULL

378:373-379	NULL
.	NULL

Tanaka	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Akira	NULL
,	NULL
K.	NULL
Yoshida	NULL
,	NULL
M.	NULL
Umemoto	NULL
,	NULL
Y.	NULL
Yoneda	NULL
,	NULL
N.	NULL
Shirafuji	NULL
,	NULL
H.	NULL
39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

J.	NULL
Virou	NULL
.	NULL

Fujiwara	NULL
,	NULL
S.	NULL
Suematsu	NULL
,	NULL
N.	NULL
Yoshida	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1995	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
discloses	NULL
its	NULL
essential	NULL
role	NULL
in	NULL
bacteria	NULL
killing	NULL
and	NULL
tumor	NULL
cytotoxicity	NULL
by	NULL
macrophages	NULL
.	NULL

Cell	NULL
80:353-361	NULL
.	NULL

Tesmer	NULL
,	NULL
V.	NULL
M.	NULL
,	NULL
A.	NULL
Rajadhyaksha	NULL
,	NULL
J.	NULL
Babin	NULL
,	NULL
and	NULL
M.	NULL
Bina	NULL
.	NULL

1993	NULL
.	NULL

NF-IL6-mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:7298-7302	NULL
.	NULL

Thomassin	NULL
,	NULL
H.	NULL
,	NULL
D.	NULL
Hamel	NULL
,	NULL
D.	NULL
Bernier	NULL
,	NULL
M.	NULL
Guertin	NULL
,	NULL
and	NULL
L.	NULL
Belanger	NULL
.	NULL

1992	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
two	NULL
C/EBP-related	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
promoter	NULL
and	NULL
the	NULL
enhancer	NULL
of	NULL
the	NULL
alpha	NULL
1-fetoprotein	NULL
gene	NULL
.	NULL

Further	NULL
analysis	NULL
of	NULL
C/EBP	NULL
beta	NULL
and	NULL
C/EBP	NULL
gamma	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:3091-3098	NULL
.	NULL

Vallejo	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
Ron	NULL
,	NULL
C.	NULL
P.	NULL
Miller	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Habener	NULL
.	NULL

1993	NULL
.	NULL

C/ATF	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
activating	NULL
transcription	NULL
factor	NULL
family	NULL
of	NULL
DNA-	NULL
binding	NULL
proteins	NULL
,	NULL
dimer-izes	NULL
with	NULL
CAAT/enhancer-binding	NULL
proteins	NULL
and	NULL
directs	NULL
their	NULL
binding	NULL
to	NULL
cAMP	NULL
response	NULL
elements	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:4679-4683	NULL
.	NULL

Williams	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
C.	NULL
A.	NULL
Cantwell	NULL
,	NULL
and	NULL
P.	NULL
F.	NULL
Johnson	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
family	NULL
of	NULL
C/EBP	NULL
-related	NULL
proteins	NULL
capable	NULL
of	NULL
forming	NULL
covalently	NULL
linked	NULL
leucine	NULL
zipper	NULL
dimers	NULL
in	NULL
vitro	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:1553-1567	NULL
.	NULL

Wu	NULL
,	NULL
F.	NULL
,	NULL
J.	NULL
Garcia	NULL
,	NULL
R.	NULL
Mitsuyasu	NULL
,	NULL
and	NULL
R.	NULL
Gaynor	NULL
.	NULL

1988	NULL
.	NULL

Alterations	NULL
in	NULL
binding	NULL
characteristics	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
factor	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

62:218-225	NULL
.	NULL

Yamanaka	NULL
,	NULL
R.	NULL
,	NULL
G.	NULL
D.	NULL
Kim	NULL
,	NULL
H.	NULL
S.	NULL
Radomska	NULL
,	NULL
J.	NULL
Lekstrom-Himes	NULL
,	NULL
L.	NULL
T.	NULL
Smith	NULL
,	NULL
P.	NULL
Antonson	NULL
,	NULL
D.	NULL
G.	NULL
Tenen	NULL
,	NULL
and	NULL
K.	NULL
G.	NULL
Xanthopoulos	NULL
.	NULL

1997	NULL
.	NULL

CCAAT/enhancer	NULL
binding	NULL
protein	NULL
epsilon	NULL
is	NULL
preferentially	NULL
up-regulated	NULL
during	NULL
granulocytic	NULL
differentiation	NULL
and	NULL
its	NULL
functional	NULL
versatility	NULL
is	NULL
determined	NULL
by	NULL
alternative	NULL
use	NULL
of	NULL
promoters	NULL
and	NULL
differential	NULL
splicing	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:6462-6467	NULL
.	NULL

